W&M ScholarWorks
Dissertations, Theses, and Masters Projects

Theses, Dissertations, & Master Projects

1996

Expression of the xenobiotic transporter P-glycoprotein in the
mummichog (Fundulus heteroclitus)
Peter S. Cooper
College of William and Mary - Virginia Institute of Marine Science

Follow this and additional works at: https://scholarworks.wm.edu/etd
Part of the Environmental Sciences Commons, Molecular Biology Commons, and the Toxicology
Commons

Recommended Citation
Cooper, Peter S., "Expression of the xenobiotic transporter P-glycoprotein in the mummichog (Fundulus
heteroclitus)" (1996). Dissertations, Theses, and Masters Projects. Paper 1539616619.
https://dx.doi.org/doi:10.25773/v5-afeh-j139

This Dissertation is brought to you for free and open access by the Theses, Dissertations, & Master Projects at W&M
ScholarWorks. It has been accepted for inclusion in Dissertations, Theses, and Masters Projects by an authorized
administrator of W&M ScholarWorks. For more information, please contact scholarworks@wm.edu.

INFORMATION TO USERS

This manuscript has been reproduced from the microfilm master. UMI
films the text directly from the original or copy submitted. Thus, some
thesis and dissertation copies are in typewriter free, while others may be
from any type o f computer printer.
The quality o f this reproduction is dependent upon the quality of the
copy submitted.

Broken or indistinct print, colored or poor quality

illustrations and photographs, print bleedthrough, substandard margins,
and improper alignment can adversely afreet reproduction.
In the unlikely event that the author did not send UMI a complete
manuscript and there are missing pages, these will be noted.

Also, if

unauthorized copyright material had to be removed, a note will indicate
the deletion.
Oversize materials (e.g., maps, drawings, charts) are reproduced by
sectioning the original, beginning at the upper left-hand comer and
continuing from left to right in equal sections with small overlaps. Each
original is also photographed in one exposure and is included in reduced
form at the back o f the book.
Photographs included in the original manuscript have been reproduced
xerographically in this copy.

Higher quality 6” x 9” black and white

photographic prints are available for any photographs or illustrations
appearing in this copy for an additional charge. Contact UMI directly to
order.

UMI
A Bell & Howell Information Company
300 North Zeeb Road, Ann Arbor MI 48106-1346 USA
313/761-4700 800/521-0600

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

EXPRESSION OF THE XENOBIOTIC TRANSPORTER P-GLYCOPROTEIN
IN THE MUMMICHOG {FUNDULUS HETEROCLITUS)

A Dissertation

Presented to
The Faculty of the School o f Marine Science
The College of William and Mary in Virginia

In Partial Fulfillment of the Requirements for the Degree of
Doctor of Philosophy

by
Peter S. Cooper
1996

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

UMI Number: 9709101

UMI Microform 9709101
Copyright 1996, by UMI Company. All rights reserved.
This microform edition is protected against unauthorized
copying under Title 17, United States Code.

UMI

300 North Zeeb Road
Ann Arbor, MI 48103

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

APPROVAL SHEET
This dissertation is submitted in partial fulfillment of
the requirements for the degree of
Doctor o f Philosophy

I/ iA h
S - Ce
Peter S. Coop©

in

Approved, November 1996

Peter A. Van Veld, PhD., Chairman

rU—

John E. Graves, PhD.

—
✓

W oB& ng3£ VogelbiS, PhD.

Morris H. Roberts, Jr., PhD

Margaret S. Saha, PhD.

Wil^am^/Wasilenko, PhD.
EasternVnginia Medical School

ii

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

Dedication
I dedicate this work to my loving wife Jeanette and my two beautiful children Pearce and
Charlotte with thanks for their patience, support and love throughout.

111

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

TABLE OF CONTENTS
ACKNOWLEDGEMENTS
LIST OF TABLES
LIST OF FIGURES
ABSTRACT
CHAPTER I - GENERAL INTRODUCTION
CHAPTER II - IMMUNOHISTOCHEMICAL AND IMMUNOBLOT
DETECTION OF P-GLYCOPROTEIN IN NORMAL AND
NEOPLASTIC FISH LIVER
INTRODUCTION
MATERIALS REQUIRED
Pgp Immunohistochemistry
Immunoblotting
METHODS
Method I: Pgp Immunohistochemistry
Method II: Immunoblot Analysis of Tissue Extracts
RESULTS AND DISCUSSION
Immunohistochemistry
Immunoblots
Advantages o f Combined Immunochemical Methods
Further Applications

iv

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

CHAPTER III - INCREASED EXPRESSION OF P-GLYCOPROTEIN
IN LIVER AND LIVER TUMORS OF MUMMICHOG (FUNDULUS
HETEROCLITUS) INHABITING A CREOSOTE-CONTAMINATED
ENVIRONMENT

61

INTRODUCTION

62

MATERIALS AND METHODS

63

Collection of Mummichog livers

63

Preparation o f Liver Extracts

64

Immunoblotting o f Mummichog Liver Extracts with the
monoclonal antibodies C219, JSB1 and C494

65

Estimation of Relative Pgp Content in Mummichog Liver Extracts

66

Laboratory Exposure of Mummichog to 3-Methylcholanthrene

66

Immunodetection of cytochrome P4501A in extracts of 3-MC
treated mummichog liver

67

Immunohistochemical staining o f mummichog liver and liver lesions

68

RESULTS

69

Immunoblot Detection of Pgp in Normal Liver

69

Immunoblot Measurement of Increased Expression of Pgp in
Livers o f Mummichog from a Creosote Contaminated Site

70

Immunoblot Assay of Pgp Expression Following I.P.
Administration o f 3-MC

70

Immunohistochemical Detection o f Pgp Expression and
Overexpression in Mummichog Hepatic Neoplasms

70

DISCUSSION

72
v

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

CHAPTER IV - EXPRESSION OF A SISTER GENE TO P-GLYCOPROTEIN
(SPGP) THE LIVER OF THE MUMMICHOG (FUNDULUS HETEROCLITUS)

99

INTRODUCTION

100

MATERIALS AND METHODS

102

Fish Collection and Tissue Preparation

102

RNA Isolation

102

First Strand cDNA Synthesis

104

General Conditions for Amplification of First Strand cDNA

105

Cloning and Sequencing of PCR Products

106

Specific Amplification Conditions for spgp cDNA Fragments

107

Sequence Analysis

111

Immunoblot Detection of P-glycoprotein Gene Family
Member Expression

113

Northern Blot detection of Mummichog spgp Expression

115

RESULTS

116

Amplification o f Expressed Pgp-related Sequences from
Mummichog Liver

116

Sequence o f Mumichog Pgp Homolog

117

Sequence Analysis

119

Relationships Among Pgp Sequences

120

Detection of Expression of Pgp Gene Family Members
in Mummichog

122

DISCUSSION

122

vi

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

CHAPTER V - PARTIAL SEQUENCE OF A MULTIDRUG RESISTANCE
TRANSPORTER (MDR) cDNA FROM THE MUMMICHOG {FUNDULUS
HETEROCLITUS)

159

INTRODUCTION

160

MATERIALS AND METHODS

161

Southern Blot Identification o f mdr Specific Amplification Products

162

Amplification o f the 5’ ATP Binding Region of Mummichog
mdrcDNA

163

Amplification o f Segments Downstream o f the ATP Binding
Fold of the Mummichog mdr cDNA

163

Sequence Analysis

165

RESULTS

167

Amplification and Analysis of the 5’ ATP Binding Region
of Mummichog mdr cDNA

167

Amplification and Analysis of the cDNA Sequences Downstream
of the 5’ ATP Binding Domain of Mummichog mdr

167

Relationships Among P-glycoprotein Sequences

171

DISCUSSION

171

LITERATURE CITED

195

VITA

208

vii

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

ACKNOWLEDGMENTS
I would like to thank my major professor Dr. Peter Van Veld for introducing me
to the topic o f P-glycoproteins and xenobiotic resistance and for all of his assistance,
helpful discussions and guidance. I am grateful to Dr. Wolfgang Vogelbein for sharing
his expert knowledge o f pathology and mummichog liver tumors with me and for his help
with the histopathology work. I am forever in the debt o f Dr. Kimberly Reece for the
generous gift o f her time and expertise in molecular biology. Without her help and
friendship the molecular biology aspects of this dissertation would not have been
possible. Thanks to Dr. Michael Unger for useful and interesting discussions. I am
indebted to Dr. Mark Siddal and David Carlini for their help with tree building and
computers. Thanks to all who generously allowed me to use their laboratories and
equipment during this project including Dr. Gene Burresson, Dr. Mohammed Faisal, Dr.
Steven Kattaari, and most especially Dr. John Graves who let me become a virtual
member o f his laboratory during this project. I thank the other members o f my
committee, Dr. Mory Roberts, Jr., Dr. William Wasilenko and Dr. Margaret Saha for their
time and advice. I am grateful for all the technical and moral support I have received from
everyone in Byrd and Davis Halls at VIMS including -but not limited to- Pat Blake, Ellen
Harvey, Phyllis Howard, John Klemmer, Dr. Chris Ottinger, Dr. Jerome La Peyre, Jan
McDowell, Patrice Mason, Barb Rutan, Doris Shafhauser, Shirley Sterling, George
Vadas, Donna Westbrook and David Zwemer. Thanks to all the graduate students who
endured with me and offered advice and support. O f these I would most especially like to
thank Susan Armknecht, Laura Bankey, Vince Buonaccorsi, David Carlini, Maria
viii

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

Cochran, Kitty Gallagher, Tom Orrell, Dan Scoles, David Shapiro, and Cindi Williams.
Last but not least, I would like to thank my wife, Jeanette and my children, Pearce and
Charlotte, for putting up with this for the past five years.

ix

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

LIST OF TABLES
Page

Table
1.

Nomenclature and classification of mammalian mdr genes

24

2.

Relative content of Pgp antigens in liver extracts of mummichog from
the cresote contaminated site (Atlantic Wood) and an uncontaminated
reference site (King Creek) determined by densitometric analysis of
immunoblots

84

3.

Primer pairs used to amplify the mummichog spgp cDNA

4.

Pairwise comparison matrices of the deduced amino acid sequences
for a selection of Pgp homologs

5.

Pairwise comparison matrix o f the deduced amino acid sequences o f the
mummichog mdr ATP binding domain and the N and C terminal ATP
binding domains of the Xenopus and hamster mdr-type P-glycoproteins

x

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout p erm ission

133

147-148

185

LIST OF FIGURES
Figure
1.

Model of P-glycoprotein in the plasma membrane showing the
domain structure o f the protein

2.

Map o f the lower Chesapeake Bay and tributaries showing the
locations of the creosote-contaminated site (Atlantic Wood)
and the two uncontaminated reference sites (King Creek and
Catlett Islands) discussed in this work

3.

C219 immunochemical detection of Pgp in liver and hepatic
proliferative lesions o f mummichog

4.

Immunoblot detection o f Pgp in mummichog liver extracts from
the creosote-contaminated site (Atlantic Wood) in the Elizabeth
River and from a clean reference site (King Creek)

5.

Expression of Pgp in liver extracts of mummichog from the creosotecontaminated site (Atlantic Wood) and an uncontaminated reference
site (King Creek)

6.

Immunoblot o f liver extracts o f mummichog 36 hr following i.p.
injections of 3-methylcholanthrene in com oil (3-MC) or com
oil (CO) alone

7.

Sections of normal mummichog liver from King Creek stained
with mAb C219

8.

Demonstration of specific immunohistochemical staining with mAb
C219

9.

Neoplasms from Atlantic Wood mummichog showing various types
of C219 immunohistochemical staining

10.

The strategy used to amplify segments of the mummichog spgp cDNA

11.

Nucleotide and deduced amino acid sequence of the mummichog spgp
cDNA determined from overlapping RT-PCR amplified fragments

xi

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

92

135-

12.

Hydropathy plots of the mummichog spgp deduced amino acid
sequence and the corresponding carboxyl teminal half of the
hamster pgp3

137-138

Multiple alignment of deduced amino acid sequences of selected
P-glycoproteins

141-145

14.

Relationships among vertebrate and invertebrate P-glycoproteins

150-151

15.

Cladistic analysis of the relationships among the vertebrate
P-glycoprotein 3’ nucleotide sequences including the sequences with
limited data

153-154

Immunoblot of membrane fractions from mummichog organs probed
with mAb C219

156

Northern blot o f total RNA from mummichog organs probed with DIG
labeled mummichog spgp fragment S4 or mummichog P-actin fragment

158

13.

16.

17.

18.

Nucleotide and deduced amino acid sequences of the mummichog mdr
cDNA fragments determined from the the sequence of RT-PCR amplified
cDNA products from mummichog intestine and liver
179-181

19.

Alignment of the deduced aminoacid sequence of the mummichog mdr
ATP binding domain with the amino and carboxyl terminal ATP binding
domains o f Xenopus and hamster mdr-type P-glycoproteins

183

20.

Hydropathy plots of the mummichog mdr deduced amino acid sequence
for cDNA fragment M3 and the corresponding region of the hamster pgp 1
sequence
186-187

21.

Multiple alignment of deduced amino acid sequences of selected
P-glycoproteins over the region of overlap with the mummichog mdr
sequence

190-192

Phenogram o f the realtionships among P-glycoprotein deduced amino
acid sequences

194

22.

xii

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

ABSTRACT
The mammalian mdrl P-glycoprotein (Pgp) has been implicated in xenobiotic resistance of
drug-resistant cell lines and tumors, and may function in excretion or exclusion o f toxic
xenobiotics at several sites within the body. Pgp gene family members are expressed in
excretory epithelia o f several aquatic taxa and may contribute to the survival o f pollutiontolerant aquatic animals in contaminated environments. For this reason the expression o f Pgp
family members was investigated in the livers and liver tumors of creosote-resistant
mummichog (Fundulus heteroclitus) inhabiting a creosote-contaminated site (Atlantic
Wood) in the Elizabeth River, Virginia. Expression of members o f the Pgp gene family was
detected by immunochemical methods using monoclonal antibody (mAb) C219. An
immunoreactive band in the size range of mammalian P-glycoproteins was observed in
immunoblots o f liver membrane fractions and detergent extracts of mummichog liver from
both Atlantic Wood and a reference site. Immunohistochemical staining of mummichog liver
demonstrated this antigen on the canalicular surface o f hepatocytes in normal liver similar
to expression in mammalian and guppy liver. The levels of Pgp were 2-3 fold higher in
immunoblots of nontumorous livers of Atlantic Wood mummichog compared with levels in
reference site fish. Similar to results reported in mammalian liver neoplasms, Pgp was
overexpressed and had aberrant immunohistochemical localization in the majority of
mummichog liver neoplasms. Because mAb C219 was expected to recognize all Pgp gene
family members expressed in mummichog, molecular techniques were used to characterize
the individual Pgp genes expressed in mummichog liver. Reverse transcriptase-polymerase
chain reaction (RT-PCR) was used to amplify Pgp gene transcripts. A cDNA fragment (3004
bp) was amplified which was most similar to the recently described mammalian sister gene
to P-glycoprotein (spgp). Northern blots showed predominant expression of this gene in
mummichog liver. Another cDNA fragment (1713 bp) was amplified from mummichog liver
and intestine which was a homo log of the mammalian multidrug-resistance or xenobiotic
transporter (mdrl). These results indicate that a xenobiotic transporter may be elevated in the
livers and liver tumors o f the pollution-tolerant mummichog consistent with the proposed
role o f these proteins in xenobiotic resistance.
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Chapter I: General Introduction

2
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3

Multidrug resistance and P-glycoprotein— It has been frequently observed that
mammalian cell lines which have been selected for resistance to a single cytotoxic
compound simultaneously become cross-resistant to many different cytotoxins (Dano,
1972; Riehm and Biedler, 1972; Ling and Thompson, 1974). A remarkable feature of
this multidrug-resistance (MDR) phenotype is that the resistance extends to many
compounds which have unrelated modes and sites of activity and are structurally and
chemically dissimilar. Although MDR cell lines have many biochemical differences
which distinguish them from sensitive cells, a common distinctive characteristic of the
MDR cells is high level expression of a large (170 kDa) heavily glycosylated plasma
membrane protein (Juliano and Ling, 1976; Kartner et al., 1983). This protein was
originally termed P-glycoprotein (Pgp). The prefix P in this case was meant to stand for
permeability since expression o f Pgp was thought to reduce the permeability o f MDR cell
lines to cytotoxins (Ling and Thompson, 1974; Juliano and Ling, 1976). Analysis of Pgp
cDNA sequences expressed in MDR cell-Iines showed that P-glycoproteins had similar
deduced amino acid sequences and similar predicted domain structures to a variety of
ATP-dependent bacterial transport proteins (Gros et al., 1986; Chen et al., 1986; Gerlach
et al, 1986). This suggested that Pgp conferred the MDR phenotype by actively
transporting cytotoxins outward across the plasma membrane of drug resistant cells. The
role of P-glycoprotein as a xenobiotic efflux pump in MDR cell lines has now been well
established (reviewed in van der Bliek and Borst, 1989; Gottesman and Pastan, 1993).
Expression of full-length P-glycoprotein cDNAs in sensitive cell lines has been shown to
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confer the MDR phenotype (Ueda et al., 1987; Devault and Gros, 1990). This is
convincing evidence that high level expression of P-glycoprotein alone is sufficient to
confer multidrug-resistance to MDR cell lines.
Resistance to multiple chemotherapeutic drugs is also characteristic of many
human neoplasms and is a major barrier to effective treatment of many human cancers
(Gottesman et al., 1993). Pgp expression and overexpression have been detected in many
different human cancers and in several experimental models of rodent
hepatocarcinogenesis (Fairchild et al., 1987; Thorgeirsson et al., 1987; Teeter et al, 1990;
Vohm et al., 1990; Bradley et al., 1992). Consistent with the role of Pgp in conferring
drug resistance in MDR cell lines, overexpression in human tumors has been associated
with resistance to chemotherapy and poor prognosis (Fojo et al., 1987; Goldstein et al.,
1989; Weinstein et al., 1991; Arceci, 1993). P-glycoprotein expression may arise in
human cancers that recur following chemotherapy (Chan et al.,1990; Miller et al., 1991).
Because many o f the antineoplastic drugs used in chemotherapy (most notably the Vinca
alkaloids) have been used as selecting agents for MDR cell lines and are substrates for Pglycoprotein in these cell lines, it has been suggested that chemotherapy may select for
resistant tumor cells that overexpress P-glycoprotein (Gottesman, 1993). However the
causes and exact role of Pgp expression in the drug-resistance and prognosis of human
cancers remains controversial (Kaye, 1992). Pgp overexpression has also been associated
with tumor aggressiveness and metastasis (Weinstein et al., 1991; Bradley et al., 1992).
Therefore Pgp overexpression may be associated with relapse and poor prognosis in
human neoplasms because it serves as a marker o f a highly malignant phenotype and may
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be independent o f any selection for drug resistance (Bradley and Ling, 1994).
The origin o f Pgp overexpression in experimentally induced rodent liver tumors is
not completely understood. Some evidence from rodent hepatocarcinogenesis models
suggests that Pgp expression may be selected for in the process of carcinogenesis
(Fairchild et al., 1987; Thorgeirsson et al., 1987). This may occur through selective
expansion o f xenobiotic resistant preneoplastic cells in the presence of cytotoxic tumor
promoters or carcinogens (Farber and Sarma, 1987, Thorgeirsson et al., 1987;
Thorgeirsson et al., 1991 ). Increased Pgp expression was detected at the mRNA level in
preneoplastic nodules in one model of rodent hepatocarcinogenesis and was associated
with xenobiotic resistance of these lesions (Fairchild et al., 1987, Thorgeirsson et al.,
1987). However, Pgp overexpression in liver tumors was also observed without
promotion by xenobiotics (Teeter et al, 1990; Vohm et al., 1990; Bradley et al., 1992).
This suggests that Pgp overexpression in liver tumors may related to oncogene activation
and tumor progression (Bradley et al., 1992; Teeter et al., 1990). Support for this idea
comes from in vitro studies which found that transfection of rat liver epithelial cells with
the oncogene v-H-ras induced high level expression of Pgp, and that high level
expression o f mutant p53 stimulated the promoter of the human MDR1 gene (Burt et al.,
1988; Chin et al., 1992). Both Ras mutations and p53 mutations are common in
mammalian neoplasms including hepatocellular carcinoma (Nigro et al., 1989; Hsu et al.,
1991; Wiseman et al., 1991). Thus Pgp overexpression may be intrinsic to neoplastic
transformation and may be independent of any selection of resistant early preneoplastic
lesions by xenobiotics.
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In addition to expression in MDR cell lines and tumors, P-glycoproteins are
expressed in a variety o f normal tissue types. In mammals these include the apical
surfaces o f many epithelial cells including hepatocytes, bile ductular epithelial cells, the
epithelial cells o f the proximal convoluted tubule of the kidney, and the cells o f the
intestinal mucosa (Thiebaut et al., 1987; Croop et al., 1989; Thiebaut et al., 1989; Teeter
et al., 1990). Pgps are also expressed in the capillary endothelial cells forming the bloodorgan barriers o f the testes and brain (Cordon-Cardo et al., 1989; Thiebaut et al., 1989).
These sites o f expression along with the role o f Pgp in conferring drug resistance suggests
that Pgp may be involved in defending against toxic compounds either through excretion
via the bile or urine or through prevention o f uptake in the intestine and blood-organ
barriers.
Pgp expression is also found in the adrenal cortex (Theibault et al., 1987;
Sugawara et al., 1987) and the pregnant uterus (Arceci et al., 1988). Expression in these
locations along with the ability of Pgp to transport certain steroid hormones suggests that
Pgp may be involved in steroid secretion or uptake in these organs (Ueda et al., 1992; van
Kalkenetal., 1993).
These expression results are complicated by the presence two or more Pglycoprotein genes in all organisms that have been studied. Multiple homologs have been
identified in vertebrates (Ling et al., 1992) in Drosophila (Wu et al., 1991; Gerrard et al.,
1993) and the nematode, Caenorhabditis elegans (Lincke et al., 1992). Recently a novel
type of P-glycoprotein, the sister of P-glycoprotein (spgp), has been identified in the rat,
the pig and the winter flounder (Childs et al., 1995). Thus the gene family in vertebrates
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contains two distinct categories o f Pgp genes; those that code for the traditional highly
related mdr P-glycoproteins and those that code for the sister of P-glycoprotein or spgp
homologs (Childs et al., 1995). The number o f mdr loci in vertebrate species ranges from
two in fish and primates to five in the pig as determined by Southern blots o f genomic
DNA (Ling et al., 1992; Childs et al., 1995; Childs and Ling, 1996). In contrast to the
mdr genes only a single spgp locus has been detected in the rat and the pig (Childs et al.,
1995).
The mdr genes o f humans and rodents are best characterized. Humans have two
genes termed MDR1 and MDR2 - also called MDR3 (Chen et al., 1986; van der Bliek et
al., 1988; Chin et al., 1989). Rodents have three mdr genes termed mdr I a -also called
mdr3 , mdr lb -also called mdrl, and mdr2 in rats and mice (Gros et al., 1986; Gros et al.,
1988; Hsu et al., 1989; Devault and Gros, 1990; Silverman et al., 1991; Brown et al.,
1993). In the hamster these are known as pgpl, pgp2 and pgp3 respectively (Endicott et
al., 1991). A summary o f the rather confusing nomenclature is given in Table 1. These
mdr genes may be classified based on whether their expression can confer drug resistance
to sensitive cell lines when transfected with the full-length cDNAs. Expression o f m drltype homologs (MDR1, mdr la, mdr lb, pgpl and pgp2) have been shown to confer drug
resistance to sensitive cells while the mdr2-type homologs (MDR2, mdr2 and pgp3) do
not (Ueda et al., 1986; Devault and Gros, 1990; Schinckel et al., 1991).
The mdr genes o f mammals are expressed in a tissue specific manner which
suggests specific physiological functions. The mdrl-type P-glycoproteins are expressed
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in all o f the sites o f P-glycoprotein expression including the liver, intestine, kidney,
uterus and adrenal medulla whereas mdr2-type isoforms are expressed predominately in
the bile canaliculus o f the liver (Buschman et al., 1992; Smit et al., 1994). Other sites of
expression o f the mdr2 P-glycoprotein include skeletal muscle, the heart and spleen (Smit
et al., 1994).
The expression patterns o f the mdrl P-glycoproteins along with the specific role
of the mdrl forms in xenobiotic transport in multidrug resistant cell lines suggests that
the mdrl forms are involved in the xenobiotic protective role and in steroid transport. In
mice these putative mdrl functions appear to be partially divided between the mdrl a and
mdr lb proteins. Predominant expression of the mdr I a gene has been detected in intestine
and the capillary endothelial cells forming the barriers of the brain and testes whereas in
the adrenal cortex and the uterus mdr lb expression is highest (Croop et al., 1989; Teeter
et al., 1990; Arceci et al., 1988; Schinkel et al., 1993). However, the sites o f expression
of the mdr2-type P-glycoprotein and its apparent lack of involvement in multidrugresistance give little information about the normal physiological function o f the mdr2
protein.
Recently strains of mice have been developed which carry homozygous
disruptions (“knock-out”) o f the mdr genes (Smit et al., 1993; Schinkel et al., 1994).
Study of these mice has provided important information on the normal physiological role
of both the mdr2-type and mdrl-type P-glycoproteins. Observations of mdr2 (-/-) mice
suggested that the physiological requirement for mdr2-type P-glycoprotein in the bile
canaliculus is in phosphatidylcholine secretion. The bile of these mice completely lacked
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phosphatidylcholine, an important component of normal bile. These mice also developed
liver disease which may have been caused by exposure to bile salts which are normally
complexed into micelles with phosphatidylcholine (Smit et al., 1993). Another study
found that mdr2 gene product expressed in yeast secretory vesicles functioned as a
phosphatidylcholine translocase, flipping the phospholipid in a directed fashion from one
leaflet to the other within the lipid bilayer (Ruetz and Gros, 1994). Thus evidence
suggests that the mdr2-type P-glycoprotein may function as phosphatidylcholine
“flippase” in the canalicular membrane of hepatocytes. Its activity is thought to increase
the local concentration o f phosphatidylcholine in the outer leaflet of the canalicular
membrane where it is extracted into micelles by bile salts (Higgins and Gottesman, 1992;
Smit et al., 1993; Ruetz and Gros, 1994).
Strong support for the xenobiotic-protective role of mdrl-type P-glycoproteins
was recently provided by study o f mice which have a homozygous disruption of the
mdr la gene (Schinkel et al., 1994). These mice were phenotypically normal and did not
show any defect until challenged with xenobiotics. The mdr la deficient mice were
highly sensitive to the toxic effects of a xenobiotic (ivermectin) which is normally
tolerated because o f the functioning of the blood-brain barrier. These mice also had
increased accumulation o f ivermectin and of the MDR substrate vinblastine in certain
organs as well as decreased elimination o f these toxic compounds. Possibly any other
physiological requirement for functional mdr la expression was compensated by the
observed increased expression o f the functional mdr lb gene in these mice.
In mammals both m drl and mdr2 expression may be regulated in part by exposure
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to xenobiotics. This regulation may be a component of an inducible response to certain
classes o f foreign compounds. Exposure to several carcinogens including the cytochrome
P4501A (CYP1A) inducer 3-methylchoIanthrene (3-MC) has been found to increase Pgp
mRNA (m drlb gene transcripts) and Pgp levels in rat liver (Burt and Thorgeirsson, 1988;
Gant et al., 1991; Thorgeirsson et al., 1991). Transcripts of the mdr2 gene as well as the
mdr2 P-glycoprotein have also been observed to increase in the livers of monkeys
following administration of drugs having a biliary excretion pathway (Gant et al., 1995).
Thorgiersson and colleagues have hypothesized that Pgp gene expression is induced in
liver by xenobiotics having biliary excretion pathways and may be a part of a coordinated
response to xenobiotic exposure which includes induction o f xenobiotic metabolizing
enzymes such as CYP1A (Thorgeirsson et al., 1991; Gant et al., 1995).
There is as yet no information on the physiological role o f the spgp Pglycoprotein. However, northern blots o f RNA from rat tissues have demonstrated that
expression of this gene is confined to liver where it is expressed along with mdr2 and
m drl P-glycoproteins in the bile canaliculus (Childs et al., 1996). It can be assumed that
its role here is in excretion o f an unidentified substance into the bile.
Despite the diversity of functions, the deduced amino acid sequences of all Pglycoproteins are well conserved and predict a highly conserved domain structure for
these proteins. P-glycoprotein sequences are similar in sequence and domain structure to
a large number o f proteins involved in ATP-dependent transmembrane transport. These
proteins are members of the ATP binding cassette (ABC) superfamily of transport
proteins (reviewed in Higgins et al., 1992 and Childs et al., 1994). Other ABC
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transporters include bacterial periplasmic uptake and transport systems (Higgins et al.,
1986), bacterial exporters such as the hemolysin B exporter of E. coli (Higgins et al.,
1986), the pigment transporter products o f the white and brown genes of Drosophila
(Dreesen et al., 1988), the yeast STE 6 mating factor transporter (McGrath and
Varshavsky, 1989), the mammalian multidrug resistance associated transporter, MRP,
(Cole et al., 1992) and the mammalian cystic fibrosis transmembrane conductance
regulator, CFTR (Riordan et al., 1989). All members of this superfamily have one or two
well conserved ATP-binding domains or cassettes of about 200 amino acids (Higgins et
al., 1986; Hyde et al., 1990) which surround and include the Walker A and B consensus
sequences for nucleotide binding found in the nucleotide binding folds of many proteins
(Walker et al., 1982). They all also have one or two hydrophobic membrane spanning
domains (Hyde et al., 1990). The ATP binding domain is believed to be involved in
coupling the hydrolysis of ATP to the transport of the substrate across the membrane
which may involve a conformational change that is transmitted to the membrane
spanning domains (Hyde et al., 1990).
P-glycoproteins conform to the general ABC transporter domain structure (Figure
1) and appear to be tandemly duplicated molecules with each half containing a
hydrophobic domain made up of six putative transmembrane helices followed by an
intracellular ATP- binding domain (Chen et al., 1986; Gros et al., 1986). The sequence of
these nucleotide binding domains are well conserved among all P-glycoproteins as well
as other ABC superfamily members. The two halves of the protein are connected by a
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highly hydrophillic region called the linker region (Chen et al., 1986). The sequence of
this region is not well conserved overall but does contain distinctive protein kinase
recognition sequences which may confer important differences in regulation to the
different classes o f homologs within a species (Endicott et al., 1991; Hsu et al., 1989).
Multixenobiotic resistance and P-glycoprotein expression in aquatic
organisms— Because o f the postulated xenobiotic protective role of mdrl-type Pglycoproteins in mammals, investigators have recently begun to investigate the possible
role of Pgp in tolerance and resistance of aquatic organisms to pollutants. It has been
observed that aquatic organisms which persist in polluted environments are exposed to
many different toxic pollutants. These pollution-tolerant organisms must have
physiological and biochemical mechanisms which allow them to cope with a range o f
toxic compounds which may have differing chemical and biological properties. Kurelec
and colleagues have noted that this ability of pollution tolerant aquatic organisms to resist
the toxic effect o f multiple unrelated toxicants is analogous to the MDR phenotype o f
mammalian cell lines. This has led to the hypothesis that the activity of P-glycoprotein
homologs in the excretory tissues of aquatic organisms is responsible for this multi
xenobiotic resistance (reviewed in Kurelec, 1992). In support of this multixenobioticresistance hypothesis, P-glycoprotein-like activities have been detected in excretory
tissues o f several pollution or toxin tolerant aquatic organisms including marine sponges
(Kurelec and Pivcevek, 1992; Kurelec et al., 1992), mollusks (Kurelec and Pivcevec,
1989; Kurelec et al., 1991; Minier et al., 1993; Kurelec et al., 1995; Cornwall et al., 1995;
Kurelec et al, 1996) and a marine worm (Toomey and Epel, 1993). All of these reports
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have relied on a competition assay for P-glycoprotein activity using the effect of the
calcium channel blocker verapamil, a known P-glycoprotein inhibitor, on uptake of
potential P-glycoprotein substrates by tissues or membrane vesicles o f aquatic organisms.
Studies have shown verapamil-sensitive ATP-dependent uptake o f carcinogens and the Pglycoprotein substrate vincristine in the presence o f verapamil in membrane vesicles
made from pollution tolerant marine sponges (Kurelec et al., 1992; Kurelec and Pivcevic,
1992 ) and from the gills o f bivalve mollusks (Kurelec and Pivcivec, 1989; Kurelec et al.,
1991). These results are analogous to those obtained in a similar assay with membrane
vesicles o f MDR cell lines and may identify the activity o f P-glycoprotein homologs in
these organisms. Using a competitive assay with a fluorescent Pgp substrate Toomey and
Epel (1993) have also shown P-glycoprotein-like activity in embryos of the innkeeper
worm (Urechis caupo). Evidence from this study suggests that this activity may protect
the innkeeper worm from toxins present in marine sediments.
Several studies have found that many important environmental contaminants
interfere with these P-glycoprotein activities (Kurelec, 1995; Cornwall et al., 1995;
Galgani et al., 1996). A range o f moderately hydrophobic to very hydrophobic
compounds including the important environmental contaminants pentachlorophenol,
DDT and its breakdown products, and the PCB mixture Arochlor 1254 inhibited the Pglycoprotein-like activity in the marine mussel, Mytilus galloprovincialis (Galgani et al.,
1996). However in a similar study using a different species o f mussel (Mytilus
californicus) only the less hydrophobic compounds interfered with Pgp-like activity
while the highly hydrophobic compound including Arochlor 1254 and DDT did not
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(Cornwall et al., 1995). Another study has found that a water extract of diesel fuel, and
organic extracts of polluted river water and sediment pore water interfere with the Pgplike activity in M. galloprovincialis (Kurelec, 1995). While the above results are
consistent with some environmental contaminants being substrates for Pgp, active
transmembrane transport o f these compounds has not yet been demonstrated and
mechanisms other than competitive inhibition may be involved.
In addition to Pgp-like activity, investigators have also detected expression o f Pglycoprotein or related antigens in the tissues of aquatic organisms. Polyclonal
antibodies raised against Pgp from a colchicine resistant Chinese hamster ovary cell line
were used to label a 125 kDa glycoprotein band in immunoblots o f detergent extracts of
two species of marine sponges (Kurelec et al., 1992). Using immunocytochemical
staining with this antibody and a monoclonal antibody (mAb C219) which recognizes a
conserved epitope present in all mammalian P-glycoproteins, the authors showed that Pgp
antigens localized to the plasma membrane o f the sponge cells (Kurelec et al., 1992).
Toomey and Epel (1992) have also used mAb C219 to detect a 140 kDa protein in
immunoblots of egg membrane fractions of the innkeeper worm and found that this
antibody labeled a 110 kDa band in immunoblots o f adult worm epidermal tissue and
intestinal tract. Several studies have used antibodies against mammalian Pgp to examine
Pgp expression in marine mollusks. Using the mAb C219, Minier and collaborators
(1993) detected two bands at 220 kDa and 240 kDa in immunoblots of detergent extracts
o f the mussel, Mytilus edulis and the oyster Crassostrea gigas. Galgani and colleagues
(1996) reported both a 145 kDa band and the 220-240 kDa doublet in immunoblots of gill
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extracts o f M. galloprovincialis probed with mAb C219. Kurelec and colleagues have
reported a 140 kDa band in immunoblots of gills of M. galloprovincialis (Kurelec et al.,
1996) and in the marine snail Monondonta tarbinata (Kurlec et al., 1995) probed with a
polyclonal antibody directed against a peptide from a conserved region of human MDR1
P-glycoprotein. Cornwall and colleagues (1995) found that both mAb C219 and a
polyclonal antibody directed against mammalian Pgp labeled a 170 kDa band in
immunoblots o f M. californicus but did not report the 220-240 kDa band seen in the other
bivalves. Pgp expression has also been detected in aquatic vertebrates. Hemmer and
colleagues (Hemmer et al., 1995) used a panel of anti-mammalian Pgp monoclonal
(including mAb C219) and polyclonal antibodies in an immunohistochemical study of
Pgp expression in the guppy. Expression of Pgp in the guppy was found to be similar to
mammals with expression in the apical membrane of the tubular epithelia of the kidney,
the brush border membrane of the intestinal epithelium and the canalicular surface of
hepatocytes as well as in the corresponding adrenal-like intrarenal tissue.
There is some evidence that, as in mammals, Pgp expression and activity in
aquatic animals may be elevated by exposure to toxicants. Increased Pgp-like activity
and elevated levels of Pgp related antigens were detected in gills and mantle tissues of
marine mollusks inhabiting polluted sites (Minier et al.,1993; Kurelec et al., 1995;
Kurelec et al., 1996). Increased Pgp-like activity was measured in a marine snail and a
mussel following laboratory exposure to water polluted with fuel oil (Kurelec et al., 1995;
Kurelec et al., 1996). In one case increased levels of Pgp antigens were detected in
immunoblots o f tissue extracts following exposure to contaminants (Kurelec et al., 1995).
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These results suggest increased Pgp expression may be an inducible response produced
by exposure to certain contaminants. This is similar to induction o f Pgp expression in
mammalian liver by xenobiotic exposure. It has been suggested that levels o f Pglycoprotein expression or activity may be correlated with the degree of tolerance or
adaptation to toxic contaminants in a particular species of aquatic organisms (Minier et
al., 1996; Kurelec et al., 1995).
Interpretation of data on Pgp expression in aquatic organisms is almost certainly
complicated by the presence of multiple P-glycoprotein homologs in individual species of
aquatic organisms. As in mammals, these homologs probably have tissue specific
expression patterns and distinct substrate specificities. Other than one report in winter
flounder (Chan et al., 1992), information on the Pgp genes o f environmentally relevant
aquatic organisms is absent. Two partial genomic clones have been sequenced for the
winter flounder. One of these, JpgpA, has now been identified as being a homolog of the
recently described mammalian sister o f P-glycoprotein (Childs et al., 1995). The
relationship o f the other winter flounder gene fragment to the mammalian genes has not
been determined, but its sequence does not fit clearly into either the mdrl or mdr2 gene
categories (Chan et al., 1992). No information has yet been published on tissue specific
expression o f mdr or spgp genes in fish although the immunohistochemical study in the
guppy shows tissue and subcellular localization of total Pgp antigens that is similar to that
o f mammals (Hemmer et al., 1995). However, in this study it was not possible to
distinguish among the different guppy Pgp isoforms.
Clarification o f the role o f Pgp expression and activity in resistance and tolerance
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o f aquatic organisms to pollutants will require molecular and biochemical
characterization o f the individual members of the P-glycoprotein gene families in aquatic
taxa. Initial molecular studies are needed to acquire sequence data. Even modest
amounts o f sequence data may allow certain functional inferences to be drawn based
upon similarities to the sequences of mammalian genes o f known function. These data
will also allow the construction of gene specific probes which may be used to investigate
regulation o f expression o f the individual genes. These gene specific probes ultimately
will be needed to screen cDNA and genomic libraries for full-length cDNA and genomic
clones. The cDNA clones may be helpful in identifying substrates and function by
allowing in vitro expression of the individual gene products (transfection) while the
genomic clones may provide insight into regulation o f the specific genes.
Scope o f the present work— Several previous studies from our laboratory have
focused on biochemical changes and adaptations in a small estuarine killifish, the
mummichog (Fundulus heteroclitus) inhabiting a marsh creek heavily contaminated with
creosote from a wood treatment facility (Atlantic Wood Industries) in the Elizabeth
River, Portsmouth, Virginia (Figure 2) (Van Veld et al., 1991; Van Veld and Westbrook,
1995; Armknecht, 1996). Mummichog from this site have been reported to have a high
prevalence of hepatic neoplasms and putatively preneoplastic lesions (altered foci) as well
extrahepatic neoplasms (Vogelbein et al., 1990; Foumie and Vogelbein, 1994). These
lesions are presumed to result from chronic exposure to polycyclic aromatic
hydrocarbons (PAHs) present in the creosote. The hepatic tumors of these fish have been
characterized with respect to expression of the xenobiotic metabolizing enzymes CYP1A
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and glutathione S-transferases (GSTs) (Van Veld et al., 1991; Van Veld et al., 1992).
These tumors were found to be similar to mammalian hepatic neoplasms and
preneoplastic lesions in having reduced expression and activity o f CYP1A (Van Veld et
al., 1992). In another study no increase in GST activity was observed within grossly
visible lesions. However the entire liver of Atlantic Wood mummichog showed elevation
o f GST expression and activity (Van Veld et al., 1991). This is in contrast to mammalian
hepatic neoplasms which have been shown to have elevated levels o f GST activity
(Farberand Sarnia, 1987).
The most remarkable feature of Atlantic Wood mummichog is their resistance to
the toxicity of creosote. Williams (1994) found that creosote amended sediments as well
as sediments collected from the Atlantic Wood site were significantly more toxic to
developing laboratory-spawned embryos of mummichog from an uncontaminated site
(Catlett Islands, York River, Virginia, Figure 2) than to laboratory spawned offspring of
mummichog from the Atlantic Wood site. This resistance in embryos was shown to be a
heritable genetic trait. Atlantic Wood sediment was also observed to be more acutely
toxic to adult mummichog collected from an uncontaminated site than to adult Atlantic
Wood mummichog (Wolfgang Vogelbein and Peter Van Veld, unpublished
observations). Whether this also represents genetic resistance in the adult fish or
physiological acclimation is uncertain.
The biochemical mechanism of the resistance or tolerance of Atlantic Wood
mummichog to creosote contaminated sediments is an active area of research in our
laboratory. Creosote is a complex mixture of toxic xenobiotics which is predominately
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PAHs but also contains phenolic compounds and nitrogen and sulfur containing
heterocyclic compounds (Mueller et al., 1989). Certain biochemical characteristics o f the
livers o f Atlantic Wood mummichog may be adaptive in the presence of PAH
contamination from the creosote. The nontumor-bearing livers of the fish from the
Atlantic Wood site had elevated levels and activity of the phase II conjugating enzyme
glutathione S-transferase (GST) and suppression o f expression and activity o f phase I
enzyme CYP1A (Van Veld et al., 1991; Van Veld and Westbrook, 1995; Armknecht,
1996). Van Veld and Westbrook (1995) have pointed out that these changes are similar
to the xenobiotic resistance phenotype of drug-resistant cell lines and mammalian
preneoplastic and neoplastic liver lesions (Farber and Sarma, 1987). As discussed
previously, another biochemical change associated with xenobiotic resistance is increased
expression o f Pgp. Could increased Pgp expression also be contributing to the creosote
resistance of these fish? This idea is particularly attractive because of the potential for
Pgp to provide a mechanism for elimination of multiple toxic lipophilic substrates as
would be required for managing a complex toxic mixture such as creosote. Furthermore,
what is the state o f Pgp expression in the liver tumors of these fish? Is overexpression of
Pgp another characteristic along with reduced CYP1A (Van Veld et al., 1992 ) which
these tumors share with mammalian liver neoplasms? Such biochemical comparisons of
cancer in fish and mammals are essential for supporting efforts to use fish as
experimental carcinogenesis models and for understanding the biochemical basis of these
environmental cancers. In order to begin to address these questions, preliminary work
was required to develop methods for identification and quantitation of Pgp in
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mummichog tissues and to characterize the nature o f specific Pgp homologs expressed in
the mummichog. Therefore the work in this dissertation extends our studies of the
biochemical properties o f the livers and liver tumors of the Atlantic Wood mummichog to
include identification and analysis of Pgp expression and the molecular cloning and
characterization o f mummichog Pgp homologs.
Chapters II and III of this dissertation focus on the development and application
o f immunological techniques using the anti-mammalian Pgp antibody mAb C219 for
detecting P-glycoprotein expression in mummichog liver and liver tumors. Both
immunohistochemical and immunoblot techniques were used. The former technique
provided useful information on the cellular and subcellular localization o f Pgp antigens in
mummichog tissues. The latter technique provided confirmation o f the specificity of
detection o f Pgp by the molecular weight of the labeled band and further provided a
means o f determining relative levels of expression o f Pgp between reference site fish and
Atlantic Wood mummichog and between normal and tumorous liver of Atlantic Wood
mummichog. The immunohistochemical staining results indicated Pgp expression in
mummichog liver on the canalicular surface of hepatocytes similar to the localization
reported in other vertebrates. Immunohistochemical staining o f the more progressed liver
tumors (hepatocellular adenomas and hepatocellular carcinomas) demonstrated altered
localization and overexpression of Pgp compared to the surrounding normal tissue. This
pattern of expression in the mummichog liver tumors is similar to that reported for
experimentally induced rodent hepatocellular carcinoma. Immunoblot analysis o f Pgp
expression in Atlantic Wood mummichog livers indicated elevation in the levels of Pgp
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compared to the levels o f Pgp in mummichog liver from an uncontaminated site. The
causes o f this elevation are uncertain but may be due to toxic liver injury, the contribution
o f overexpression in hidden tumors or induction o f expression by one or more
components o f creosote. This elevation is also consistent with constitutive elevation as a
component o f the genetic resistance of these fish.
Because the monoclonal antibody (C219) used in the above immunochemical
studies recognizes all categories o f Pgp (mdrl-type, mdr2-type and spgp), it was
necessary to identify the categories of Pgp expressed in mummichog liver in order to
better interpret the toxicological relevance o f Pgp expression. The method of reverse
transcriptase-polymerase chain reaction (RT-PCR) was used to amplify expressed Pgp
sequences from mummichog liver RNA. Comparison o f the acquired sequences to
mammalian sequences was used to categorize the mummichog Pgp homologs.
Application o f the RT-PCR technique and the analysis of the mummichog Pgp sequences
acquired in this way are discussed in Chapters IV and V of this dissertation.
Chapter IV o f this dissertation reports the sequence of a fragment o f mummichog
Pgp cDNA which is the closest homolog to the mammalian spgp P-glycoproteins.
Northern blotting results indicated that this mRNA is moderately expressed in
mummichog liver but not in intestine or kidney. This liver-specific expression is
consistent with that observed for the mammalian spgp gene. The mummichog spgp Pglycoprotein likely contributes significantly to the signal seen in immunohistochemical
and immunoblot detection o f Pgp in mummichog liver. The toxicological relevance of
this protein is unknown as its function has not yet been investigated in any animal.
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However, the highly conserved sequence between teleosts and mammals and liverspecific expression o f this gene indicate an essential function in liver as a canalicular
transporter o f an unidentified substrate.
Chapter V o f this dissertation reports the sequence of a fragment of a
mummichog mdr P-glycoprotein. Overlapping fragments of this cDNA were obtained by
RT-PCR o f mummichog liver and intestinal RNA. While sequence similarities indicated
that this product is most similar to the mammalian and Xenopus mdr-type P-glycoprotein,
overall sequence comparison did not clearly assign this homolog to either the mammalian
mdrl or mdr2 categories. Concerted evolution among the mammalian Pgp genes has
apparently greatly diminished sequence differences between the mammalian mdrl and
mdr2 homologs over large portions o f the sequence making assignment of the
mummichog homolog difficult. However the presence o f mdrl-specific protein kinase
recognition sequences in the linker region o f the deduced amino acid sequence of the
mummichog mdr cDNA fragment establish that this is a mummichog mdrl-type Pglycoprotein and is likely to be a xenobiotic transporter. Amplification of this cDNA
from both liver and intestine is consistent with the mammalian tissue specific expression
of mdrl-type P-glycoproteins. These results indicate that mummichog liver expresses a
xenobiotic transporter homolog. Increased expression o f this protein could contribute to
the survival o f mummichog at the Atlantic Wood site. However it is not known at this
time which of the Pgp isoforms are elevated in the liver and liver tumors of the Atlantic
Wood mummichog.
Further work along several lines of investigation is required to determine if Pgp
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expression in Atlantic Wood mummichog has toxicological relevance and contributes to
the tolerance or resistance o f these fish to their highly contaminated environment. A
comparison o f Pgp-like activity in liver o f Atlantic Wood mummichog and reference site
fish is necessary to corroborate expression results. The effect o f creosote and its
components on this activity also must be investigated. Now that two mummichog partial
cDNA sequences are available, gene specific probes may be produced to assess
expression of the specific forms and determine which isoform is elevated in the Atlantic
Wood mummichog. This will require cloning at least a fragment of the expected
mummichog mdr2 homolog. These gene specific probes may also be used to further
investigate regulation o f expression of the mummichog Pgp homologs in laboratory
exposures o f mummichog to creosote and its components and to investigate relative
levels o f Pgp forms in resistant and sensitive fish. The cDNA fragments described in this
dissertation may also be used to screen a mummichog liver cDNA library for full-length
sequences of mummichog P-glycoprotein mRNAs expressed in liver. The cloning of
full-length cDNAs may allow expression of these mummichog proteins in cultured cells
and should permit functional characterization of these gene products.
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Table 1. Nomenclature and classification of mammalian mdr genes. Alternative
designations are given in parentheses
Pgp class

human

hamster

mouse/rat

multidrug
resistance

mdrl-type

MDRl

PgP I

mdr la. (mdr3)

yes

Pgp2

mdr lb (mdr 1)

yes

mdrl-type

-

mdr2-type

MDR2 (MDR3)

Pgpl

m drl
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Figure 1. Model o f P-glycoprotein in the plasma membrane showing the domain
structure o f the protein. IN and OUT refer to cytoplasmic and extracellular side of the
plasma membrane respectively. The protein is made up of two similar halves connected
by a poorly conserved hydrophillic segment (Linker). The first extracellular loop of the
N-terminal half contains the glycosylation sites (branched structure). Each half of the
protein contains a transmembrane domain (TMD) made up of six membrane spanning
helices. Each half also has an ATP binding cassette (ABC) which contains a highly
conserved ATP binding fold (circled) within which are the Walker motifs (A and B)
found in a variety o f nucleotide binding proteins.
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Figure 2. Map of the lower Chesapeake Bay and tributaries showing the locations o f the
creosote contaminated site (Atlantic Wood, AW) and the two uncontaminated reference
sites (King Creek, KC and Catlett Islands, Cl) discussed in this work.
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Chapter II. Immunohistochemical and Immunoblot Detection of P-Glycoprotein in
Normal and Neoplastic Fish Liver
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INTRODUCTION
P-glycoprotein expression in mammals— P-glycoprotein (Pgp) is a membrane
transport ATPase that plays a role in efflux of cytotoxic agents from multidrug-resistant
(MDR) mammalian cell lines (Kartner et al., 1983; van der Bliek and Borst, 1989,
Gottesman and Pastan, 1993). The MDR phenotype arises in cell lines selected for
resistance to one cytotoxic agent. These cells are cross-resistant to a variety o f other
toxicants with differing structures and modes of action. A consistent biochemical change
in these cell lines is increased expression o f P-glycoprotein (reviewed in van der Bliek
and Borst, 1989; Gottesman and Pastan, 1993). Studies of accumulation and efflux of
labeled Pgp substrates in MDR cell lines indicate that Pgp expression is associated with
decreased accumulation and increased ATP dependent efflux of drugs in these cells
(Hamada et al., 1988; Horio et al 1988). Although drug-resistant cell lines often have
many biochemical alterations that distinguish them from sensitive cells, transfection of
sensitive cells with full length cDNA clones of Pgp transcripts has been found to be
sufficient to confer dmg resistance (Ueda et al., 1987; Devault and Gros, 1990). This is
convincing evidence that overexpression of Pgp alone is sufficient to confer the MDR
phenotype.
Since the initial discovery of Pgp in MDR cell lines, normal tissues have been
found to express Pgp. The apical surface of many excretory epithelia including those of
the intestine, liver and kidney show Pgp expression (Thiebaut et al., 1987; Thiebaut et al.,
1989; Bradley et al., 1990). This pattern of expression along with the role of Pgp in
efflux of cytotoxins from cell lines suggests that the normal role of Pgp may be the
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excretion o f endogenous or exogenous toxic compounds or their metabolites. Pgp may
therefore represent a line o f defense against toxic compounds. Up regulation o f Pgp
expression could be an adaptive response of organisms to toxicants. In the liver o f the
rat, Pgp mRNA levels increase following exposure to many xenobiotics including some
of the classic P450 inducers (Burt and Thorgiersson, 1988). Thus it is possible that Pgp
expression in mammals may be a part of the inducible xenobiotic response pathway that
includes the phase I and phase II xenobiotic metabolizing enzymes (Burt and
Thorgeirsson, 1988; Thorgeirsson et al., 1991). Although there are many hints that the
normal function o f Pgp is elimination of xenobiotics or toxic metabolites, the normal
substrates for Pgps are unknown, and the relevance o f these proteins to toxicology
remains uncertain.
In addition to expression in normal tissues, Pgp expression and overexpression are
seen in human and animal neoplasia. Overexpression of Pgp occurs in a number o f
human neoplasms derived from a variety of tissue types (Miller et al., 1987; Fojo et al.,
1987; Chan et al., 1990; Goldstein et al., 1990; Weinstein et al., 1991; Gottesman, 1993).
In many human tumors Pgp expression is associated with resistance of the tumors to
chemotherapy and poor prognosis (Chan et al., 1990; Weinstein et al., 1991; Gottesman
et al., 1993). Some cases o f overexpression are associated with tumors that recur
following chemotherapy (Chan et al., 1990; Miller et al., 1991). Chemotherapy may
select for tumor cells that are resistant because of Pgp overexpression (Gottesman, 1993).
Pgp overexpression has also been observed in several different laboratory models of
rodent hepatocarcinogenesis (Fairchild et al., 1987; Thorgeirsson et al., 1987; Teeter et
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al., 1990; Bradley et al., 1992). Evidence from one model suggests that Pgp
overexpression occurs early in carcinogenesis and is related to promotion of xenobiotic
resistant preneoplastic liver lesions (Fairchild et al., 1987; Thorgeirsson et al., 1987).
Other evidence suggests that Pgp overexpression in hepatocellular carcinoma may arise
without promotion by xenobiotics (Teeter et al., 1990; Bradley et al., 1992).
P-glycoprotein expression in aquatic animals— Because o f the importance of
Pgp in conferring MDR, there is interest in the role that Pgp expression may play in
tolerance or resistance o f aquatic organisms to toxicants. Pgp expression and activity
have been detected in tissues o f a number of aquatic organisms (Kurelec and Pivcivec,
1991; Kurelec and Pivcivec, 1992; Kurelec et al., 1992; Kurelec 1992; Toomey and
Eppel, 1993; Minier et al., 1993). Kurelec and co-workers have hypothesized that certain
strains or species of aquatic organisms that are tolerant of pollutants may be so because of
the presence and activity o f Pgp homologs (reviewed in Kurelec, 1992). They suggest
that chemical pollutants or natural toxins may be excluded from these organisms by the
externally directed pumping activity o f Pgp homologs in epithelial tissues. They have
termed such a mechanism "multixenobiotic resistance" (MXR) since, by analogy to the
MDR phenotype, such organisms may show cross-resistance to a variety o f structurally
unrelated toxicants.
Although the above studies suggest a role for Pgp in resistance or tolerance to
toxicants, the significance o f Pgp expression in aquatic organisms is not clear. Additional
studies are needed to establish whether differences in relative levels of Pgp expression or
activity are associated with sensitivity of aquatic organisms to toxicants. There is also a
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need for the development o f methods that would allow measurement of Pgp expression in
aquatic organisms.
We are currently investigating expression of Pgp in the liver of the mummichog,
Fundulus heteroclitus, a small estuarine killifish. Our study site in the Elizabeth River,
Virginia is heavily contaminated with polycyclic aromatic hydrocarbons (PAHs) derived
from creosote (Vogelbein et al., 1990). High prevalences o f hepatic (Vogelbein et al.,
1990) and extra-hepatic neoplasms (Foumie and Vogelbein, 1994; Vogelbein and
Foumie, 1994) have been reported in mummichog from this site. This situation gives us
a unique opportunity to study both the response of Pgp expression to environmental
exposure to PAHs in fish liver and to examine alterations in Pgp expression occurring in
neoplastic and putative preneoplastic lesions during environmental hepatocarcinogenesis
in fish.
The purpose o f this Chapter is to describe protocols that we have developed for
the immunochemical detection o f Pgp expression in fish tissues, primarily liver and liver
tumors. These methods should be applicable to other fish tissues and possibly tissues of
other aquatic organisms as well. Detailed protocols are given for both
immunohistochemical staining and immunoblotting procedures. Whenever possible we
use both techniques because o f the complementary information that can be derived from
each.

MATERIALS REQUIRED
Where manufacturers are not given, materials are readily available from many sources.
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Pgp Immunohistochemistry
1.

Staining rack and jars: (Shandon, Tissue Tek II).

2.

PAP pen: (Research Products International, Mount Prospect IL, cat. no. 195500).

3.

Ethanol: 100%, 95% and 70%.

4.

Xylene.

5.

Elite Avidin-Biotin Complex (ABC) immunohistochemical staining kit, murine:
(Signet Laboratories, Dedham MA, cat. no. 2158).

6.

Normal Horse Serum: (Sigma, cat. no. H0146).

7.

Bovine Serum Albumin (BSA), Fraction V: ( Sigma, cat. no. A9647).

8.

3,3'-Diaminobenzidine Substrate Tablets: (Sigma, cat. no. D4168).

9.

Permanent Mounting Medium: (Preservaslide, EM Science, or equivalent).

10.

Phosphate Buffered Saline (PBS): (10 mM sodium phosphate, pH 7.4, 150 mM
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NaCl). This is prepared as a 1OX stock. 14.2 g o f anhydrous dibasic sodium
phosphate and 87.7 g o f NaCl are added to 900 ml of deionized water. The pH is
adjusted to 7.4 with 6 M NaOH. The volume is then made up to 1 I with
deionized water. The solution is sterilized by filtration (0.2 pm) and stored at
room temperature. The 10X stock is diluted with 9 parts deionized water
immediately before use.

11.

Blocking Solution: (10% normal horse serum, 0.02% sodium azide in 1 X PBS).
This solution can be divided into aliquots and stored at - 20° C.

12.

3% Hydrogen Peroxide: This solution must be prepared fresh daily by dilution of
1 part 30% hydrogen peroxide into 9 parts deionized water.

13.

Antibody Buffer: (1% w/v BSA, 0.02% w/v sodium azide in 1 X PBS). This
solution is stored at 4° C. It is stable for at least 2 weeks.

14.

C219 mAb: (Signet, cat. no. 2158). This reagent is provided lyophilized (100 pg)
by the manufacturer. It is diluted with 1 ml of antibody buffer and stored frozen
(-70° C) in 20 pi aliquots. For immunohistochemistry, aliquots are diluted
immediately before use with 1.3 ml of antibody buffer (1% BSA in PBS).

15.

Mouse Myeloma (UPC 10) Protein (IgG 2a,K): (Sigma, cat. no. M 9144). The
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lyophilized protein is diluted to 1.5 pg/ml with antibody buffer and stored in I ml
aliquots at -20° C.

16.

Harris Hematoxylin: 5 g o f hematoxylin powder (Fisher Scientific, cat. no. H345)
is dissolved in 50 ml of 95% ethanol. 100 g of potassium alum is dissolved in
1000 ml o f deionized water in a 2 liter Erlenmeyer flask on a heating stirplate.
The hematoxylin solution is added to the alum solution, and the mixture is
brought to a boil while stirring. 2.5 g of mercuric oxide is carefully added to the
hot solution. The solution is heated until a deep purple color is obtained and then
is cooled by plunging the flask into cold water. It then is filtered and stored at
room temperature. The solution is filtered before each use. The stain is stable for
several months at room temperature.

Immunoblotting
1.

Power Homogenizer. We use an electric drill (Sears Roebuck Co., model 15
315.10042) mounted in a drill press stand (Sears model 25921) to drive a 2 ml
Potter-Elvehjem tissue grinder (Wheaton, no. 358003).

2.

Vertical Slab Gel Electrophoresis Apparatus, MiniPROTEAN II: (Bio-Rad, cat.
no. 165-2940).

3.

Electrophoretic Transfer Apparatus, Mini Trans-Blot: (Bio-Rad, cat. no. 170-
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3935).

4.

Electrophoresis Power Supply: (Bio-Rad, Model 200/2.0, cat. no. 165-4761).

5.

Nitrocellulose Membranes: (Bio-Rad, cat. no. 162-0147).

6.

40% Acrylamide Stock (37.5:1, Acrylamide:Bis-Acrylamide): (Fisher Scientific,
cat. no. BP 1410-1).

7.

C219 mAb: (Signet, cat. no. 2158). For immunoblotting, the lyophilized mAb
(100 (ig) is dissolved in 40 ml immunoblot antibody dilution buffer (see below),
divided into two aliquots and stored at - 20° C. Each aliquot can be saved after
use, frozen and used again at least ten times.

8.

Goat Anti-Mouse IgG Alkaline Phosphatase Conjugate: (Bio-Rad, cat. no. 1706520). The undiluted conjugate is stored at 4° C. Immediately before use the
conjugate is diluted 1:3000 with immunoblot antibody dilution buffer.

9.

Lysis Buffer Stoct. 6.06 g tris(hydroxymethyl)aminomethane (Tris) (Sigma, cat.
no. T-8524), 8.77 g NaCl, 1.86 g disodium ethylenediaminetetraacetate (EDTA)
(Sigma, cat. no. E-4884), 10.0 g sodium deoxycholate (Sigma, cat. no. D-6750),
1.0 g sodium dodecyl sulfate (SDS)(Sigma, cat. no. L-4390) and 10 ml Triton X-
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100 (Sigma, cat. no. X-100) are dissolved in 800 ml deionized water. The
solution is adjusted to pH 7.4 with 6 M HC1. The volume is made up to 960 ml.
The buffer is stored at 4° C. Just before use, the volume o f lysis buffer required is
prepared in a tube on ice by adding the protease inhibitors from stock solutions.

10.

Protease Inhibitor Stocks:

N-p-tosyl-L-arginine methyl ester HC1 (TAME): (Sigma, cat. no. T 4626). A
stock solution o f 38 mg/ml in deionized water is prepared fresh before use.

Penylmethylsulfonyl flouride (PMSF): (Sigma, cat. no. P 7626). PMSF is
dissolved at a concentration o f 10 mg/ml in 100% 2-propanol. The solution is
stable for several months at room temperature.

Aprotinin solution (10 units/ml): (Sigma, cat. no. A 6279). This stock is used as
is from the producer.

Leupeptin: (Sigma, cat. no. L 2023). Leupeptin is dissolved in deionized water at
5 mg/ml. The solution is divided into 20 pi aliquots and is stored at - 20° C.

11.

I X Lysis Buffer. (50 mM Tris HC1, pH 7.4,150 mM NaCl, 1% v/v Triton X-100,
1% w/v sodium deoxycholate, 0.1% w/v SDS, 5 mM EDTA, containing freshly
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added 2% v/v aprotinin solution, 380 pg/ml N-tosylamido-L-arginine methyl
ester, 100 (ig/ml phenylmethylsulfonyl fluoride, 10 pg/ml leupeptin). The
following are mixed in a tube on ice immediately before use.

Aprotinin solution (10 U/ml)

0.200 ml

TAME (38 mg/ml)

0.100 ml

PMSF (10 mg/ml in 2-propanol)

0.100 ml

Leupeptin (5 mg/ml)

0.020 ml

Lysis Buffer Stock

12.

9.6 ml

Electrode Buffer: (25 mM Tris, 192 mM glycine, 0.1% w/v SDS). This is made
as a 5X stock containing 15 g Tris base, 72 g glycine and 5 g SDS per liter of
solution. The pH of the 5X buffer is near 8.5. The pH should not be adjusted
with acid or base as this will increase the electrical conductivity. 5X electrode
buffer is diluted with 4 parts water before use.

13.

I M T ris HCl, p H 6.8: This buffer is stable for several months at 4 °C.

14.

1.5 M Tris HCl, p H 8.8: This buffer is stable for several months at 4 °C.

15.

10% w/v SDS: This is stored at room temperature.
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16.

1 MDithiothreitol (DTT): This is divided into aliquots and stored at -20° C.

17.

10% w/v Ammonium Persulfate (10% APS): 100 mg of APS is added to 1 ml of
deionized water. This solution is prepared fresh daily.

18.

N,N,N',N'-Tetramethylethylenediamine(TEMED): This is used undiluted from the
bottle.

19.

SDS Sample Buffer: (60 mM Tris-Cl, pH 6.8,2% w/v SDS, 10% v/v glycerol,
0.025% bromphenol blue, 100 mM dithiothreitol). This is prepared as a stock
without the reducing agent dithiothreitol (DTT). The stock is stable at room
temperature.
Water
1.0 M Tris, pH 6.8

24.5 ml
3.0 ml

10% SDS

10.0 ml

Glycerol

5.0 ml

0.5% Bromphenol blue

2.5 ml

Just before use, 100 pi o f 1 M DTT is added to every 0.9 ml of sample buffer
needed for the experiment.

20.

Resolving Gel (5.6 %>total acrylamide): This is made in a 15 ml disposable
screwcap tube. This recipe makes enough for two mini-gels (0.075 cm X 8.0 cm
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X 7.3 cm).
Water

5.9 ml

40% Acrylamide stock

1.4 ml

1.5 M Tris, pH 8.8

2.5 ml

10% SDS

0.1ml

Just before pouring, 100 pi o f 10% APS and 8 pi of TEMED are added. The tube
is mixed by inversion, and the gels are poured immediately.

21.

Stacking Gel (3% total acrylamide): This is made in a 15 ml disposable tube.
This recipe makes more than enough for two 1 cm stacking gels for the mini-gels.
Water

2.34 ml

40% Acrylamide stock

0.225 ml

1 M Tris, pH 6.8

0.375 ml

10% SDS
0.030 ml
Just before pouring, 30 pi o f 10% APS and 3 pi TEMED are added. The tube is
mixed by inversion, and the gels are poured immediately.

22.

Tris Buffered Saline (TBS): (20 mM Tris HCl, pH 7.5,0.5 M NaCl). This buffer
is prepared as a 1OX stock. 24.2 g of Tris and 292.2 g of NaCl are dissolved in
800 ml of deionized water. The pH is adjusted to 7.5 with 6 M HCl. The volume
is made up to 11 with deionized water. The buffer is sterilized by filtration (0.2
pm) and is stored at room temperature. Before use, the 10X buffer is diluted with
9 volumes of deionized water.
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23.

Tris Buffered Saline with Tween 20 (TTBS): (IX TBS + 0.05% v/v Tween-20
(Sigma, cat. no. P-9416)). This buffer is usually made up fresh for each run.
About I I is required.

24.

Transfer Buffer: (25mM Tris, 192 mM glycine, 20% v/v methanol). This buffer is
made up for each run (1 1) and is chilled before use. 14.4 g glycine (Sigma, cat.
no. G-7032) and 3.0 g Tris are mixed with 200 ml methanol. The volume is made
up to 1 I with deionized water. As with SDS-PAGE electrode buffer, the pH
should be around 8.5 and should not be adjusted with acid or base.

25.

Blocking Buffer: (5% w/v nonfat dry milk, 0.02% sodium azide in TTBS). This
buffer is stable for at least two weeks at 4° C.

26.

Immunoblot Antibody Dilution Buffer: (1% nonfat dry milk, 0.02% sodium azide
in TTBS). This buffer is stable for at least two weeks at 4° C.

27.

Alkaline Phosphatase Buffer (AP Buffer): (lOOmM Tris HCl, pH 9.5, 100 mM
NaCl, 50mM MgCU). 12.1 g of Tris and 5.8 g of NaCl are dissolved in 900 ml of
deionized water. The pH is adjusted to 9.5 with 6 M HCl before adding 10.0 g o f
MgCl2-6H20 . The volume is then adjusted to 1 1with deionized water. This
buffer is filter sterilized (0.2 pm) and stored at room temperature.
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28.

5-Bromo-4-chloro-3-indolyl-phosphate, toluidine salt (BCIP'): (50 mg/ml in N,Ndimethylformamide, Boehringer Mannheim, cat. number 1383 221). This
solution is stored at -20° C.

29.

4-Nitro blue tetrazolium chloride (NBT): (100 mg/ml in 70% v/v N,Ndimethylformamide, Boehringer Mannheim, cat. no. 1383 213). This solution is
stored at -20° C.

30.

Alkaline Phosphatase Substrate Solution: 45 pi NBT stock solution and 35 pi
BCIP are added to 10 ml o f AP buffer. This solution is unstable and light
sensitive. It should be prepared immediately before use.

31.

TE: (10 mM Tris HCl, pH 8.0, ImM EDTA). This buffer is filter sterilized (0.2
pm) and stored at room temperature.

METHODS
For both immunoblotting and immunohistochemical staining we have used the
monoclonal antibody (mAb) C219. This mAb was originally raised against membrane
fractions from MDR Chinese hamster ovary cells (Kartner et al., 1985). C219 recognizes
a highly conserved linear epitope which is found in all Pgp deduced amino acid
sequences including the only published fish sequences (Georges et al., 1990; Chan et al.,
1992). This epitope is denaturation resistant which makes the mAb useful both in
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immunoblots and in immunohistochemical staining on formalin-fixed paraffin-embedded
tissues.
Method I: Pgp Immunohistochemistry
Immunohistochemical staining provides information on Pgp expression at the
cellular and subcellular levels. Relative levels of expression in different cell types can be
compared on the same slide within the same section. However, variability from slide to
slide and from block to block makes this technique difficult to use for quantitative
comparisons o f expression between individuals. More quantitative information can be
obtained from immunoblots (see below).
Several controls are necessary to avoid artifacts in this technique. It is standard
practice to include both a positive and a negative control on each slide in the form of a
tissue that is known to express Pgp and one that does not. It is also important to incubate
sections with an irrelevant antibody to control for nonspecific binding of IgG. For our
studies mummichog liver sections serve as both positive and negative tissue controls
since these contain cell types that express Pgp (hepatocytes) and cells that apparently do
not such as red blood cells. For an antibody control we use a matched isotype mouse
myeloma protein (IgG2a, kappa) at the same dilution as C 219 (1.5 (ig/ml). The irrelevant
antibody control can be performed on the adjacent section on the same slide if the
sections are circled with a PAP pen (Research Products International). This pen deposits
a hydrophobic film on the slide which will retain the antibody solutions on the section
and prevent spill-over between sections.
We have developed the immunohistochemical staining protocol for use with
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Bouin's fixed paraffin-imbedded tissues. This has allowed us to examine much of the
archival material from past histopathological studies when we have routinely fixed
specimens in Bouin's fluid. Other fixatives, such as neutral buffered formalin, should
give similar results.
Whenever fresh material is used, sub-samples of normal liver and tumors are
taken and frozen immediately in liquid nitrogen for analysis by immunoblot (see below).
The remaining tissue is fixed and rinsed as follows. Tissues are fixed in Bouin's fluid
(Luna, 1968) for 18-24 hrs. The fixed specimens are rinsed in running tap water
overnight and are then soaked in several changes of Li2C 0 3 saturated 50% ethanol to
remove soluble picrates. Specimens are then stored in 70% ethanol prior to processing.
The Signet ABC reagents in conjunction with mAb C219 are used for detection of
antigen. Biotinylated horse anti-mouse IgG is used as a secondary antibody. Bound
secondary antibody is detected with an avidin-biotinylated horseradish peroxidase
complex (ABC). 3,3' diaminobenzidine (DAB) and hydrogen peroxide are used as
chromogenic substrates.
The following procedure begins with 5 pm thick paraffin-embedded tissue
sections adhered to slides with gelatin. A section from each specimen is also stained with
hematoxylin and eosin (H&E) to allow histopathologic diagnosis o f any lesions present.
Processing of small fish for histopathological studies has been described by Foumie and
colleagues (1996).
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Procedure
This procedure is most easily carried out with the aid o f a hand staining rack
(Shandon, TissueTek II) to hold the various baths. A humidity chamber is required for
the antibody incubations. Plastic food storage boxes with tight fitting lids work well for
this purpose. The bottom of the box is covered with several layers of wet paper towels or
other bibulous paper (Whatman 3MM or similar).
Tissue sections on slides are deparaffinized and rehydrated by the following series
o f baths: xylene, 2 changes, 5 minutes each; 100% EtOH, 2 changes, 3 minutes each;
95% EtOH, 2 changes, 3 minutes each, deionized water, 2 changes, 2 minutes each
followed by a 5 minute bath in deionized water. Then slides are transferred to PBS for 5
minutes. Endogenous peroxidase activity in the sections is then blocked by a bath in 3%
hydrogen peroxide for 5 minutes. The slides are returned to the PBS bath for 5 more
minutes. Slides are removed from the PBS, and the area surrounding the sections is
wiped dry. The section is circled with a PAP pen. This deposits a ring o f hydrophobic
material around the specimen and serves as a well to retain the antibody solutions on the
specimens.
The slides are placed in the humidity chamber and a solution of 10% (w/v) normal
horse serum in PBS is applied to each section using a transfer pipet. In this and all
subsequent steps, enough solution is applied to completely fill the ring made by the PAP
pen and form a bead of solution over the section. The sections are blocked with the horse
serum for 1 hour at room temperature. The slides are then held upright and tapped to
remove excess blocking solution. The primary antibody solution (C219, 1.5pg/ml in PBS
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containing 1% BSA) is applied and the slides are incubated in the humidity chamber
overnight (18 hrs.) at 4° C.
The following morning the ABC reagent is prepared according to the
manufacturers instructions. This solution must be prepared fresh daily and requires a 30
minute incubation at room temperature before use to insure complete complex formation.
The slides are tapped to remove the primary antibody solution and then are rinsed with
PBS by gently flooding the surface of the slide several times using a transfer pipet. The
biotinylated secondary antibody (biotinylated horse anti-mouse, used at the kit
concentration) is then applied to the sections, and the sections are incubated in the
humidity chamber at room temperature for 20 minutes. The secondary antibody solution
is tapped off, and the slides are rinsed with PBS. The sections are then incubated with the
ABC reagent for 20 minutes at room temperature. During this incubation the DAB/H20 ,
(SYgmaFast, Sigma) solution is prepared. After rinsing the slides with PBS, the DAB
solution is applied to the sections, and the reaction is allowed to proceed for 3-5 minutes.
The reaction is quenched by rinsing the slides with deionized water. The slides are then
given a 5 min. tap water rinse, and are counterstained by dipping them for 3-5 seconds in
Harris' hematoxylin. The sections are then differentiated in saturated, aqueous N aH C 03
for 2 minutes. The slides are rinsed in tap water and dehydrated through graded alcohols
to xylene. The sections are coverslipped using synthetic mounting media (Preservaslide,
EM Science).

Method II: Immunoblot analysis of tissue extracts
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Immunoblotting provides both a means of quantifying Pgp expression and a check
on specificity o f detection. Immunoblots have been used frequently to assay expression
of Pgp in mammalian organs and tumors (Richert et al., 1988; Lieberman et al., 1989;
Fredericks et al., 1991). In these studies crude membrane fractions or microsomes are
prepared to generate a Pgp enriched sample. The small size of tissues and especially
tumors from small fishes makes this approach of limited use for our application. We
routinely use detergent lysates (modified RIPA lysis buffer) of unfractionated organ and
tumor samples in immunoblots. This greatly simplifies sample preparation and, in our
system, results in sufficient Pgp signal on the blots.
Immunoblots can provide supporting evidence that the signal seen in
immunohistochemistry results from Pgp expression and not from an unrelated crossreactive protein. The expected molecular weight for Pgps is in the vicinity of 170 kDa
(Kartner et al., 19832). In addition, known Pgps are heavily glycosylated and are
expected to produce a somewhat diffuse band in an immunoblot due to
microheterogeneity in glycosylation (Richert et al., 1988). A single band in immunoblots
in this molecular weight range and o f this characteristic appearance is consistent with
specific detection o f Pgp.
We use pre-stained, calibrated molecular weight standards for SDS-PAGE (BioRad, cat. no. 161-0309) in our immunoblots. These give visible molecular weight
markers on the membrane following transfer. They also provide a check on transfer
efficiency, thus eliminating the need to stain the nitrocellulose membrane for total protein
following transfer.
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Usually a Pgp positive control sample is loaded with each run. We use extracts o f
the colchicine resistant CHRC5 cell line (a generous gift from Dr. Victor Ling, Ontario
Cancer Institute) for this purpose. Extracts of any convenient mammalian tissue known
to have a high level o f expression of Pgp should also be useful for this (e.g. adrenal
gland).
Densitometric scans o f immunoblots can be used to quantify relative levels of
expression between individuals with different exposure histories or between tumor and
normal tissue. For this purpose it is necessary to load several different amounts o f a Pgp
standard. This can be prepared from the tissues of interest (e.g. pooled mummichog liver
extract) or can be made from any convenient source o f Pgp. The different loadings of the
Pgp standard are used to form a standard curve of densitometric peak area versus total
protein. It is important that standards and samples fall within the linear range of this
assay. In our blots using mummichog liver extracts as a standard, this range is usually
between 1 and 20 pg o f total protein per lane.
The following procedure is used in our laboratory for extraction o f Pgp from mummichog
liver and liver tumors and subsequent analysis and quantitation of expression by
immunoblotting. We use the traditional Laemmli discontinuous sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) system (Laemmli, 1970) followed by
'wet1electrophoretic transfer to nitrocellulose membranes (Towbin et al., 1979). Pgp is
detected on the membrane using an indirect technique. The mAb C219 is incubated with
the membranes. Bound C219 is detected with alkaline phosphatase conjugated goat anti
mouse IgG followed by reaction with NBT/BCIP.
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Procedure
a. Preparation o f Tissue Extracts— Fish are anesthestized by placing them in a
bath o f tricane methanesulfonate (200 mg/1 in seawater). Fish are then killed by cervical
transection. Samples o f liver or other tissues are excised as quickly as possible and either
used immediately or snap frozen in liquid nitrogen and stored at -70° C. Homogenization
o f soft tissues such as liver is accomplished in a teflon-glass homogenizer powered by a
electric drill motor. The sample is allowed to just thaw and is placed in the prechilled (on
ice) teflon glass homogenizer (Potter-Elvejehm type) containing 5 volumes o f cold lysis
buffer. The tissue is homogenized by 3 up and down strokes at full speed.
The resulting crude homogenate is transferred to a 1.5 ml polypropylene
microcentrifuge tube and is spun at full speed for 5 minutes in a microcentrifuge
(Eppendorf, model 5415) in the cold. The homogenate separates into three layers during
centrifugation; a floating layer o f lipid material, a layer of clear supernatant and a pellet
o f insoluble tissue debris plus nuclear DNA. The lipid layer is carefully removed with a
cotton tipped applicator. The supernatant is then transferred to a fresh tube on ice. The
clear lysate can be stored frozen at -70° C at this stage or can be used immediately in
immunoblots.
Protein concentrations are determined using a modified Lowry assay that is
compatible with the detergents in the lysis buffer (Bio-Rad, Dc Protein Assay, cat. no.
500) using BSA as a standard.
b. SDS-PAGE— Samples are resolved on discontinuous SDS-PAGE Laemmli
gels using the Bio-Rad Miniprotean II apparatus. We use resolving gel concentration of
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5.6% total acrylamide and a 3% stacking gel with the standard buffer. We find it
unnecessary to degas the gels if the concentration of ammonium persulfate in the gel
recipes is increased to 1%. Gels are prepared from a 40% acrylamide stock solution
(acrylamide:bismethylene acrylamide ratio 36.5:1). The electrophoresis apparatus is
assembled according to the manufacturer's instructions. The resolving gel is prepared and
is poured between the plates using a 10 ml pipet to within 1 cm of the bottom of the gel
comb. The gel is then immediately overlain with 0.5 ml of deionized water using a
syringe needle. The resolving gel is allowed to polymerize for 30 minutes. The water
overlay is poured off, and the residual liquid is blotted out with filter paper. The stacking
gel is prepared and poured with the comb in place. After another 30 minutes the combs
are removed, and the gel sandwiches are set up in the electrophoresis box according to the
manufacturer's instructions.
While the gels are polymerizing, the samples are prepared for electrophoresis.
Samples are thawed and kept on ice at all times. Each sample is diluted with Laemmli
sample buffer to a final protein concentration o f 0.5 to 2 pg/pl. Samples are heat
denatured in a 65° C water bath for four minutes and then placed on ice until they are
loaded onto the gel. (Note: Higher denaturation temperatures result in polymerization of
Pgp.) Usually between 1 and 20 pg o f total protein per lane is loaded in a 10 pi volume of
sample buffer for mummichog liver samples. Samples are loaded with a Hamilton
syringe. Using the small well combs of the minigel apparatus, up to 15 pi of sample can
be loaded in each well. Normally a lane of molecular weight standards and a lane
containing a Pgp positive control sample are also loaded.
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The gels are run at 200 V (constant voltage) at room temperature until the dye
front just reaches the bottom of the gel. This takes about 30 minutes.
c.

Electrophoretic Transfer to Nitrocellulose Membranes— At the end o f the run,

the gel sandwiches are disassembled. The somewhat fragile gels are best manipulated
while still stuck to the glass plate. Each sandwich is held horizontally with the large plate
down, and the small plate is gently pried off using one of the spacers. Usually the gel
remains stuck to the large plate. The stacking gel is cut off of each gel and is discarded.
This is easily accomplished using one of the gel spacers to gently pull this stacking gel
away. The first lane o f each gel is marked by cutting off the comer of the gel over the
first lane. If two gels are run at the same time they may be identified by cutting different
sized pieces from each one.
Each gel is gently floated off of its plate by dipping the plate with the attached gel
in a plastic dish containing 100 ml o f transfer buffer until the gel slides into the dish. The
gel is washed in transfer buffer for 20 minutes at room temperature with gentle agitation.
The blotting materials are prepared while the gels are equilibrating. The
nitrocellulose membranes are cut to a size slightly larger than the gels. These are then
soaked in transfer buffer. Four sheets (per gel) of chromatography paper (Whatman
3MM) cut to the size of the transfer cassette are also soaked in cold transfer buffer. After
20 minutes the transfer buffer is carefully poured off of the gels and replaced with 100 ml
of fresh transfer buffer. The gels are now ready to be placed in the transfer cassette.
The cassette is placed cathode side (black side) down in a baking dish containing
a few cm o f cold transfer buffer. One of the porous plastic pads provided by the
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manufacturer (a rectangular plastic scouring pad also works) is placed in the dish and any
bubbles are forced out. The saturated pad is placed on top o f the cathode side o f the
transfer cassette. The gel is then moved onto a stack o f two sheets of saturated paper by
submerging the papers in the dish containing the gel and floating the gel onto the center
of the paper stack. The papers and the gel are then placed on top of the plastic pad in the
transfer cassette. All air bubbles are carefully removed from beneath the gel and the
blotting paper by rolling a test tube over the surface o f the gel. The pre-wetted
nitrocellulose membrane is then placed on the gel, and all air bubbles are removed as
before. The transfer sandwich is completed by placing two more sheets of buffersaturated paper on top o f the nitrocellulose followed by another saturated plastic pad.
The cassette is then placed in the slot in the transblot device. The ice pack is placed next
to it, and the buffer chamber is filled with cold transfer buffer. About 1 1of buffer is
required for each run. The assembled transfer chamber is placed in a chromatographic
refrigerator (4° C). The gels are transferred for 16-18 hours at 34 V (constant voltage).
Under these conditions, the apparatus draws about 50 mA of current at the beginning of
the run. By the next day the ice in the cooling pack has melted, and the current has
increased to about 80 mA.
d.

Detection o f Immune Complexes— After transfer, the cassettes are

disassembled and each membrane is cut to the exact size of its gel. The corresponding
comer is cut off to provide unambiguous orientation and the membrane is labelled on the
back with a pencil to identify it.
It is possible to stain the membrane for total protein at this point using Ponceau S
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to verify transfer efficiency. Membranes are placed directly into Ponceau S solution
(0.1% w/v Ponceau S in 5% acetic acid, Sigma, cat. no. P7170) for 10 minutes. This
reversibly stains all protein bands on the blot. If molecular weight standards are included,
the position o f these is marked at this time with a pencil. If no bands appear, it is not
worth continuing, since transfer did not occur. A common cause o f this is failure to
orient the transfer cassette correctly in the transfer apparatus (cathode(black)-gelnitrocellulose-anode(red)).
An easier alternative to check transfer efficiency and provide size standards is to
use pre-stained molecular weight standards as mentioned previously. These are readily
visible on the membrane. All but the highest molecular weight standard should
completely transfer from the gel. This lane unambiguously shows the orientation of the
blot and makes cutting a comer o f the blot unnecessary.
After transfer is verified, the membranes are placed in a covered plastic dish
containing 100 ml o f blocking buffer for 1 hour at room temperature. During all
incubation and washing steps, constant gentle agitation is provided by an orbital shaker
platform. The membranes are transferred to another plastic dish containing 20 ml of
diluted C219 at a concentration o f 2.5 jig/ml (1:40 dilution o f reconstituted C219) in
antibody buffer. Membranes are incubated in the primary Ab for 1 hour at room
temperature. (Note: The primary antibody solution can be saved at - 20° C and reused at
least 10 times before loss in sensitivity becomes noticeable.) After 1 hr., the membranes
are transferred to a container with 100 ml of TTBS and washed for 5 minutes. The wash
step is repeated before transferring the membranes to the secondary Ab conjugate
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solution. The membranes are incubated for 1 hour at room temperature with 25 ml of
freshly diluted goat anti-mouse alkaline phosphatase conjugate (1:3000 in antibody
dilution buffer). The membranes are then washed with two changes of TTBS as before,
followed by another 5 minute wash in TBS without Tween 20. The membranes are then
given a final wash for 2 minutes in AP buffer. The membranes are then placed in a
plastic bag containing 10 ml o f BCIP/NBT substrate solution. All air bubbles are
removed from the membrane surfaces, and the membranes are incubated in the dark until
the lowest concentration bands become visible. This usually takes about 15 minutes.
The color development reaction is stopped by washing the membrane in deionized water
and placing it in TE. Membranes are stored at 4° C in TE.
Blots are then photographed (Polaroid Pos./Neg. film type 665) and are subjected
to densitometry if quantitation is desired. We use a Shimadzu 930 TLC scanner set at
550 nm for quantitation.

RESULTS and DISCUSSION
Immunohistochemistry— Immunohistochemical staining has been used to detect
Pgp expression in normal mammalian tissues. This technique has shown Pgp expression
on the canalicular surface of hepatocytes in normal liver (Thiebaut et al., 1987; Thiebaut
et al., 1989; Bradley et al., 1990). We have found that immunohistochemical staining of
sections o f normal mummichog liver showed specific staining that corresponds to the
mammalian pattern of expression with allowances for the differing architecture o f fish
liver (Hampton et al., 1985). The immunoperoxidase stain clearly showed the structure
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o f the bile canaliculi within the section (Figure 3A). There was no stain in the cytoplasm
or other organelles in normal hepatocytes. No other hepatocellular elements were stained
in these preparations. This pattern o f subcellular localization is consistent with the
hypothesis that P-glycoprotein may have an excretory function in fish liver as has been
suggested for mammals (Arias, 1990; Thorgeirsson et al., 1991).
Increased expression o f Pgp has been detected by C219 immunohistochemical
staining in human neoplasms (Weinstein et al., 1991). Immunohistochemical staining has
shown Pgp overexpression in experimentally induced rat hepatocellular carcinoma and
advanced preneoplastic lesions (Bradley et al., 1992). Using mummichog from a
creosote contaminated site with a high prevalence of hepatic neoplasms, we were able to
examine Pgp expression in hepatic tumors of fish. Many tumors showed increased C219
immunoperoxidase staining (overexpression) as well as alterations in the pattern of
expression (Figure 3B). Often there was a loss of polarity with the entire plasma
membrane staining. Cytoplasmic staining and some paranuclear (Golgi) staining was
also evident. The alterations in pattern and degree of immunohistochemical staining
observed in these fish liver tumors were similar to those reported for rat liver hyperplastic
nodules and hepatocellular carcinoma (Bradley et al., 1992).
In both tumor and normal liver preparations we observed no staining when mouse
myeloma protein was used in place o f C219 (Figure 3C).
Immunoblots— Immunoblots have been used to identify and quantify Pgp
expression in drug resistant mammalian cell lines (Kartner et al., 1985) and in
mammalian tumors and normal tissues (Hitchins et al., 1988; Liberman et al., 1989;
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Fredericks et al., 1991). Immunoblots have also been used to identify Pgp family
members in some aquatic organisms (Kurelec et al., 1992; Toomey and Eppel, 1993;
Minier et al., 1993). We have identified a single main immunoreactive band in
immunoblots of mummichog liver and tumor extracts (Figure 3D). The mummichog Pgp
band migrated at a relative molecular weight o f 177 kDa. This is a higher molecular
weight than that of the immunoreactive band in extracts o f the multidrug-resistant CHRC5
cell line in our system (165 kDa) but is within the molecular weight range reported for Pglycoproteins. The mummichog liver and liver tumor Pgp bands also had the same
characteristic diffuse appearance as the mammalian Pgp. This is consistent with
glycosylation of the putative mummichog Pgp. These results help confirm that the
antigen labeled in immunohistochemical staining is a Pgp family member.
Densitometric analysis of the immunoblot shown in Figure 3D indicated
approximately a three fold increase in expression of Pgp in a mummichog liver adenoma
compared to the adjacent normal tissue. These results are consistent with the
overexpression seen in immunohistochemical staining of this adenoma and allow a
quantitative estimate o f overexpression.
Advantages of Combined Immunochemical Methods— We have found that
using immunohistochemical staining and immunoblotting together provides information
that neither one alone could give. Immunoblots combined with densitometric analysis
have allowed comparison of relative levels of expression between individuals and
between discrete proliferative lesions and surrounding non-neoplastic liver.
Immunohistochemical staining has proved less quantitative but has provided
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important information on the relative level of expression at the cellular and subcellular
levels which is destroyed in whole organ homogenates. In our system the two techniques
have supported the assumption that the protein labelled is a P-glycoprotein. Immunoblots
show specific staining of a single band o f the correct molecular weight and
characteristics. Immunohistochemical staining shows that in normal fish liver, as in
mammalian liver, Pgp is present only on the canalicular surface of hepatocytes; whereas
in hepatic tumors there is often overexpression as well as loss of polar expression o f this
antigen.
Further Applications— We are continuing to use these techniques in our studies
of Pgp expression in the mummichog. We are investigating induction of Pgp in
mummichog liver in response to environmental and laboratory exposures to PAHs. We
are also studying relationships between relative Pgp expression and hepatic lesion
classification in fish from the PAH contaminated site. The highly conserved nature o f the
C219 epitope and the high specificity demonstrated with mummichog tissues should
make the immunochemical techniques described here useful in detecting Pgp expression
in many other aquatic organisms.
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Figure 3. C219 immunochemical detection of Pgp in liver and hepatic proliferative
lesions o f mummichog. A: Immunochemical localization o f Pgp in normal mummichog
liver on the bile canalicular surface (arrowheads) o f hepatocytes. B: Immunochemical
localization of Pgp in a mummichog liver adenoma showing overexpression, paranuclear
(Golgi) staining (arrowheads) and degeneration o f polar membrane expression including
staining o f the sinusoidal surface (arrows) of hepatocytes. C: Matched isotype mAb
negative control o f section adjacent to that shown in B. D: Immunoblot of paired
samples o f grossly visible lesions (lanes 2 and 4) and adjacent uninvolved liver (lanes 1
and 3); the pair in lanes 1 and 2 are subsamples of the liver and lesion shown in A and B.
Positions o f standards are shown with their molecular weight (kDa) at the left.
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INTRODUCTION
Chapter II (Cooper et al., 1996) o f this dissertation presented methods that use
monoclonal antibody (mAh) C219 (Kartner et al., 1985) in immunoblots and
immunohistochemical staining to detect and measure relative levels of Pgp expression in
mummichog liver and in mummichog liver tumors. Results using these methods
indicated that one or more P-glycoprotein homologs are expressed in the bile canalicular
surface o f hepatocytes in mummichog liver. This expression pattern is consistent with
expression reported in mammalian (Thiebaut et al., 1987; Thiebaut et al., 1989; Bradley
et al., 1990) and guppy liver (Hemmer et al., 1995). We also have found that some
mummichog liver tumors from mummichog inhabiting a heavily creosote-contaminated
site (Atlantic Wood) overexpress P-glycoprotein and have altered subcellular localization
o f this antigen. This is similar to the altered expression of Pgp reported for mammalian
hepatic neoplasms (Fairchild et al., 1987; Thorgeirsson et al., 1987; Teeter et al, 1990;
Vohm et al., 1990; Bradley et al., 1992). The conditions at the Atlantic Wood site
provide a unique opportunity to study the response of Pgp expression in fish liver to
environmental contaminant exposure and to examine changes in Pgp expression during
environmental hepatocarcinogenesis in a teleost. In the present Chapter, we have used
our immunochemical techniques to survey expression patterns and levels o f Pgp antigens
in environmentally induced liver tumors and in the livers of mummichog from the
Atlantic Wood site.
We have compared levels of Pgp expression in the non tumor-bearing livers of
chemically resistant fish from the Atlantic Wood site to levels to expression in sensitive
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fish from an uncontaminated environment (King Creek) in order to determine whether the
analogy to the xenobiotic resistance phenotype reported for these livers (Van Veld and
Westbrook, 1995) extends to increased expression o f Pgp. In order to address whether
changes in Pgp expression in the livers o f resistant fish could result from induction o f Pgp
expression by exposure to PAHs, we have measured Pgp expression in sensitive fish
following exposure to a single carcinogenic PAH (3-methylcholanthrene). We have also
extended our studies o f the biochemical properties of hepatic proliferative lesions of these
fish to include Pgp, a putative marker of the drug-resistance phenotype in mammalian
liver tumors (Farber and Sarma, 1987; Fairchild et al., 1987; Thorgeirsson et al., 1987;
Thorgeirsson et al., 1991).
Results reported here demonstrate detectable increases of Pgp expression in non
tumor bearing liver of Atlantic Wood mummichog as well as high level overexpression
and altered patterns o f expression in a majority of hepatic neoplasms examined from
these fish. This is the first report of increased Pgp expression in a teleost from a polluted
environment and is the first study of Pgp expression in the tumors of a lower vertebrate.
These results are similar to what is known about Pgp expression in mammalian liver and
liver tumors. This increased Pgp expression may have implications for the tolerance or
adaptation of these fish inhabiting a contaminated environment.

MATERIALS AND METHODS
Collection of mummichog livers— Mummichog were collected with minnow
traps in October o f 1994 and July of 1996 from a creosote contaminated site and a
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relatively uncontaminated site. The contaminated site was a marsh creek that collects
run-off from a defunct wood treatment facility (Atlantic Wood Products) in the Elizabeth
River in Portsmouth, VA. This site has been reported to have very high sediment
concentrations of PAHs (2200 mg/Kg dry sediment) (Vogelbein et al., 1990). The
uncontaminated site was King Creek, a marsh creek tributary to the Severn River in
Gloucester County, VA. Fish from each site were collected within one day of each other
and were killed within 48 hr with an overdose of tricaine methane sulfonate (Sigma, St.
Louis, MO). Livers were removed, snap frozen in liquid nitrogen and stored at -70° C
until use. Only male fish without grossly visible tumors were used in these analyses.
Preparation of liver extracts— Processing of mummichog livers essentially
followed the protocols given in Chapter II of this dissertation (Cooper et al., 1996).
Mummichog livers were homogenized in 5 to 10 volumes of ice cold lysis buffer (50 mM
Tris HC1, pH 7.4, 150 mM NaCl, 1% v/v sodium deoxycholate, 0.1% w/v SDS, 5 mM
EDTA) which contained freshly added protease inhibitors (2% v/v aprotinin solution
(Sigma), 380 pg/ml N-toluenesulfonylamido-L-arginine methyl ester, 100 pg/ml phenyl
methyl sulfonyl fluoride, 10 (ig/ml leupeptin). Livers were homogenized in a Polytron
homogenizer (Brinkman Instruments, Westbury, NY). Homogenates were allowed to
stand on ice for 10 minutes and then were clarified by centrifugation in an Eppendorf
model 5415 microcentrifuge (10 min, 12000 rpm, 4° C). Protein concentrations of the
extracts were determined using the Lowry assay with bovine serum albumin as a
standard.
Immunoblotting of mummichog liver extracts with the monoclonal
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antibodies C219, JSB1 and C494— The procedure for SDS-PAGE, electrophoretic
transfer and immunodetection using mAb C219 essentially were as described in Chapter
II (Cooper et al., 1996). Mummichog liver extracts were diluted to a concentration of 0.5
mg/ml with SDS-PAGE sample buffer (60mM Tris-HCl, pH 6.8, 2 % w/v SDS, 10% v/v
glycerol, 100 mM dithiothreitol, 0.025% bromphenol blue). Samples were heated to 65°
C for 4 min, and were then loaded onto a 5.6% (total) acrylamide SDS-PAGE mini-gel
(7.3cm X 8.0 cm X 0.075cm) at 2 pg per lane. Several different amounts o f a pooled
extract of 5 livers from the uncontaminated site were also loaded onto each gel to serve as
a quantitation standard. Usually 0.5 pg, 2 pg, 4 pg and 8 pg of this reference extract
were loaded in separate lanes. Samples were electrophoresed under standard conditions
(200 V, 30 min). The SDS-Page gels were then transferred electrophoretically (34 V, 18
hr) to nitrocellulose membranes (BioRad, 0.2 pm). The transfer buffer was 25 mM Tris
base, 192 mM glycine containing 20% v/v methanol. Following transfer, the
nitrocellulose membranes were blocked in Tris buffered saline (TBS) (20mM Tris-HCl,
pH 7.5, 0.5M NaCl) containing 5% w/v nonfat dry milk and 0.1%Tween-20. Following
blocking the membranes were incubated with mAb C219 (Signet, Dedham, MA) (2.5
pg/ml, in TBS with 1% Tween-20, 1% nonfat dry milk) for 1 hr at room temperature.
The membranes were washed twice for 5 min in TBS-Tween 20 and were then incubated
for 1 hr at room temperature with goat antimouse IgG-alkaline phosphatase conjugate
(BioRad, Richmond, CA) (1:2000 in TBS-Tween 20). The membranes were then washed
twice in TBS-Tween 20. After a final wash in TBS, immune complexes were detected on
the membrane using 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and p-nitro blue
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tetrazolium chloride (NBT) as chromogenic substrates for alkaline phosphatase. In
addition to mAb C219 two other mammalian monoclonal antibodies, C494 and JSB1
(Signet, Dedham, MA), were also used in immunoblots. The procedure used for
detection using these antibodies was similar to that given here for C219 except that these
antibodies were used at higher concentrations (10 pg/ml) and were incubated with
immunoblot membranes for up to 24 hrs with the goal of increasing sensitivity. Up to 30
pg o f total protein was loaded per lane in gels used with these antibodies.
Estimation of relative Pgp content in mummichog liver extracts— The
intensity o f staining of immunoblots probed with mAb C219 was measured with a
Shimadzu CS-930 scanning densitometer set at a wavelength of 550 nm. The
densitometric peak area for each Pgp band was normalized by comparing it to a standard
curve of peak area versus total protein for varying amounts of a pooled extract o f King
Creek mummichog liver loaded on each blot. Values of Pgp expression were then
expressed relative to this standard extract. Arbitrary units were devised by assigning a
value of 100 to the signal obtained from 1 pg of the pooled King Creek liver extract. The
specific content o f Pgp in each sample was then expressed in terms of these arbitrary
units per microgram o f protein.
Laboratory exposure of mummichog to 3-methylcholanthrene— Male
mummichog collected from King Creek that had been maintained in captivity for several
months were used in this portion of the study. Fish were given intraperitoneal (i.p.)
injections o f either 3-methylcholanthrene (Sigma, St. Louis, MO) dissolved in com oil
(10 mg/ml) or com oil alone. Injection volumes were adjusted so that each fish received
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a dose of 100 mg/Kg body weight or 10 ml com oil/Kg body weight. The two groups of
fish were maintained in separate 10 gallon aquaria provided with flowing water from the
York River for 24 hrs before and for 36 hrs following treatment. The fish were fed once
daily during this period. Thirty six hrs after injection the fish were killed by overdose
with tricaine methane sulfonate and their livers were removed, frozen in liquid nitrogen
and stored at -70° C. Detergent extracts of the livers were analyzed for Pgp expression as
described above. In addition these extracts were analyzed for relative levels o f CYP1A
expression as described in the next section using the monoclonal antibody (mAb 1-12-3)
produced against the CYP1A protein o f the scup (Park et al., 1986). This antibody has
been used to measure cytochrome P4501A levels in many fish species including the
mummichog (e.g. Van Veld et al., 1992; Van Veld et al., 1990; Gallagher et al., 1995).
Student’s t-test was used to test for significant differences among means of
expression levels between the contaminated and uncontaminated sites or between
3-methylcholanthrene exposed fish and control fish.
Immunodetection of cytochrome P4501A in extracts of 3-MC treated
mummichog liver— Immunodetection of cytochrome P4501A in 3-MC treated liver
followed a similar protocol to the one given above for Pgp immunodetection with the
substitution o f mAb 1-12-3 (Park et al., 1988) as the primary antibody. (This antibody
was a generous gift o f Dr. John Stegeman, Wood’s Hole Oceanographic Institute.)
Samples were analyzed by electrophoresis on 10% acrylamide gels instead of 5.6%
acrylamide gels because of the lower molecular weight o f the CYP1A protein. For
CYP1A analysis, 20 pg o f total liver protein was loaded per lane of the blot. All other
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electrophoresis, transfer and incubation conditions were identical to those for immunoblot
detection of Pgp with mAb C219.
Immunohistochemical staining of mummichog liver and liver lesions— Many
o f the mummichog liver and tumor specimens used in this study were archival specimens
used in previously reported histopathological studies (Vogelbein et al., 1990). These
specimens were collected in August 1989 and 1990 from the Atlantic Wood site in the
Elizabeth River. Additional specimens were collected in 1992 from both Atlantic Wood
and King Creek. The fixation and processing of the fish tissues were as described
(Vogelbein et al., 1990). Over 90 histologic sections o f livers from the creosote
contaminated site containing proliferative lesions were stained for Pgp.
Immunohistochemical staining o f Bourn’s fixed paraffin embedded tissue sections
followed the protocols presented in Chapter II (Cooper et al., 1996). For
immunohistochemical staining with mAb C219, 5 pm thick sections were cut from the
paraffin blocks and were adhered to slides with gelatin. A section from each block was
also processed for routine staining with hematoxylin and eosin (Luna, 1968). To control
for nonspecific binding o f the primary and secondary antibodies, histologic sections were
also incubated with mouse myeloma protein (Sigma) o f the same isotype as mAb C219
(lgG 2a, kappa) and processed as described for mAb C219.
Tissue sections were deparaffinized in xylene and rehydrated through graded
alcohols to phosphate buffered saline (PBS). Endogenous peroxidase activity was
blocked by a bath in 3% aqueous H20 2. After rinsing in PBS, sections were incubated in
10% normal horse serum in PBS to block nonspecific binding. The sections were then
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incubated for 18 hrs at 4° C with mAb C219 (Signet, Dedham, MA) (1.5 pg/ml in PBS
with 1% bovine serum albumin). Detection o f C219 was accomplished using a
biotinylated secondary antibody (biotinylated horse anti-mouse) and an avidinbiotinylated horseradish peroxidase complex (Elite Avidin-Biotin Complex
Immunohistochemical Staining Kit, Signet Laboratories, Dedham, MA). Immune
complexes were stained using 3,3' diaminobenzidine and H20 2 (Sigmafast tablets, Sigma,
St. Louis, MO) as chromogenic substrates for horseradish peroxidase. Sections were
counter stained lightly with Harris’ hematoxylin and differentiated in aqueous N aHC03.
Sections were dehydrated through graded alcohols to xylene and mounted in synthetic
mounting medium (Preservaslide, EM Science).

RESULTS
Immunoblot detection of Pgp in normal liver— Three different monoclonal
antibodies to mammalian Pgps were used in immunoblots to detect P-glycoprotein
expression in mummichog liver. Immunoblots of extracts of mummichog liver using the
mAb C219 showed a highly immunoreactive band at a size near 170 kDa (Figure 4A).
The mAb JSB-1 also reacted with a protein o f this molecular weight in mummichog liver
extracts although the signal was much weaker (Figure IB). In the present study no
immunoreactive proteins were detected in mummichog liver extracts using the mdrl
specific mAb C494 (Georges et al., 1990) under the same conditions (not shown).
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Immunoblot measurement of increased expression of Pgp in livers of mummichog
from a creosote contaminated site— The mAb C219 was used to evaluate changes in
Pgp expression in mummichog exposed to PAHs. Analysis of mummichog liver extracts
from Atlantic Wood and King Creek mummichog collected at two different times
indicated a significant increase (Student’s t-test, p<0.05) in Pgp expression in the livers of
Atlantic Wood mummichog (Figure 5, Table 2). The average increase in expression of
the Pgp was 3.2 fold and 2.6 fold (Table 2) in the livers of fish from Atlantic Wood in
1996 and 1994 respectively.
Immunoblot assay of Pgp expression following i.p. administration of 3-MC—
There was no significant increase in the intensity of staining for Pgp in immunoblots of
liver extracts o f mummichog given intraperitoneal injections of 3-methylcholanthrene (3MC) compared to a group o f fish injected with com oil (36 hrs post injection). The
relative Pgp contents in the two treatments were 144±30 units/pg protein and 128±32
units/pg protein for the 3-MC and com oil treatments respectively. However the levels of
CYP1A were found to be ten-fold higher in the 3-MC treated fish in immunoblot analysis
(Figure 6). This increase in CYP1A established that effective exposure of the fish to the
3-MC had taken place.
Immunohistochemical detection of Pgp expression and overexpression in
mummichog hepatic neoplasms and advanced preneoplastic lesions— We used
immunohistochemical staining with C219 to examine samples of mummichog liver and
liver tumors for Pgp expression. Histologic sections of normal livers of fish from either
the creosote contaminated site or from a relatively clean site showed typical specific
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immunohistochemical staining o f the canalicular surface of hepatocytes (Figure 7). No
staining o f mummichog liver or liver tumor sections was observed when a matched
isotype mouse myeloma protein was used in place o f mAb C219 in the
immunohistochemical staining protocol (Figure 8).
There was no clear indication of altered expression o f Pgp in putative early
preneoplastic lesions (altered foci) of Elizabeth River mummichog (not shown) although
many o f the livers exhibited regional heterogeneity o f staining for Pgp. Unlike the early
proliferative lesions however, many of the hepatocellular carcinomas and adenomas
exhibited obvious alterations in expression of P-glycoprotein (Figure 9). Eight
adenomas, sixteen hepatocellular carcinomas and two hepatoblastomas were examined.
These lesions have been described previously (Vogelbein et al, 1990; Van Veld et al.,
1992; Vogelbein et al., 1996). Many of these lesions had elevated levels of
immunohistochemical staining indicating over-expression of Pgp (Figure 9A-F). O f the
sixteen hepatocellular carcinomas ten had clear overexpression compared to the
surrounding parenchyma while the remainder had reduced or approximately equivalent
expression to the surrounding normal tissue. Many of the carcinomas had aberrant
localization of the Pgp antigen as well. There were examples of cytoplasmic staining
(e.g. Figure 9C&D), paranuclear or “Golgi” staining (e.g. Figure 9 G ), and varying
degrees o f loss o f polarity ranging from an increase in size of the region stained
surrounding the bile canaliculus (Figure 9B) to staining of the entire plasma membrane
(Figure 9E ). Six of the eight adenomas had elevated Pgp staining. There was
predominant polar staining of the bile canaliculus in all cases (Figure 6 A). Three of
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these lesions also had tracts o f extreme overexpression, and in these regions there was
loss of polarity. High level expression of Pgp was observed in the two hepatoblastomas.
One hepatoblastoma had very well developed canalicular staining (Figure 9F ) while the
second exhibited loss o f polar expression. These patterns o f expression are consistent
with the degree of differentiation of the two lesions at the ultrastructural level (Vogelbein
et al., 1996). Overall the retention of polar (canalicular) staining in all three categories o f
progressed proliferative lesions was correlated with the degree o f differentiation of the
lesion (morphological resemblance to normal liver).

DISCUSSION
We found elevated expression of one or more P-glycoprotein homologs in the
livers and liver tumors o f mummichog inhabiting an environment severely contaminated
with PAHs. This is believed to be the first evidence of increased expression o f Pgp in
teleosts from a polluted environment. It also is the first evidence of P-glycoprotein
overexpression in the tumors o f a lower vertebrate.
Chapter II o f this dissertation reported immunoblot and immunohistochemical
techniques for detection o f Pgp in mummichog liver tumors using mAb C219 (Cooper et
al., 1996). Results reported here with mAb C219 and JSB-1 confirm specific
identification of Pgp isoforms in immunoblots of mummichog liver. The molecular
weight (170 kDa) and characteristic broad appearance of the labeled band in immunoblots
indicating a high degree o f glycosylation strongly suggest that the C219 and JSB-1
monoclonal antibodies are detecting Pgp homologs expressed in mummichog liver. C219
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reacts with a highly conserved epitope (VQEALD) present in all known Pgp deduced
amino acid sequences including the only published fish sequences (Georges et al., 1990;
Chan et al., 1992). JSB-1 reacts with an unknown epitope present in human and rodent
drug-resistance Pgp isoforms (Scheper et al., 1988). This antibody has been reported to
react in a specific manner with bile canaliculi o f guppy liver in immunohistochemical
staining (Hemmer et al., 1995). The failure o f the MDRl/pgpl specific mAb C494
(Georges et al., 1990) to react with mummichog liver extracts in immunoblots is also
consistent with the reported absence of immunohistochemical staining o f guppy
hepatocytes with this antibody (Hemmer et al., 1995).
The specificity o f detection in immunoblots using mAb C219 shows that the
increased staining seen in immunoblots of Atlantic Wood mummichog livers represents
elevated levels of one or more P-glycoprotein isoforms in the livers of these fish.
Elevated levels of Pgp related antigens have been reported in gill and mantle tissue of
marine mollusks from contaminated sites (Minier, et al., 1993; Kurelec et al., 1995;
Kurelec et al., 1996). This is the first report of elevated levels of Pgp in a teleost
associated with environmental contaminants. There may be several possible causes for
this elevation in the nontumor bearing livers of the Atlantic Wood site: 1) specific Pgp
genes may be induced in response to specific components of creosote or their
metabolites; 2) Pgp levels may be elevated as a more general response to toxic injury
resulting from hepatotoxic contaminant exposure; 3)There may be some contribution to
Pgp expression from overexpression in hidden liver tumors; 4) Pgp levels in these fish
may be constitutively elevated in the livers of mummichog from this site and are a
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component of the observed genetic adaptation of these fish to the acutely toxic effects of
creosote. Each of these possibilities is discussed in turn below.
Because Pgp genes are induced in mammalian livers following exposure to
xenobiotics including PAHs, it seems likely that Pgp genes may be induced in
mummichog liver by exposure to xenobiotics (presumably PAHs) present at the Atlantic
Wood site (Thorgeirsson et al., 1988; Gant et al., 1990; Gant et al., 1995). Thorgiersson
and colleagues have hypothesized that Pgp gene expression is induced in liver by
xenobiotics or their metabolites having biliary excretion pathways (Thorgeirsson et al.,
1988; Gant et al., 1995). In fish as well as in mammals biliary excretion is an important
route of elimination of PAH metabolites (Varanasi et al., 1989; Schintz et al., 1993). In
the present study however we were not able measure increase in Pgp in King Creek
mummichog 36 hr following i.p. injection of 3-MC. These conditions did produce a large
increase in immunodetectable CYP1A however. While 3-MC has been found to induce
expression of Pgp in rat liver, exposures in these cases were for longer times
(Thorgeirsson et al, 1988; Gant et al., 1990). Long term exposures to 3-MC may produce
induction of Pgp in the mummichog as well. However it is possible that the Pgp genes of
fishes may not be responsive to PAHs or their metabolites.
Another explanation for these observations is that the elevated levels of Pgp in
mummichog liver from the creosote contaminated site are a result o f liver damage in
these fish rather than induction o f mummichog Pgp genes by PAHs. The livers of
mummichog from this site show a high prevalence of pathological changes associated
with toxic injury and cell death in addition to the proliferative lesions (Vogelbein et al.,
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1990; Wolfgang Vogelbein, personal communication). Levels of Pgp mRNA has been
observed to increase in rodent liver under conditions o f liver injury such as partial
hepatectomy, cholestasis (Thorgeirsson et al., 1987; Marino et al., 1990; Teeter et al.,
1991; Schrenk et al., 1993). The Pgp genes in mummichog liver may respond in a similar
manner to toxic injury.
Although livers without grossly visible lesions were chosen for this study, it is
possible that many of these livers contained neoplasms that were not externally visible.
The contribution o f Pgp overexpression in small tumors present in Atlantic Wood
mummichog liver to the elevated signal seen in immunoblots cannot be ruled out.
Finally, there is also a possibility that elevated levels of hepatic Pgp in Atlantic
Wood mummichog are component o f the observed genetic resistance of the mummichog
at this site to the acute toxicity o f creosote (Horton et al., 1993; Williams et al., 1994).
Van Veld and Westbrook (1995) have hypothesized that the toxicity resistance in these
fish may be related to constitutive alterations in levels and activities o f liver enzymes
involved in biotransformation and detoxification. These changes are similar to alterations
observed multixenobiotic-resistant preneoplastic liver lesions and multidrug-resistant
mammalian cell lines and include suppression of phase I oxidative enzymes involved in
activation of carcinogens and elevated levels of phase II detoxifying enzymes (such as
GSTs) in nontumor-bearing livers o f these fish (Van Veld et al., 1991; Van Veld and
Westbrook, 1995). Another biochemical alteration seen in chemically resistant cells is
increased expression of Pgp. Thus the livers of mummichog from the creosote
contaminated site have several o f the changes associated with the “resistant hepatocyte”
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phenotype seen in chemical carcinogenesis and multidrug resistant cell lines (Farber,
1984a; Farber, 1984b; Farber and Rubin, 1991). These alterations may contribute to the
survival o f these fish in a PAH contaminated environment. Whether any o f these changes
in liver biochemistry are inherent or whether they are a result o f acclimation (i.e.
induction) and other reversible changes is unknown at this point.
Immunohistochemical results reported here confirm localization o f Pgp to the
canalicular surface o f hepatocytes in teleost liver. Similar staining patterns have been
reported for histologic sections of guppy liver using this antibody (Hemmer et al., 1995).
These staining patterns o f teleost livers indicate that the expression of Pgp in fish liver is
homologous with the expression pattern of Pgp in mammalian liver with allowances for
the differing architecture of fish liver (Hampton et al., 1985). This pattern of expression
suggests that Pgp is involved in biliary excretion in teleosts.
We observed overexpression of Pgp in the majority of mummichog hepatic
neoplasms examined in this study. Overexpression of Pgp is characteristic o f mammalian
liver tumors (Goldsmith et al., 1990; Huang et al., 1992; Teeter et al, 1990; Bradley et al.,
1992). The altered immunohistochemical staining patterns seen in the mummichog
neoplasms here are strikingly similar to those reported for experimentally induced rodent
liver neoplasms, human hepatocellular carcinoma and human colon carcinoma (Bradley
et al., 1992; Weinstein et al., 1991). These altered patterns include cytoplasmic and
paranuclear staining as well as nonpolar plasma membrane expression.
Thus, Pgp overexpression is another biochemical property of mummichog tumors
in addition to reduced CYP1A which is similar to biochemical alterations observed in
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mammalian liver tumors and that are associated with xenobiotic resistance ( Farber
1984a, Farber 1984b; Fairchild et al., 1987; Farber and Rubin, 1991; Van Veld et al.,
1992, Van Veld and Westbrook, 1995).
The origin o f Pgp overexpression in liver tumors is not well understood. It has
been associated with xenobiotic resistance in preneoplastic lesions (Thorgeirsson et al.,
1987). Selective promotion of Pgp-expressing lesions in the presence of cytotoxic
carcinogens may account for the overexpression observed in hepatocellular carcinoma.
However, Pgp overexpression in liver tumors has also been observed without promotion
by xenobiotics (Teeter et al, 1990; Bradley et al., 1992). Therefore Pgp overexpression in
liver tumors may be a late event related to oncogene activation and tumor progression
(Teeter et al., 1990; Bradley et al., 1992; Bradley and Ling, 1994). The environmentally
induced liver tumors in mummichog from the Elizabeth River provide an interesting
system in which to examine these two alternatives, Pgp expression arising from selection
of Pgp overexpressing lesions versus Pgp overexpression as a marker of neoplastic
transformation. Mummichog inhabiting the creosote contaminated site are exposed
continuously to a mixture o f toxic xenobiotics that includes carcinogenic PAHs
(Vogelbein et al., 1990). Such conditions seem ideal for the promotion of xenobiotic
resistance in early preneoplastic lesions and their eventual progression to resistant tumors.
The livers of fish from this site show a variety o f microscopic histopathology including
several categories o f altered foci. Some of these are presumed to be preneoplastic lesions
(Vogelbein et al., 1990). If selection o f Pgp expression is occurring during
carcinogenesis in these fish, then Pgp overexpression should have been apparent in
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putative early lesions. This was not the case however. Over 90 different mummichog
livers were stained for Pgp expression using mAb C219. Within these livers, only
neoplasms (hepatocellular adenomas and hepatocellular carcinomas) showed evidence of
overexpression o f Pgp. While the majority of these neoplasms overexpressed Pgp, some
had reduced or equivalent levels o f Pgp expression. Thus Pgp overexpression in these
fish tumors is probably a late event which may be independent o f selection of xenobiotic
resistance in the lesions. This overexpression may be caused by activation of specific
oncogenes during tumor progression in mummichog liver.
Consistent with this hypothesis are reports that transfection of rat liver epithelial
cells with the oncogene v-H-ras induces high level expression o f Pgp, and that high level
expression of mutant p53 stimulates the promoter of the human MDRI gene in vitro (Burt
et al., 1988; Chin et al., 1992). Both Ras mutations and p53 mutations are common in
mammalian neoplasms including hepatocellular carcinoma (Nigro et al., 1989; Hsu et al.,
1991; Wiseman et al., 1991). It seems reasonable to assume that these kinds of mutations
are also common in hepatocellular carcinoma of teleosts and are responsible for Pgp
overexpression in mummichog liver tumors.
Summary— The results reported here show evidence for moderate increases in
expression of one or more Pgp homologs in the livers of mummichog from a creosote
contaminated site. In addition liver neoplasms of these fish show overexpression of Pgp
which is similar to that seen in mammalian hepatocellular carcinoma. The mechanisms
responsible for this up regulation of Pgp in these fish livers are unknown. Further work is
required to determine if increased expression of Pgp can be induced in laboratory
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exposures o f these fish to components of creosote particularly individual PAH
components. Although no increase in expression of Pgp in mummichog liver was
observed following i.p. injection o f 3-MC, these results must be viewed as inconclusive
since longer times may be required for up regulation of these genes. In tumors high level
expression beginning at the neoplasm stage rather than earlier suggests that oncogene
activation rather than a role o f Pgp expression in chemical resistance of preneoplastic
lesions may be responsible for increased expression seen in these tumors.
In the case o f both normal mummichog liver and mummichog liver tumors the
question o f which Pgp family members are increased remains to be answered. Because
the antibody used in the present study recognizes an epitope found in all known Pgp
deduced amino acid sequences, our expression results include all isoforms expressed in
mummichog liver. Further understanding of the relevance o f increased Pgp expression to
the survival of mummichog in the creosote contaminated environment will require
characterization of the Pgp genes expressed in mummichog liver and liver tumors and the
development o f gene specific probes for these genes. Chapters IV and V of this
dissertation report the identification, partial sequence and molecular analysis of two
distinct Pgp isoforms expressed in mummichog liver.
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Figure 4. Immunoblot detection o f Pgp in mummichog liver extracts from the creosote
contaminated site (Atlantic Wood) in the Elizabeth River and from a clean reference site
(King Creek). A: Immunoblot probed with mAb C219 (1.5 pg/ml). Lanes 1-5 Elizabeth
River mummichog liver extracts. Lanes 6-10 King Creek mummichog extracts. B:
Immunoblot probed with mAb JSB-l (10 pg/ml). Lane 1 Pgp standard, multidrugresistant CHRC5 cell line extract. Lanes 1-5 King Creek mummichog liver extracts,
Lanes 6-10 Elizabeth River mummichog liver extracts. Positions of molecular weight
standards are shown at the left.
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Figure 5. Expression of Pgp in liver extracts of mummichog from the creosote
contaminated site (Atlantic Wood) and an uncontaminated reference site (King Creek)
determined from immunoblotting o f mummichog liver extracts using mAb C219. Five
fish from each site were used. Expression is reported in arbitrary units per microgram of
liver protein. Units are defined so that 1 pg of a pooled liver extract from reference site
mummichog contains 100 units. A: Mummichog collected July 1996. B: Mummichog
collected October 1994. At both times, Elizabeth River mummichog from the creosote
contaminated site showed significant elevation of the C219 antigen (Student’s t-test,
P<0.05).
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Table 2. Relative content o f Pgp antigens in liver extracts o f mummichog from the
creosote contaminated site (Atlantic Wood) and an uncontaminated reference site (King
Creek) determined by densitometric analysis of immunoblots using mAb C219.
Site
Date
July 1996

Atlantic Wood

King Creek

Relative Increase

374±167a

115=1=11

3.25

199±66a
75±52
2.65
October 1994
Values are arbitrary Pgp units per microgram of liver protein, average of 5 livers from
each site ±S D ;a significantly different from reference site (King Creek) (Student’s t-test,
p<0.5). Relative increase is the ratio of expression in livers of Atlantic Wood fish to
expression in King Creek fish.
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Figure 6. Immunoblot o f liver extracts of mummichog (4 pg/lane) 36 hr following i.p.
injections o f 3-methylcholanthrene in com oil (3-MC) or com oil alone (CO). Upper blot
was probed with anti P-glycoprotein antibody (mAb C219). The lower blot was probed
with anti scup CYP1A (mAb 1-12-13).
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Figure 7. Sections o f normal mummichog liver from King Creek. Top panel: C219
immunohistochemical staining. Positive immunoperoxidase stain is reddish brown and
localizes to the bile canalicular surface of hepatocytes. Bottom panel: H&E stained
section from the same liver.
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Figure 8. Demonstration of specific immunohistochemical staining with mAb C219.
Top panel: Immunohistochemical staining using C219 of overexpressing hepatocellular
carcinoma with connective tissue component. Note absence of immunoperoxidase stain
in connective tissue component (central portion). Bottom panel: Immunohistochemical
staining of adjacent serial section to the one shown in the top panel using matched iso type
mouse myeloma protein (IgG2a, kappa) as primary antibody negative control.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

Reproduced
the
copyright ow
owner.
Further reproduction
reproduction prohibited
prohibited w
without
permission.
R
ep ro d u ced with ppermission
erm ission ooff th
e copyright
ner. Further
ithout perm
ission.

91

Figure 9. Neoplasms from Elizabeth River mummichog showing various types o f C219
immunohistochemical staining. Top panel: Immunohistochemical staining with C219.
Bottom panel: H&E staining. A: Hepatocellular adenoma showing overexpression and
polar staining for Pgp. Note the well defined border between the over expressing
neoplasm and adjacent nonneoplastic liver. B: Well differentiated hepatocellular
carcinoma showing overexpression of Pgp and predominant polar staining. C, D & E:
Hepatocellular carcinomas showing overexpression and loss o f polar expression for Pgp
including cytoplasmic staining ( C & D) and expression on the entire plasma membrane
(E). F: Hepatoblastoma with hepatocellular carcinoma component showing high level
polar expression for Pgp within the hepatoblastoma (top panel, lower left). The
hepatocellular carcinoma component shows overexpression and loss of polarity (top
panel, extreme upper right). G: Hepatocellular carcinoma (lower left) with very large
cells showing apparent reduction in staining for Pgp as well as paranuclear staining.
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INTRODUCTION
In Chapters II (Cooper et al., 1996) and III of this dissertation we have used
immunohistochemical and immunoblot techniques to examine Pgp expression during
environmental hepatocarcinogenesis in mummichog from the creosote-contaminated
Atlantic Wood site. The results reported there indicate that a protein or proteins related to
P-glycoprotein is elevated in non-tumor-bearing liver o f AW mummichog. The elevation
in normal liver may be a result o f environmental induction by components of creosote or
other reversible changes. However it may also be a component of the genetic resistance
of these fish. Similar elevation o f Pgp-like activity or antigens have been reported in
pollution-tolerant mollusks from contaminated sites, and it has been suggested that
increased levels o f Pgp activity may play a role in the survival of these organisms in
contaminated habitats (Minier et al., 1993; Kurelec et al., 1995; Kurelec et al., 1996). We
also found that Pgp was overexpressed and had altered patterns of expression in the
majority o f the progressed environmentally induced liver tumors of the AW mummichog.
These results are similar to those reported for experimentally induced rodent liver
neoplasms (Teeter et al., 1990; Bradley et al., 1992). The association o f increased
expression o f specific Pgp isoforms (mdrl-type) with xenobiotic resistance in
mammalian cell lines suggests that this increased expression of Pgp may contribute to the
survival of these fish in the highly contaminated environment.
However, the specific forms of Pgp expressed in the livers and liver tumors of
these fish are unknown. The antibody (mAb C219) used in the studies reported in
Chapters II and III o f this dissertation binds a highly conserved epitope found in the
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deduced amino acid sequences o f all known Pgp gene family members (Kartner et al.,
1983; Georges et al., 1990). Thus multiple Pgp homologs may contribute to the signal
seen in immunoblots and immunohistochemical staining of normal mummichog liver and
liver tumors. Southern blots o f genomic DNA of several fish species indicate that fish
have at least two Pgp genes (Ling et al., 1992; Chan et al., 1992). As is the case with
mammalian mdr and spgp genes, the teleost homologs o f these genes are probably
regulated differently from each other, and their gene products have distinct functions.
Further understanding o f the significance of expression o f Pgp in mummichog from the
creosote contaminated environment will require characterization o f the Pgp gene
sequences expressed in mummichog liver and liver tumors.
In the present Chapter we have used reverse transcriptase-polymerase chain
reaction (RT-PCR) to amplify Pgp sequences expressed in mummichog liver. Our goals
were to amplify, clone and sequence Pgp related sequences expressed mummichog liver,
to use these sequences as probes to investigate tissue specific expression of the
mummichog gene in northern blots and to relate these sequences to other vertebrate Pgps
o f known function. These studies are necessary background to investigating the nature of
Pgp sequences which are elevated in mummichog from contaminated environments.
We report that we have amplified and cloned overlapping cDNA fragments that
are most closely related to the winter flounder pgpA gene and the rat and pig spgp Pglycoproteins. This Chapter presents a comparison o f the sequences from mummichog
liver to that of other vertebrate spgp and Pgp cDNA sequences. Evidence presented here
supports the spgp gene category as a distinct and highly conserved branch of the Pgp
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multigene family. In the mummichog, as in mammals spgp is most strongly expressed in
liver. To our knowledge, this represents the first cDNA sequence of a Pgp homolog from
a teleost and is the first report on tissue specific expression of a Pgp gene in a fish.

MATERIALS AND METHODS
Fish collection and tissue preparation— Mummichog were collected in a
minnow trap from King Creek a tributary o f the Severn River in the Gloucester County
Virginia. Fish were sacrificed within 48 hrs of capture by overdose with tricaine methane
sulfonate (Sigma). Livers, anterior kidney, brain and intestine were excised and either
processed immediately or snap frozen in liquid nitrogen and stored at -70° C until use.
RNA isolation— A l aqueous solutions used with RNA were either treated with
dethylpyrocarbonate (DEPC) (Sigma, St. Louis, Missouri) or were made with DEPCtreated water (DEPC H20 ) to inhibit any contaminating exogenous ribonucleases (Farrell,
1993).
Total RNA was prepared by a modification method of Chomczynski and Sacchi
(1987) using the commercial preparation Tri-Reagent (Chomczynski, 1993) according to
the manufacturers instructions (Molecular Research Center, Inc., Cincinnati, Ohio).
Frozen organs were quickly broken into small pieces with a hammer and added to 10
volumes of ice cold Tri-Reagent in a Potter-Elvjehm Teflon-glass homogenizer.
Homogenization was accomplished using an electric drill motor to drive the Teflon
pestle. Seven or more up and down strokes at full speed were used to ensure complete
disruption of tissues. Phase separation was achieved with chloroform as described in the
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Tri-Reagent protocol. The overlying aqueous phase was collected and total RNA was
precipitated from it with isopropanol. The precipitated RNA was colected by
centrifugation and washed with 75% ethanol. The pellet was then resuspended in 0.5%
SDS, and the concentration of total RNA was estimated by measuring the absorbance of
the solution at 260 nm (Farrell, 1993). RNA was then precipitated with sodium acetate
and ethanol. Precipitated RNA was stored as a suspension at -80° C until use. The
integrity and yield o f total RNA was confirmed by agarose/formaldehyde gel
electrophoresis using 0.66M formaldehyde concentration in both the gel and the sample
buffer (Farrell, 1993). Ethidium bromide was included in the sample buffer so that the
RNA bands could be visualized without staining and destaining the entire gel.
A polyA+ enriched RNA fraction was prepared from mummichog liver total RNA
using oligo-(dT) cellulose columns (Molecular Research Center) according to standard
protocols (Sambrook et al., 1989). The frozen suspension o f total RNA was thawed on
ice and an aliquot containing between 1 and 1.5 mg of RNA was removed, pelleted in a
microcentrifuge, and washed with 75% ethanol. The pellet was then dissolved in 1 ml of
binding buffer (0.5 M LiCl, 50 mM disodium citrate, 0.1% SDS) and heated to 70° C for
5 minutes. After cooling on ice for 5 minutes, the entire solution was applied to the
equilibrated column. The flow through fraction was collected in a tube on ice and applied
onto the column again. The column was then washed with four 0.5 ml portions of
binding buffer. A poly A enriched fraction was eluted as a single fraction with 0.6 ml of
elution buffer (ImM disodium citrate, 0.1% SDS). This fraction was collected in a pre
chilled microcentrifuge tube on ice. Yield of the poly A+ enriched RNA was estimated
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by measuring the absorbance of the solution at 260 nm. This poly A+ fraction was then
precipitated with 0.1 volume of sodium acetate, 5 pi of Microcarrier gel (Molecular
Research Center) and 2 volumes o f ethanol. Precipitated RNA was stored at -80° C until
use.
First strand cDNA synthesis— First strand cDNA was synthesized using poly
A+ liver RNA and recombinant Moloney murine leukemia virus-reverse transcriptase
(MoMLV) (Superscriptll™ reverse transcriptase, Life Technologies, Bethesda,
Maryland). Reverse transcription was primed with either random hexamers (Life
Technologies, Bethesda, Maryland) when the resulting cDNA was to be used for
amplifying internal segments or an oligo-(dT)17 adapter primer (Table 3, custom
synthesis, Life Technologies) when amplification o f the 3' end of the cDNA was sought
(Frohman, 1988 ). (See the description of 3' RACE given below under Amplification o f
the 3' end (S2) o f the mummichog spgp cDNA.) An aliquot of suspended poly A+ RNA (1
gg) was pelleted, washed with 75% ethanol and dried in a SpeedVac (Savant,
Farmingdale, New Y ork). The pellet was dissolved in 17.5 pi o f DEPC treated water
(DEPC H20 ) containing either 125 ng of random hexamers or 500 ng of the oligo-(dT)17
adapter primer (Table 3). This primer-RNA mixture was heated to 70° C for five
minutes, chilled on ice and used immediately in the first strand synthesis reaction. All
first strand reactions took place in 50 pi IX reverse transcriptase buffer (50 mM TrisHC1, pH 8.3, 75 mM KC1, 3mM MgCL) containing dithiothreitol (lOmM), Rnasin (1
unit/pl) (Promega, Madison, Wisconsin) and the four deoxynucleotide triphosphates
(dNTPs, 500 pM each, Life Technologies). Reverse transcriptase (MoMLV, 300 units)
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was added to start the reaction which was incubated for 10 minutes at room temperature
and then placed in a 42° C water bath for 1 hour. First strand cDNA pool was
precipitated with sodium acetate /ethanol and stored overnight at -20° C. On the
following day, the cDNA pool was pelleted in a microcentrifuge, washed with 75%
ethanol and dissolved in 100 pi of DEPC H20 . The cDNA pool was then divided into 10
pi aliquots and stored in 0.2 ml PCR tubes at -20° C until use.
General conditions for amplification of first strand cDNA— The polymerase
chain reaction (PCR) was used to amplify specific regions o f the mummichog spgp first
strand cDNA. Oligonucleotide primers were synthesized by Genosys (The Woodlands,
Texas) and Life Technologies Inc. (Bethesda, Maryland). Taq DNA polymerase was
from Boehringer-Mannheim (Indianapolis, Indiana). Sequences of the primers as well as
the regions amplified are given in Table 3. Amplifications were performed on Biometra
UNO-Thermoblock™ thermocycler (Biometra, Tampa, Florida). All reactions took place
in 100 pi IX PCR buffer (lOmM Tris-HCl, pH 8.3, 50 mM KC1) containing MgCL (1.5
m M ) and the four dNTPs (200 pM each). Primer concentrations were usually 1 pM
except where noted for specific amplifications. For each amplification 10 pi o f either the
random primed or oligo-(dT)17 adapter primed cDNA pool was used. Taq polymerase
(2.5 units) was added to each reaction only after the mixture was denatured for 5 min at
94° C and cooled to 72° C in the thermocycler.
For most amplifications the technique of touchdown PCR (Don et al., 1991) was
used. In this technique the annealing temperature during the thermal cycling protocol
was initially set higher than the expected annealing temperature of the primers. At each
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cycle, the annealing temperature was lowered incrementally through the expected
annealing temperature. Several cycles of amplification were then performed using the
lowest annealing temperature. This protocol should give a selective advantage to
products resulting from primer template pairs with the fewest mismatches (highest Tm).
Touchdown PCR has proven useful in reducing the number of nonspecific products in
situations where degenerate primers have been used (Don et al., 1991; Roux et al., 1994)
as is the case in the present study. The relative sizes of the PCR products were
determined by agarose gel electrophoresis. Details of the specific amplification
conditions for each fragment (SI, S2, S3 and S4) are given at the end of this section..
Cloning and sequencing of PCR products— PCR products were cloned using
the Prime PCR Cloner Kit (5prime- 3prime Inc, Boulder, Colorado). This kit
incorporates a column clean-up step of the amplification reaction prior to modification
and ligation of the PCR products. For all amplified fragments greater than 1 kb in size a
gel purification step was substituted for the for the column clean-up step in the kit
protocol. The gel purification step was necessary because o f the presence of multiple
nonspecific bands in many o f the amplification reactions. This step also increased the
yield of recombinant colonies per cloning reaction because it concentrated the DNA. The
entire amplification reaction (100 pi) was separated by electrophoresis on a 1% agarose
gel. Following electrophoresis and staining, the band o f interest was cut from the gel.
The DNA was separated from the gel matrix using the GeneClean kit (Bio 101, Vista,
California). The DNA was eluted from the resulting glass-milk suspension in 15 pi of
H20 . The entire volume was then used in the PCR Cloner protocol according to the
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manufacturers instructions. Transformants were selected on Luria Bertani (LB) agar
plates containing ampicillin (100 pg/ml), and recombinant colonies were selected by
blue/white screening on LB agar plates containing isopropyl P-D-thiogalactopyranoside
(IPTG) and 5-bromo-4-chloro-3-indolyl-P-D-galactopyranoside (X-gal) (Sambrook et al.,
1989). Colonies were screened for insert size by agarose gel electrophoresis. Single
colonies with the expected insert were grown overnight in LB broth containing ampicillin
(100 (ig/ml). Plasmids were isolated and prepared for sequencing using the standard
alkali lysis protocol (Sambrook et al., 1989).
The nucleotide sequence o f the cloned inserts was determined by routine dideoxy
chain termination protocol using the Sequenase kit (United States Biochemical,
Cleveland, Ohio) following the manufacturers recommendations for sequencing double
stranded templates, a Thio [35S]dATP was used as an internal label. Labeled products
were resolved on a 6% acrylamide / 6M urea gel buffered with TBE (Sambrook et al.,
1989).
Specific Amplification conditions for spgp cDNA fragments—
I.

Amplification o f the segment (SI) containing the 3' ATP binding region o f

mummichog spgp— Degenerate oligonucleotide primers were used to amplify the distal
(3') ATP binding region of the mummichog spgp transcript. These primers were designed
to match the codons of vertebrate Pgp homologs in the vicinity o f the downstream
Walker A and B nucleotide binding motifs. The nucleotide inosine was used in the
primer sequences in the third position of codons with four base degeneracy to limit the
number of different primer molecules (Knoth et al., 1988). The sense strand primer
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(Primer A, Table 3) codes for the amino acid sequence Val-Gly-Ser-Ser-Gly-Cys-GlyLys (VGSSGCGK) which corresponds to positions 1066-1073 of the hamster Pgpl
amino acid sequence (Endicott et al., 1991). The antisense strand primer (Primer B,
Table 3) corresponds to the peptide Ala-Thr-Ser-Ala-Leu-Asp (ATSALD), positions
1199-1204 o f the hamster Pgpl sequence (Endicott et al., 1991). These amino acid
positions are identical in all published vertebrate P-glycoprotein deduced amino acid
sequences.
The predicted 417 bp fragment, SI, was amplifed from random primed cDNA
using primers A and B (4 pM each) and a touchdown cycling protocol. Following
denaturation at 94° C, the primers were annealed for 2 min initially at 62° C. The
products were then extended at 72° C for 1.5 min followed by denaturation at 94° C for 30
sec. Fifty cycles were carried out with an incremental decrease of 0.4° C in the annealing
temperature at each cycle. An additional ten cycles were carried out with the annealing
temperature fixed at 42° C. Products were then given a final extension at 72° C for 10
min. The product was cloned and sequenced as described above. The sequence was used
to generate a gene specific primer (gspl) which was used to amplify the 3' end of the
mummichog spgp cDNA. (See 3 below). Additional gene specific primers were
designed which were used in conjuction with another degenerate primer (primer C) to
amplify the segment between the two ATP binding regions as described in 2 below.
2.

Amplification o f the segments (S3 and S4) spanning the second transmembrane

domain and the linker domain o f mummichog spgp cDNA— Primer C (Table 3) was
designed to match the consensus sequence of the upstream ATP binding region of
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vertebrate Pgps. This primer codes for the peptide Gly-Gln-Lys-Gln-Arg-Ile-Ala
(GQKQRIA) corresponding to positions 533-539 o f the hamster Pgpl deduced amino
acid sequence (Endicott et al., 1991). These positions are identical in all published
vertebrate Pgp deduced amino acid sequences. Primer C was used initially with a gene
specific primer (gsp2, Table 3) designed from the downstream ATP binding region of the
mummichog S 1 sequence. This primer pair was expected to amplify a segment spanning
the two predicted ATP binding regions. These were used in a touch down cycling
program with random primed mummichog liver cDNA pool. The cycling program was
identical to that used for amplification o f the S 1 fragment except that the extension time
was increased to 3 minutes. Under these conditions a 1.3 kb fragment, S3, was amplified.
The sequence o f this fragment matched the downstream portion of the expected product.
However the gsp2 primer sequence was present on both ends of the amplified fragment.
A pair of overlapping gene specific primers (gsp3 and gsp4) were then designed from the
sequence o f S3 to be used in conjunction with primer C. Gsp3 and gsp4 were used in
successive rounds o f amplification. In the first round primer C and gsp3 were used in a
touchdown cycling protocol. The annealing temperature was decreased from 60° C to
50° C in 50 cycles. Annealing was for 1 min and extension for 2.5 min. The annealing
temperature was maintained at 50° C for an additional ten cycles. All other cycling
parameters were the same as described above. A fragment of expected size (1.2 kb) was
amplified in low yield. This product was gel purified, and the DNA was extracted using
the GeneClean kit. A 1 pi aliquot of the eluted DNA was subjected to a second round of
amplification using primer C and gsp4. Thirty cycles were performed with the annealing
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temperature fixed at 50° C. A 1.2 kb fragment (S4, Table 1) was obtained in good yield.
3. Amplification o f the 3' end (S2) o f the mummichog spgp cDNA— The 3' end of
the mummichog liver spgp cDNA was amplified using the method o f rapid amplification
o f cDNA ends (31RACE) (Frohman, 1988). This method uses an oligo (dT)17 primer
with an adapter sequence (Table 1) at its 5' end to prime first strand cDNA synthesis.
This primer initiates cDNA synthesis at the complementary poly A tail of the mRNA. It
also introduces an artificial sequence, the adapter, at the 5' end of the cDNA. The adapter
sequence is used with an upstream gene specific primer to amplify the 3' end o f the
sequence in PCR. A gene specific primer (gspl, Table 3) and the adapter primer were
used to amplify the mummichog liver cDNA pool that had been primed with the
oligo(dT)17-adapter primer. A touchdown cycling program was used. The annealing
temperature was decreased from 62° C to 48° C over 50 cycles. Annealing was for 2 min
and extension was for 3 min. An additional 10 cycles were carried out with the annealing
temperature maintained at 45° C. The resulting I kb product (S2) was cloned and
sequenced as described.
4. Amplification o f a mummichog fr-actin fragment— Universal actin
oligonucleotide primers (Melanie Wilson, Mississippi State Medical Center, unpublished)
were used as amplification controls in all cDNA amplifications. These primers gave the
expected 660 bp fragment in amplification reactions of liver cDNA pool. This fragment
was also cloned and sequenced as described for the mummichog spgp fragments. Its
sequence verified that it was a P-actin cDNA fragment. This fragment was used as a
control probe in northern blots o f mummichog RNA.
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Sequence analysis— Sequences were compiled and edited with the aid of of the
computer program ESEE (The Eyeball Sequence Editor, version 3, Cabot and
Beckenbach, 1989). The PROSITE computer program and data base on the ExPASy
World Wide Web Molecular Biology Server (Geneva, Switzerland) was used for
identification of putative protein kinase phosphorylation sites in the deduced amino acid
sequence (Bairoch et al., 1995). The PCGene computer program package (Inteligenetics,
Mountain View, California) was used to locate putative membrane spanning regions
using Kyte and Doolitle hydropathy plots (Kyte and Doolittle, 1982) and the method of
Eisenberg (Eisenberg et al., 1984). Other features o f the sequence were identified by
inspection o f the multiple sequence alignment and comparison with cDNA and deduced
amino acid sequences of human (Chen et al., 1986; van der Bliek et al., 1988) hamster
(Endicott et al., 1991) and Xenopus (Castillo et al., 1995) mdr isoforms and the rat spgp
iso form (unpublished data kindly provided by Sarah Childs). Sequences of Pgp
homologs were obtained from the GENBANK sequence database using the World Wide
Web server at the National Center for Biotechnology Information (National Institutes of
Health, Bethesda, Maryland).
Multiple alignment of the amino acid sequences of Pgp sequences was
accomplished with the aid of the computer program CLUSTAL W (Thompson and
Higgins, 1994) using the default parameters of the program. Similarity and identity
scores on aligned sequences were calculated using the computer program Genedoc
(Nicholas and Nicholas, 1996). For amino acid sequences similarity scores were
calculated using the BLOSUM62 matrix provided with the program.
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Relationships among selected vertebrate and invertebrate P-glycoprotein
sequences were assessed by phenetic (overall distance) and cladistic (parsimony)
approaches. Both methods relied on the alignment o f the deduced amino acid sequences
to assign homologous positions. The sequence of the yeast STE6 mating factor
transporter (McGrath and Varshavsky, 1989), a member o f the ABC superfamily, was
also included in the analysis to serve as an out group sequence. The phenetic analysis
was done with the aid o f the PHYLIP (Version 3.5c) computer program package
(Felsenstein, 1993). A pairwise distance matrix of the aligned amino acid sequences was
calculated using the PHYLIP Protdist computer program. The PAM/Dayhoff matrix
option was used. The resulting distance matrix was used in the PHYLIP implemetation
of the neighbor joining method to construct a phylogenetic tree (Saitou and Nei, 1987).
For parsimony analysis, the aligned nucleotides of the coding regions o f Pgp homologs
were input into the computer program PAUP (Swofford, 1993 ). The nucleotide
alignment was created by using amino acid alignment from CLUSTAL W to align the
codons o f the selected Pgp homologs within the region o f overlap with the mummichog
sequence. Data were available for the winter flounder sequences and the pig spgp
sequence only at the extreme 3' end o f this region. The missing portions o f these
sequences were filled with gaps over the consensus length o f the alignment. These were
treated as missing data in the analysis. Untranslated regions were not considered in the
analysis since no significant alignment could be found among any o f the untranslated
regions except the mammalian mdr sequences (data not shown). This gave an alignment
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with a consensus length of 2394 positions. All nucleotide positions were weighted
equally, and uninformative characters were ignored. Most parsimonious trees were
searched using the heuristic search option of the PAUP computer program.
Immunoblot detection of P-glycoprotein gene family member expression—
Immunoblotting using the monoclonal antibody C219 (Signet Laboratories, Dedham,
MA) was used in to detect expression o f Pgp gene family members in mummichog liver,
kidney, brain, intestine and gill. Immunoblotting and immunohistochemical staining
were performed essentially as described in Chapters II and III of this dissertation. In the
present study the method was modified to include preparation of a plasma membrane
enriched microsomal fraction in order to increase the sensitivity of detection (Fredericks
et al., 1991).
Mummichog liver, kidney, brain and gill samples were collected as described
above (Fish collection and tissue processing). For these, the entire organs were
homogenized to make membrane fractions. For intestines, only the epithelial lining was
used. This was collected as follows. The entire intestinal tract was removed from the
fish. The mesenteries and adhering organs were cut away. Then the intestines were
flushed out with ice cold Tris-buffered saline (50 mM Tris-HCl, pH 7.4, 150 mM NaCl)
by forcing the solution through from the anterior end using a syringe fitted with a 20 Ga
needle. The intestine was cut along its entire length and laid open on a clean microscope
slide. A second slide was then used to scrape off the lining of the intestine while the
anterior end was held with forceps. The lining was then homogenized immediately.
All mummichog organs were homogenized in 20 volumes of ice cold Tris-
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buffered saline (50 mM Tris-HCl, 150 mM NaCI, pH 7.4) containing 5 mM EDTA and
freshly added protease inhibitors, N-toluene sulfonamido-L-arginine methyl ester (0.38
mg/ml), aprotinin (2% v/v), phenylmethyl sulfonyl fluoride (100 pg/ml) and leupeptin
(10 jig/ml). All inhibitors were from Sigma. Homogenization was accomplished using a
Polytron homogenizer (Brinkman Instruments, Westbury, NY).
The plasma membrane enriched microsomal fraction was prepared by differential
centrifugation in a Sorvall RS28 centrifuge (DuPont, Wilmington, Delaware) using the
F28/13 rotor. Homogenates were centrifuged at 4000 x g for ten minutes at 4°C to
collect a crude nuclear/mitochondrial pellet. The supernatant was collected and
centrifuged at 100,000 x g for 1 hr at 4° C. The supernatant was removed, and the
microsomal pellet was dissolved in a minimum volume of Tris buffered saline containing
1% v/v Triton X -100,1% w/v sodium deoxycholate, 0.1% w/v SDS and the protease
inhibitors listed above. Protein concentrations were determined by the Lowry assay using
bovine serum albumin as a standard.
The solubilized membrane fractions were then analyzed by immunoblotting.
Membrane fractions (30 pg total protein) from each organ were separated by
electrophoresis on a 5.6% acrylamide SDS-PAGE gel. A detergent extract of the
colchicine-resistant cell line CHRC5 (Kartner et al., 1993) was also loaded as a positive
control. Electrophoresis, electrophoretic transfer to a nitrocellulose membrane, and
immunochemical detection conditions were identical to those described in Chapters II
and III. The relative molecular weights o f immunoreactive bands were determined by
comparing their positions with those of prestained protein molecular weight standards
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(BioRad, Richmond, California) on the immunoblot.
Northern Blot detection of mummichog spgp expression— Expression o f
mummichog spgp sequences was examined in total RNA of several mummichog organs
using northern blots. Total RNA was prepared from mummichog intestine, gills, liver,
and brain as described above. Total RNA (12 (ig) from each organ was electrophoresed
on a 1% agarose-formaldehyde gel. Following electrophoresis, RNA was capillarytransferred to positively charged nylon membrane (Boehringer Mannheim) according to
standard protocols (Farrell, 1993). After transfer, RNA was crosslinked to the membrane
using ultraviolet light (Stratalinker, Stratagene, La Jolla, C A ). An antibody-based
chemiluminescent labeling and detection system (Genius™ System, BoehringerMannheim, Indianapolis, Indiana) was used to prepare digoxigenin labeled cDNA probe
and to detect hybridrizing RNA species. The membrane was probed with the digoxigenin
(DIG) labeled S4 cDNA fragment or with a DIG labeled mummichog actin fragment.
The S4 fragment spans the poorly conserved linker region o f the mummichog spgp and
therefore was expected to serve as a gene specific probe. Labeled pobe was prepared by
random priming o f the gel-purified (GeneClean) S4 fragment or mummichog actin
fragment with digoxigenin-11-dUTP using the Genius System Labeling Kit (BoehringerMannheim). The prehybridization and hybridization protocol followed that o f EnglerBlum and colleagues (1993). The membrane was prehybridized for 1 hr at 68° C in
0.25M sodium phosphate, pH 7.2, ImM EDTA, 20% SDS, 0.5% Boehringer-Mannheim
blocking reagent. After lhr, the prehybridization solution was replaced with fresh
prehybridization solution that contained an estimated 25 ng/ml of digoxigenin-labeled
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probe. The membrane was hybridized overnight at 68° C. On the following day, the
membrane was washed three times for 20 min each of 20mM sodium phosphate, pH 7.2,
ImM EDTA, 1% SDS at 65° C. After these washes, DIG-labelled hybrids were detected
on the membrane according to the Genius™ System protocol using anti-digoxiginen
alkaline phosphatase conjugate. Lumiphos 530 served as a chemiluminescent substrate.
Chemiluminescent blots were exposed to X-ray film (Fuji RX) for from 1 to 5 hr.

RESULTS
Amplification o f expressed Pgp-related sequences from mummichog liver—
A combination of RT-PCR strategies was used to amplify four overlapping segments (SlS4) of a Pgp gene family member expressed in mummichog liver (Figure 10).
Degenerate oligonucleotide primers ( primers A and B, Table 3) to the conserved Walker
A and B motifs of the ATP binding region of Pgp homologs were used to amplify the
corresponding fragment o f cDNA from mummichog liver. An amplified product of
expected size (SI, 417 bp) was cloned and sequenced. The sequence of this fragment
corresponded best to the downstream ATP binding region o f vertebrate Pgps. A gene
specific primer (gspl, Table 3) was chosen from this new sequence and used in a 3'
RACE protocol with the adapter primer (Table 3) to amplify the region downstream of
the S 1 fragment and 3' end o f the putative Pgp cDNA (Frohman et al., 1989). The
sequence o f the resulting product (S2, 1007 bp) was most similar to the 3' end of
vertebrate Pgp homologs and included a portion of the 3' untranslated region (3' UTR).
To amplify sequences upstream of the SI segment, we used a degenerate oligonucleotide
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matching the Walker B motif for the upstream primer (primer C, Table 3) and a gene
specific oligonucleotide (gsp2, Table 3) as the downstream primer. A product was
amplified (S3,1327 bp) which overlapped with the SI region. The upstream sequence of
S3 was similar to the transmembrane domain of the 3' half of vertebrate Pgps as expected
but did not include the expected Walker B sequence (primer C). Instead it contained the
gsp2 primer at the 5' end as well. A nested pair of downstream primers (gsp3 and gsp4,
Table 3) was chosen from within the sequence of S3. Using nested amplifications with
these gene specific primers and primer C, a fragment was amplified (S4, 1209 bp) which
contained the transmembrane domain region and the expected upstream Walker B
sequence.
Sequence o f mummichog Pgp homolog— The overlapping clones o f the
amplified fragments yielded the 3004 bp cDNA sequence shown in Figure 11. The
fragment continued the reading frame of the C primer. This reading frame terminated in
TAA 2295 bp downstream from the primer. There were 700 bp o f untranslated sequence
beyond the termination codon. The 3' untranslated region did not contain a consensus
polyadenylation signal or a poly A tail. This apparently truncated product may have
resulted from mispriming of the mRNA during first strand synthesis at an adenosine rich
region upstream o f the poly A tail. The translation of these overlapping cDNA fragments
spanned 765 amino acids. A comparison of the deduced amino acid sequence of this
mummichog pgp fragment with that of the full-length hamster pgpl cDNA indicated that
the mumichog sequence spanned 58% of the coding region of the mRNA.
The basic features of P-glycoprotein sequences are present in the mummichog
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homolog (Figure 11). The fragment includes the Walker B motif o f the upstream ATP
binding region, the linker region connecting the two halves of the protein, the membrane
spanning domain o f the second half o f the protein and the downstream ATP binding
region including the Walker A and B motifs. Analysis of the mummichog sequence for
membrane spanning helices using the Eisenberg (1984) algorhythm indicated the
presence o f only five membrane spanning segments in the mummichog sequence. The
segments correponding to the ninth and tenth transmembrane helices in mammalian Pgp
were identified as a single transmembrane segment. Hydropathy plots o f the mummichog
deduced amino acid sequence and the hamster pgp3 sequence were very similar over this
region (Figure 12) suggesting that the spgp P-glycoprotein also has six membrane
spanning segments in this region as has been proposed for mammalian mdr Pglycoproteins (Endicott et al., 1991). Therefore transmembrane segments nine and ten
(Figure 12) were assigned based on the multiple alignment o f vertebrate Pgp sequences
(Figure 13B).
The mummichog sequence contained the epitope for the mAb C219 (Val-GlnGlu-Ala-Leu-Asp, VQEALD, Georges et al., 1990) in both halves of the protein. The
calcium and phospholipid dependent protein kinase (protein kinase C) recognition
sequence (Kemp and Pearson, 1990) (Thr/Ser)X(Arg/Lys) occured eleven times in the
mummichog deduced amino acid sequence (Figure 11). A cluster of three sites was
present in the linker region of the protein in the sequence Ser-Tvr-Arg-Ala-Ser-Leu-ArgAla-Ser-Ile-Arg (potential phosphorylation sites underlined) in a similar location to the
protein kinase C sites found in the linker region of mammalian mdr isoforms (Endicott et
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al., 1991). The sequence lacked the consensus cAMP dependent protein kinase (protein
kinase A) recognition sequence found in the linker regions of mammalian mdr 1-type
sequences (Endicott et al., 1991).
Sequence analysis— The only published Pgp sequence data from teleosts are the
winter flounder pgpA and pgpB sequences which comprise 348 and 354 nucleotides of
the 3' end o f the coding sequence respectively (Chan et al., 1993). For this reason the
mummichog sequence was compared to other Pgp homologs over this region initially. A
few small gaps were needed for alignment o f this portion of the mummichog deduced
amino acid sequence and ten other vertebrate P-glycoprotein sequences (Figure 13A).
Over this region, 60 o f 118 positions (51%) were occupied by identical amino acids and
13 more positions by conservative substitutions in all eleven sequences (62% overall
similarity). A pairwise comparison of the mummichog sequence to each o f these
sequences showed that the mummichog sequence was most similar to the three spgp class
sequences (Table 4A). These are the pig spgp sequence (94% similar, 87% identical), the
rat spgp sequence (93% similar, 86% identical) and the winter flounder pgpA sequence
(88% similar, 80% identical). All spgp-type sequences including the mummichog
sequence share a distinctive conserved carboxyl teminal peptide, Thr-Gly-Ala-Pro-IleSer. The similarity o f the mummichog sequence to the other Pgp sequences was lower
although still high (76-80% similar, 62-68% identical, Table 4A). This indicates that the
region o f Figure 13A is well conserved in all of these P-glycoproteins.
The mummichog deduced amino acid sequence was aligned with six other
vertebrate Pgp sequences over the entire region of overlap (Figure 13B). Significant gaps
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were placed in the poorly conserved linker region to optimize the multiple alignment. A
pairwise comparison o f these sequences showed the mummichog sequence to be most
similar to the rat spgp sequence (83% similar, 68% identical, Table 4B). The similarity
to the other five vertebrate sequences was significantly lower than this (71-72% similar,
48-50% identical). Both the rat spgp and the mummichog sequence had a longer linker
region (78 and 90 amino acids) than the mdr sequences (59-62 amino acids). The
alignment also showed that the rat spgp and the mummichog sequence shared the cluster
of protein kinase C recognition sites within the linker region in the conserved sequence
Ser-Tyr-Arg- X-Ser-Leu-Arg-Ala-Ser-Ile-Arg (where X is Ala in the mummichog
sequence and Asp in the rat sequence). Like the mummichog sequence the rat spgp
sequence lacked protein kinase A recognition sequences, Arg/Lys-Arg/Lys-X-Ser (Kemp
and Pearson, 1990) present in the linker regions of the mdrl sequences and the Xenopus
mdr sequence.
Relationships among Pgp sequences— Both phenetic analysis of the deduced
amino acid sequences and cladistic analysis of the aligned nucleotides of the cDNAs of a
selection of vertebrate and invertebrate Pgp gave nearly identical relationships among the
Pgp gene family members (Figure 14). In both cases the rat and mummichog spgp
homologs were most closely related to each other and formed a sister group to all other
vertebrate P-glycoproteins. Within the vetebrate mdr forms, the mammalian sequences
were most closely related to each other while the Xenopus sequence was distant from
these. The mammalian mdr homologs separated into two groups. This division parallels
functional differences between the identified mdrl and mdr2 P-glycoproteins. The three
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Drosophila homologs formed a single clade which was the sister group to all o f the
vertebrate P-glycoproteins. The Caenorhabditis elegans homologs, on the other hand,
did not group together. Futhermore, the C. elegans mdrC/pgp3 form was quite divergent
from all other P-glycoprotein homologs.
The winter flounder pgpA, pgpB and the pig spgp sequences were not included in
the above analyses because of the small amount of coding sequence data available for
these. When all vetebrate sequences including these were subjected to parsimony
analysis, a single most parsimonious tree was obtained (Figure 15A). In this case, the pig
spgp sequence was closest to the rat spgp sequence in the spgp clade as expected. Both
of the flounder sequences also grouped in the spgp clade. However the placement of the
winter flounder pgpB sequence in the spgp clade was unstable when the data were
subjected to “bootstrap” resampling and replacement in the PAUP program. Included in
the tree in Figure 15 are the levels of bootstrap support for each group in the tree. The
pgpB sequence grouped with the spgp sequences in only 48% of the bootstrap replicates
(60 of 124, Figure 15A) while in 27% of the replicates (35 of 124, Figure 15A) this
sequence was grouped with the vertebrate mdr clade. In contrast the winter flounder
pgp A sequence was within the spgp clade in 90% of the replicates (111 of 124, Figure
15A). All other groups within the vertebrate Pgp family members were supported in at
least 92% o f the replicates. When the winter flounder pgpB sequence was eliminated
from the analysis, a single most parsimonious tree was found ( Figure 15B) supporting
the division of the vertebrate Pgp gene family members into spgp and mdr classes. It also
showed the winter flounder pgpA sequence as the closest homolog to the mummichog
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spgp sequence.
Detection o f expression of Pgp gene family members in mummichog— Both
immunoblotting with the monoclonal antibody C219 and northern blotting using DIGlabelled mummichog S4 fragment were used to detect expression o f Pgp in mummichog
organs. The mAb C219 was expected to recognize all P-glycoproteins while the S2
fragment was expected to function as a gene specific probe for expression of mummichog
spgp. The mAb C219 labeled a band at the molecular weight o f P-glycoprotein (170
KDa) in immunoblots o f mummichog and intestine membrane fractions (Figure 16).
Under the same conditions no band in the size range of P-glycoproteins was detected in
the mummichog kidney, gill or brain membrane fractions. Several bands of lower
molecular weight were present in the CHRC5, mummichog liver and brain lanes. These
may have been cross-reactive proteins or proteolysis products. The mummichog spgp
fragment S4 gave a hybridization signal in northern blots o f total RNA from mummichog
liver (Figure 17). Under the same conditions no signal was seen in RNA from intestine,
brain or anterior kidney. Comparison of the intensity of this signal from liver with that of
an actin control suggested that the Pgp message is moderately expressed in liver. The
molecular size o f the band in liver RNA was estimated to be approximately 5.5 Kb.

DISCUSSION
We report the partial sequence of a cDNA for Pgp gene family member expressed
in the liver of the mummichog. As far as we know, this is the most complete sequence of
a P-glycoprotein cDNA from a teleost reported to date. The sequence o f this cDNA was
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highly similar to the 3' terminal exons o f the winter flounder pgpA gene, and the rat and
pig spgp cDNA sequences. The mummichog sequence is therefore a transcript o f the
mummichog spgp gene o f the newly described sister o f P-glycoprotein division o f the Pglycoprotein gene family which has recently been identified in three other vertebrate
species (Childs et al., 1995).
The basic structure o f the P-glycoprotein gene family members is conserved in the
mummichog spgp sequence. The fragment reported here contains the upstream Walker B
nucleotide binding motif, the linker region connecting the two halves o f the gene product,
the six putative transmembrane helices, followed by the downstream loop containing the
ATP binding motifs. The mummichog sequence is most similar to the other vertebrate
Pgp sequences in the ATP binding regions and is most divergent from the other
sequences within the linker region.
The nucleotide sequence shows that the mummichog spgp transcript has a
relatively long 3' untranslated region. Childs and colleagues (1995) have suggested that a
long 3' UTR may be characteristic o f spgp genes. Our data on the mummichog spgp
transcript also support this idea. The 3' RACE product for the mummichog spgp cDNA
obtained here has a truncated 3' UTR that is 700 bp long. The message size (5.5 Kb) of
the spgp transcript estimated from northern blots of mummichog liver RNA indicates a 3'
UTR longer than 1000 bp. This transcript is similar in size to the mRNA of the rat spgp
gene (Childs et al., 1995). The winter flounder spgp gene ipgpA) transcript is predicted
to have a 3' UTR in excess o f 1020 bp (Chan et al, 1992). The function of the
untranslated region of mRNA is uncertain but is thought to influence message stability.
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The long 3' untranslated regions o f the spgp transcripts may confer similar stabilities to
these transcripts in different species.
Inspection of the alignment o f vertebrate P-glycoprotein homologs reveals some
features which may be characteristic o f spgp proteins. All four representatives have a
distinct carboxyl-terminal peptide, Thr-Gly-Ala-Pro-Ile-Ser (TGAPIS). However, the
remainder o f the sequence in the region o f overlap with the flounder and pig sequences is
highly conserved with 78-80% of positions conserved between spgp and mdr Pglycoproteins. The alignment o f the more complete sequences show some features that
are shared only by the rat and by the mummichog spgp sequences. Both o f these spgp
sequences have a longer linker region compared to other vertebrate Pgp members forcing
significant gaps into the multiple alignment. The linker region has been identified as a
potential regulatory domain in Pgp family members and contains consensus recognition
sequences for both the calcium phospholipid dependent protein kinase (protein kinase C)
and the cyclic AMP dependent protein kinase (protein kinase A) in mammalian and
Xenopus mdr sequences ( Endicott et al., 1991; Chambers et al., 1993; Castillo et al.,
1995). Both the rat and the mummichog spgp sequences share a cluster of three potential
protein kinase C (PKC) phosphorylation sites at corresponding positions the within the
linker region. A slightly different cluster o f conserved PKC recoginition sequences
occurs in the linker region o f mammalian and Xenopus mdr P-glycoproteins (Endicott et
al., 1991; Castillo et al., 1995). These sites on the human MDR1 protein are
phosphorylated in intact drug-resistant cell lines and in vitro in membrane vesicle
prepartions by PKC (Chambers et al., 1992; Chambers et al., 1993). The mammalian
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mdrl-type P-glycoproteins and the Xenopus homolog also contain protein kinase A
recognition sequences in the linker region. However neither the mummichog nor the rat
Spgp sequences contain such sites. Phosphorylation seems to be involved in upregulating
the pumping activity drug resistance homologs in drug-resistant cell lines (Chambers et
al., 1990; Ma et al., 1991). The presence of analogous PKC phosphorylation sites in the
spgp homologs suggests that they may also be phosphorylated and regulated by PKC.
The distinct but highly conserved nature of the cluster of protein kinase C recognition
sequences in the linker region of the two spgp-type P-glycoproteins may indicate some
divergence in regulation between the mdr and spgp isoforms.
Previous cladistic analysis o f the deduced amino acid sequences of several ABC
superfamily members and several P-glycoproteins indicated the existence of the spgp
class of P-glycoproteins (Childs et al., 1996). This analysis was performed only over the
limited data available for the deduced amino acid sequence of the 3' end of the pig spgp
cDNA, a region that contains highly conserved amino acid positions among all Pglycoproteins. The previous analysis did not include any invertebrate Pgp sequences. In
order to examine the validity and extent of the spgp category we have peformed cladistic
and phenetic analyses o f the relationships among P-glycoprotein sequences using a
different data set which includes the more complete mummichog spgp cDNA sequence
and the rat spgp sequence (kindly provided by S.Childs). We have also included
invertebrate P-glycoprotein sequences. Both phenetic analysis o f the deduced amino acid
sequences and cladistic analysis o f the coding sequence of P-glycoproteins support the
spgp gene class as a distinct and well conserved lineage within the vertebrate P-
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glycoprotein gene family. In our analysis the spgp sequences from two teleosts and two
mammals form a sister group to the vertebrate mdr sequences which includes the
amphibian sequence (Xenopus mdr). This suggests that the apparent gene duplication
event separating the spgp lineage from the mdr forms occured in some common ancestor
o f the vertebrates. However, it is notable that none of the invertebrate sequences nor the
amphibian homolog can be assigned to either of the vertebrate P-glycoprotein categories
(mdrl or mdr2) by this method. Furthermore the individual homo logs in Drosophila and
the nematode (C.elegans) are less closely related within taxa than are the mammalian
mdr and spgp forms. Although this is consistent with independent origins o f multiple Pglycoproteins in vertebrate and invertebrate lines, another explanation is the operation of
a homogenization mechanism (concerted evolution) within the gene family in various
lineages (Amheim, 1983). The very high relatedness of the mammalian mdr Pglycoproteins has been noted before, and there is evidence of concerted evolution within
the mdr genes o f the hamster (Endicott et al., 1991), the mouse (Hsu et al., 1991) and man
(Van der Bliek et al., 1988).
In order to determine the sites of expression of the mummichog spgp gene we
have used immunoblotting to detect expression of all P-glycoprotein forms in
mummichog organs. We also have used a poorly conserved region o f the mummichog
spgp cDNA as a gene specific probe for mummichog spgp expression in northern blots of
RNA from mummichog organs. The work in Chapter II and III o f this dissertation as
well as another study in the guppy (Hemmer et al., 1995) have found P-glycoprotein
expression in teleosts in the bile canalicular membrane of hepatocytes. Pgp expression
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was also detected in the apical membrane of the epithelial cells of the kidney tubules and
the intestine in the guppy (Hemmer et al., 1995). These are also sites of expression in
mammals (Thiebault et al., 1987; Thiebault et al., 1989; Cordon-Cardo et al., 1990;
Bradley et al., 1990). Our results here using immunoblots with mAb C219 show
evidence o f high level expression of P-glycoprotein family members in liver and lower
level expression in intestine of the mummichog. However we did not detect Pglycoprotein expression in mummichog kidney. The reason for our inability to detect
expression in this organ is unknown. It is possible that the large amount of hematopoetic
tissue in the anterior kidney of the mummichog may have diluted the P-glycoprotein
signal from the tubules. The hematopoeitic tissue did not react with C219 in
immunohistochemical staining of guppy kidney (Hemmer, 1995). Therefore membrane
fractions from the whole organ may not contain enough Pgp to detect in immunoblots
under our conditions which have been developed for liver. Thus Pgp family members are
likely expressed in mummichog liver, intestine and kidney. Since the mummichog spgp
P-glycoprotein has the C219 epitope in two places in its sequence, immunochemical
results using mAb C219 should detect both spgp and mdr P-glycoproteins. For this
reason we have used the S4 fragment o f the mummichog spgp cDNA to examine specific
expression o f spgp gene in these organs. S4 spans the less well conserved linker region
and should be less likely to cross-hybridize with mdr gene transcripts. Northern blots of
RNA from brain, kidney, intestine and liver probed with S4 demonstrated expression of
the spgp gene only in liver. This result is in accord with the liver specific expression
reported for the rat spgp gene (Childs et al., 1995). Thus results here indicate that
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expression o f the spgp homolog is responsible for a portion o f the signal seen in
immunohistochemical staining o f histologic sections and immunoblots of teleost liver
with C219 in previous studies. The signal seen in other organs o f teleosts including
kidney and intestine probably results from expression o f one or more other homologs.
Restriction o f spgp expression to the liver in both the rat and the mummichog
along with the highly conserved structure and sequence o f the gene across such large
evolutionary distances suggests that the spgp homolog has an essential role in normal
liver physiology o f all vertebrates. Immunohistochemical staining of mammalian and
teleost liver with C219 has shown Pgp expression mainly on the bile canalicular
membrane (Thiebault et al., 1987; Thiebault et al., 1989; Cordon-Cardo et al., 1990;
Bradley et al., 1990; Hemmer et al., 1995). The mAb C219 also recognizes the spgp Pglycoprotein; therefore the spgp protein is probably expressed in the canaliculus as well.
The sister of P-glycoprotein probably functions in ATP dependent transport of substances
into the bile.
In mammalian liver the mdr homologs may have roles in in biliary excretion.
Both mdrl and mdr2 type P-glycoproteins are expressed in mammalian liver (Buschman
et al., 1992; Smit et al., 1994; Teeter et al., 1990). Evidence suggests a physiological
requirement for expression of mdr2 P-glycoprotein in transport o f phosphatidylcholine
into bile (Smit et al.,1993; Ruetz and Gros, 1994). The role of the smaller amount of
mdrl is less certain but seems to be that of a xenobiotic transporter (Schinkel et al.,
1994). Since the biliary excretion pathway is similar in teleosts and mammals (Honkanen
et al., 1985; Sanz et al., 1993 ), fish are expected to have a requirement for a
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phosphatidylcholine translocator (mdr2 function) as well as a xenobiotic transporter
(mdrl function) in addition to the spgp function. Southern blots o f genomic DNA of
several fish species indicate the presence of two mdr genes (Ling et al., 1992). It seems
likely that these will turn out to have homologous roles and expression patterns to the
mammalian mdrl and mdr2 genes. One such gene may be the the winter flounder pgpB
gene. However the relationship o f the winter flounder pgpB gene to the other vertebrate
genes is not resolved here because o f the limited amount o f coding sequence data which
spans a highly conserved region. Perhaps additional sequence will show the winter
flouder pgpB gene to be a member of the vertebrate mdr class.
Measurement o f Pgp expression in liver of teleosts with generic Pgp probes such
as mAb C219 may be detecting as many as three different proteins (mdrl, mdr2 and
spgp). These proteins will have different functions and the expression of each may be
regulated differently. Our previous studies have shown elevation of expression of one or
more Pgp isoforms in the livers of mummichog and liver tumors of mummichog from the
highly contaminated Atlantic Wood site. Understanding the significance of our data on
Pgp expression to the survival o f mummichog at Atlantic Wood requires knowledge of
the specific forms (xenobiotic transporters, phospatidylcholine translocators or spgp)
being measured in mummichog liver and liver tumors. Chapter V of this dissertation
reports the identification and sequence of a mummichog mdrl homolog expressed in
intestine and liver.
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Figure 10. The strategy used to amplify segments of the mummichog spgp cDNA. The
top o f the Figure (dark line) shows a full-length mRNA for a pgp gene. The 5' end of the
molecule is at the left. The Walker A and B nucleotide binding motifs of the upstream (A
and B) and downstream (A’ and B’) ATP binding regions are shown. The 3' untranslated
region (3' UTR) and the poly A tail (A(n)) are also shown. The mRNA was reverse
transcribed (RT) to make first strand cDNA. cDNA was then amplified using the
polymerase chain reaction (PCR) using primers (boxes with arrows) to specific regions of
the cDNA. Primers A,B and C are degenerate primers to conserved regions. Primers
gspl-gsp4 are gene specific primers to the mummichog spgp. Primers and the segments
amplified are shown in Table 1.
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Table 3. Primer pairs used to amplify mummichog spgp cDNA. Peptide sequences are
given for degenerate primers (A,B andC). The regions amplified are referenced to
conserved features o f Pgp sequences; Walker A and Walker B = sequences of the
nucleotide binding fold, TMD= transmembrane domain, UTR=untranslated region. The
nucleotide binding folds and TMDs occur twice within the sequence and are identified as
belonging to either the 5' or 3' half o f the molecule. Plus (+) strand primers are
complementary to the first strand cDNA. Minus (-) strand primers are complementary to
the second strand cDNA. The size o f the amplified fragment was determined by
sequencing and includes the primer. Key to mixed and unusual base symbols: R=A+G,
M=A+C, Y=C+T, H=A+C+T, I=inosine.
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Primer
Name

Sequence

Strand

Consensus
Peptide

Region
Amplified

Size of amplified
fragment

A

GTIGGIAGYAGYGGITGTGG1AAR

+

VGSSGCGK.

3' Walker A - 3' Walker B

417 bp

B

RTCIAGIGCIGAIGTIGC

-

ATSALD

gspl

ATTGCCAGGGCGATCATACG

+

3' Walker B - 3* UTR

1007 bp

adapter

TCTGAATTCTCGAGTCGACATCTT

gsp2

CATGCTGATTTCCCGCAAGTTGTC

-/+

3' TMD - 3' Walker A

1327 bp

C

GGICARAARCARMGIATHGC

+

5' Walker B - 3' TMD

1209 bp

gsp3

TCCTTCCCTAAGCCTGCGATGG

-

gsp4

AGCCTGCGATGGTGCGGATGTTG

-

GQKQRIA

134

Figure 11. Nucleotide and deduced amino acid sequence o f the mummichog spgp cDNA
determined from overlapping RT-PCR amplified fragments. The nucleotide sequence is
numbered in 5' to 3' orientation. The sequence does not include the 3' degenerate primer
(primer C). Amino acids are aligned with the second nucleotide o f each codon.
Termination codon (TAA) is indicated by a * in the amino acid sequence. Sequences
corresponding to the Walker A and Walker B nucleotide binding motifs are indicated
with a line over the sequence. The C219 epitope is also indicated with an overline. The
six transmembrane domains are indicated with a double overline and are numbered
(TM7-TM12). Potential protein kinase C recognition sequences are marked with a ★.
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Figure 12. Hydropathy plots (Kyte and Doolittle, 1982) of the mummichog spgp (A)
deduced amino acid sequence and the corresponding carboxyl terminal half of the
hamster pgp3 (B) deduced amino acid sequence (Endicott et al., 1991). The plots were
created using the SOAP program of the PCGene computer program package
(Intelligenetics, Mountain View, California) using a window of nine amino acids.
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Figure 13. Multiple alignment o f deduced amino acid sequences o f selected Pglycoproteins. Multiple alignments were created with the aid of the computer program
CLUSTAL W (Thompson and Higgins, 1994). Positions with identical amino acids to
mummichog spgp are shown as a dot ( .) . Gaps inserted into the sequences to optimize
the alignment are shown as a dash (-). The positions of the Walker motifs, the linker
region, the putative transmembrane segments (TM) and the C219 epitope are indicated.
A: Multiple alignment o f the carboxyl end of P-glycoproteins in the region of the 3'
terminal exons o f winter flounder sequences. B: Multiple alignment o f the carboxyl
region of more complete P-glycoprotein sequences beginning at the N-terminal Walker B
motif. References', human MDR1 (Chen et al., 1986); human MDR2 (van der Bliek et al.,
1988); hamster pgpl, pgp2 and pgp3 (Endicott et al., 1991); mouse m drla (Hsu et al.,
1990); mouse mdr2 (Gros et al., 1988); rat mdrlb (Silverman et al., 1991); rat mdr2
(Brown et al., 1993); winter flounder pgpA and pgpB (Chan et al., 1993); pig spgp
(Childs et al., 1995); rat spgp (unpublished data kindly provided by S.Childs); Xenopus
mdr (Castillo et al., 1995).
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Table 4. Pairwise comparison matrices o f the deduced amino acid sequences for a
selection of Pgp homologs. The three numbers for each entry below the diagonal give the
number o f positions in the alignment that are identical between the two sequences (top
number), identical positions plus conservative substitutions (center number) and the
number o f positions that line up with a gap (bottom number). The region o f the matrix
above the diagonal gives these values as percentages. The number along the diagonal
gives the number of amino acids in the sequence. Conservative substitution groups from
the BLOSUM 62 scoring matrix are (D, N); (E, Q); (S, T); (K, R); (Y, W, F) and (L, I, V,
M). A: Pairwise matrix of the comparison over the region of the winter flounder
sequences. B: Pairwise matrix for sequences with complete data over the length o f the
mummichog spgp sequence. References: human MDRl(Chen et al., 1986); human
MDR2 (van der Bliek et al., 1988); hamster pgpl, pgp2 and pgp3 (Endicott et al., 1991);
mouse mdr la (Hsu et al., 1990); mouse mdr2 (Gros et al., 1988); rat mdr lb (Silverman et
al., 1991); rat mdr2 (Brown et al., 1993); winter flounder pgpA and pgpB (Chan et al.,
1993); pig spgp (Childs et al., 1995); rat spgp (unpublished data kindly provided by
S.Childs); Xenopus mdr (Castillo et al., 1995).
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Table 4 A

Mummichog Spgp

Mummichog

Flounder

Pig

Ral

Flounder

Xenopus

Human

Human

Hamster

Hamster

Spgp

PgpA

Spgp

Spgp

PgpB

Mdr

MDRI

MDR2

Pgpl

Pgp2

Pgp3

80%

87%

86%

62%

70%

67%

68%

68°/'.

68%

61%

88%

94%

93%

79%

80%

76%

78%

79%

78%

78%

0%

0%

0%

2%

3%

1%

1%

2%

3%

1%

77%

77%

68%

69“/'.

66%

66%

68%

68%

66%

8S%

84“/.

82%

79“/'.

76%

76%

77%

77%

77%

0%

0°/.

1%

4%

2“,'.

2%

3%

4%

2%

91%

62%

68%

67%

67%

68°/'.

68%

65%

IIS

96%

82“/.

79%

79%

81%

81%

80%

82%

0%

2%

3%

1%

1%

2%

3%

1%

62%

68%

69%

69%

70%

70%

67%

81%

78%

77%

79%

79%

79%

81%

2%

3%

1%

1%

2%

3%

1%

74%

70%

68%

70%

70%

66V.

85%

83%

83%

83%

83%

81%

2%

0%

0%

1%

2%

0%

80%

82%

84%

83%

82%

88%

88%

90%

88%

88%

1%

1%

0%

3“,'.

1%

94%

94%

93%

87%

97%

97%

95%

94%

0“,'.

0%

1%

0%

92“,'.

91%

90%

95%

94%

96%

0%

1%

0%

97%

90%

97%

95%

IIS

93
Flounder PgpA

103

116

1

Pifi Spgp

Ral Spgp

Flounder PgpB

Xenopus MDR

Human MDR1

Human MDR2

Hamster Pgpl

Hamster Pgp2

Hamster Pgp3

101

90

109

99

0

1

100

90

105

107

98

III

0

1

0

7-1

81

74

74

94

97
2

97

96

3

3

3

83

82

80

80

88

94

94

93

92

101

4

5

4

4

3

79

79

79

81

83

94

90
2

90

93
2

91

99

104

3

2

1

2

80

78

79

81

81

96

no

92
2

90

95
2

93
2

99
1

104
2

114

3

80

81

80

82

83

98

111

108

93

92

95

93

99

105

114

112

3

4

3

3

2

1

1

1

80

81

80

82

83

98

109

107

114

92

91

94

93

98

103

112

5

4

4

3

4

2

111
2

114

4
79

78

77

79

79

96

102

106

106

106

92
2

91

96

103
2

110

113

112

no

2

95
2

96

3

0

0

1

2

115

118

1

115

117

117

0

116

2%

1lamste

0%
90%

115

3

94%
1%

117
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Table 4B
M ummichog

Mummichog Spgp

765

Rat

Xenopus

Human

Human

Hamster

68%

50%

48%

50%

49%

48%

49%

83%

71%

71%

71%

71%

71%

71%

1%

4%

4%

4%

4%

4%

4%

48%

48%

48%

48%

47%

48%

69%

70%

70%

70%

71%

70%

3%

3%

3%

3%

3%

2%

66%

66%

67%

63%

65%

82%

82%

81%

79%

81%

1%

1%

1%

1%

1%

76%

88%

82%

73%

88%

95%

92%

86%

0%

0%

0%

0%

737

73%
86%

72%
85%

90%
95%

0%

0%

0%

526
Rat Spgp

639

753

14

Xenopus Mdr

Human MDR1

Human MDR2

Hamster Pgpl

Hamster Pgp2

Hamster Pgp3

386

370

549

528

36

26

737

376

371

496

550

536

616

33

23

11

386
552

368
531

493

568

612
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Figure 14. Relationships among vertebrate and invertebrate P-glycoproteins. A: Results
o f phenetic (distance) analysis using the PHYLIP computer program package
(Felsenstein, 1993) o f aligned amino acid sequences. Neighbor-Joining (Saitou and Nei,
1987) was used to assess relationships. Branch lengths are scaled to reflect distances. B:
The single most parsimonious tree resulting from cladistic analysis on aligned nucleotide
sequences using the PAUP computer program (Swofford, 1993). Branch lengths are
scaled to the number of steps along each branch. References: human MDRl(Chen et al.,
1986); human MDR2 (van der Bliek et al., 1988); hamster pgpl, pgp2 and pgp3 (Endicott
et al., 1991); mouse m drla (Hsu et al., 1990); mouse mdr2 (Gros et al., 1988); rat mdrlb
(Silverman et al., 1991); rat mdr2 (Brown et al., 1993); rat spgp (unpublished data kindly
provided by S.Childs); Xenopus mdr (Castillo et al., 1995); Caenorhabditis elegans
mdrA/pgpl and mdr C/pgp3 (Lincke et al., 1992); Drosophila mdr49 and mdr65 (Wu et
al.,1991) and mdr49 (Gerrard et al., 1993); yeast STE6 (McGrath and Varsharvsky,
1989).
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Figure 15. Cladistic analysis o f the relationships among the vertebrate P-glycoprotein 3'
nucleotide sequences including the sequences with limited data (flounder pgpA and pgpB
and pig spgp). Analysis was accomplished with the PAUP computer program (Swofford,
1993). Branch lengths are not shown because of incomplete data. A: Single most
parsimonious tree obtained with all sequences. Levels of bootstrap support for each node
are given. Values are the number of times out of 124 replicates of resampling and
replacement that the groups subtended by that node were supported. B: Single most
parsimonius tree obtained without the winter flounder pgpB sequence. References:
winter flounder pgpA and pgpB (Chan et al., 1993), pig spgp (Childs et al., 1995). The
references for the other sequences are given in Figure 14.
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Figure 16. Immunoblot of membrane fractions (30 pg per lane) from mummichog
organs probed with mAb C219. Lane 1: Extract of cholchicine resistant CHRC5 cell line.
Lane 2: Gill. Lane 3: Brain. Lane 4: Intestine. Lane 5: Anterior kidney. Positions of
molecular weight standards are shown at the left.
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Figure 17. Northern blot o f total RNA from mummichog organs probed with DIGlabeled mummichog spgp fragment S4 (upper panel) or mummichog P-actin fragment
(lower panel). Hybridizing bands were identified using anti-digoxigenin antibody
conjugated with alkaline phosphatase and Lumiphos 530 as a chemiluminescent
substrate. Lane 1: Anterior kidney. Lane 2: Liver. Lane 3: Brain. Lane 4: Intestine.
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Chapter V: Partial sequence of a multidrug resistance transporter (mdr) cDNA
from the mummichog (Fundulus heteroclitus)
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INTRODUCTION
Chapter IV o f this dissertation reports on the analysis of cDNA fragments from
the liver of the mummichog which were derived from transcripts o f the mummichog
sister of P-glycoprotein gene. Using one of these amplified fragments as a probe in
northern blots, we have shown that, as in mammals (Childs et al., 1995), expression of
the spgp gene may be restricted to liver in the mummichog. This is the first information
on tissue specific expression of Pgp genes in a teleost. These results indicate that some of
the signal seen in the immunoblots and immunohistochemical staining o f mummichog
liver and liver tumors reported in Chapters II and III of this dissertation results from
expression of the mummichog spgp gene. The toxicological significance of expression of
spgp P-glycoprotein homologs is unknown the physiological role o f these proteins has
not been determined in any animal. Our primary interest in P-glycoprotein expression in
mummichog is understanding the role that expression of potential xenobiotic transporter
(mdrl-type) P-glycoproteins may play in the resistance or tolerance of mummichog to the
toxic components o f creosote. Results reported in Chapter III o f this dissertation show
elevation of one or more Pgp homologs in the livers and liver tumors of mummichog
from a creosote contaminated site. The elevation o f Pgp in the livers o f a chemically
resistant fish is interesting because o f the paralell to the role o f the mdrl P-glycoproteins
in xenobiotic transport in drug-resistant cell lines and tumors. Several other biochemical
alterations reported in the livers o f these fish are similar to alterations seen in drugresistant cell lines and tumors (Van Veld and Westbrook, 1995). However understanding
the sigificance o f elevated hepatic Pgp will require identification and characterization of
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the specific Pgp homologs that are elevated in the liver and liver tumors of the Atlantic
Wood mummichog because o f the diversity of function o f the vertebrate P-glycoprotein
gene products. An approach to this problem is molecular cloning and sequence analysis
o f the P-glycoprotien transcripts expressed in mummichog liver.
In the present study we have used the same RT-PCR strategies reported in
Chapter IV to amplify overlapping fragments corresponding to a second member of the
Pgp gene family from mummichog intestine and liver RNA. We report that we have
amplified and cloned cDNA fragments that are most closely related to the vertebrate mdr
branch of the P-glycoprotein multigene family. These fragments are probably those of
the mummichog mdr 1-type P-glycoprotein homolog, a xenobiotic transporter. This is
represents the first cDNA sequence o f an mdr homolog from a teleost. Gene specific
probes derived from these fragments should be useful in investigating expression of mdr
genes in teleosts. Increased expression of this homolog in the liver s of Atlntic Wood fish
could potentially contribute to the survival of these fish in the creosote-contaminated
environment.

MATERIALS AND METHODS
Procedures for collection and processing of mummichog liver and intestinal RNA,
synthesis of first strand cDNA, general conditions for amplifications of cDNAs by the
polymerase chain rection and cloning and sequencing of PCR products were identical to
those detailed in Chapter IV of this dissertation. Procedures specific to the present
Chapter are given below.
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Southern blot identification of mdr specific amplification products— Because
many o f the amplification reactions gave multiple products, it was necessary to identify
amplified mdr fragments by Southern blotting. A fragment o f the human MDR1 cDNApHDRV13 (Choi et al., 1988)- was used as a probe in Southern blots o f PCR reactions to
identify mdr specific fragments. An aliquot (10 pi) of the amplification reaction was
separated on a 2% agarose gel. The separated products were capillary transferred to
postively charged nylon membranes (Boehringer-Mannheim, Indianapolis, Indiana)
according to standard protocols (Sambrook et al., 1989). An antibody-based colorimetric
labeling and detection system (Genius™ System, Boehringer-Mannheim, Indianapolis,
Indiana) was used to prepare digoxigenin (DIG) labeled cDNA probe and to detect
hybridizing species in Southern blots. Labeled pobe was prepared by random priming of
the gel-purified (GeneClean) HDR13 fragment with digoxigenin-11-dUTP using the
Genius System Labeling Kit (Boehringer-Mannheim). Following transfer and UV crosslinking of the DNA to the membrane, the membrane was prehybridized for 1 hr at 65° C
in 5X SSC containing 0.1% sodium N-Iauroylsarcosine, 0.1% SDS and 1% BoehringerMannheim blocking reagent. After lhr, the prehybridization solution was replaced with
fresh prehybridization solution that contained an estimated 25 ng/ml o f DIG-labeled
probe. The membrane was hybridized overnight at 50° C. On the following day, the
membrane was washed briefly in 2X SSC, 0.1% SDS and then in two changes of 0.5X
SSC, 0.1% SDS at 50° C for 15 min each. After these washes, DIG-labeled hybrids were
detected on the membrane according to the Genius System protocol using antidigoxiginen alkaline phosphatase conjugate with p-nitro blue tetrazolium (NBT) and 5-
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bromo-4-chloro-indolyl phosphate (BCIP) as colorimetric substrates for the alkaline
phosphatase conjugate.
Amplification of the 5' ATP binding region of mummichog mdr cDNA—
Degenerate oligonucleotide primers were used to amplify the cDNA sequences
corresponding to the 5' ATP binding region of the mummichog mdr transcript from poly
A+ selected intestinal RNA. These primers were used in Chapter IV to amplify the
downstream ATP binding region of the mummichog spgp cDNA from liver RNA . The
sense strand (upstream) primer (primer A, Table 3, Chapter IV this dissertation) matches
codons near the conserved Walker A motif which occurs twice in all known Pgp deduced
amino acid sequences. The antisense strand (downstream) primer (primer B, Table 3,
Chapter IV this dissertation) matches codons near the conserved Walker B motif which
also occurs twice in all known P-glycoproteins. A touchdown PCR protocol similar to
that given in Chapter IV was used to ampilify this region of the cDNA. Primers A and B
(4 (J.M each) were used with random primed first strand cDNA pool from mummichog
intestine. Following denaturation at 94° C, the primers were annealed for 1 min at 60° C.
The products were then extended at 72° C for 1.5 min followed by denaturation at 94° C
for 30 sec. Fifty cycles were carried out with an incremental decrease of 0.25° C in the
annealing temperature at each cycle. The annealing temperature maintained at 45° C for
ten more cycles. A final extension was performed at 72° C for 10 min. The resulting
product (M l) was cloned and sequenced.
Amplification of segments downstream of the ATP binding fold of the
mummichog mdr cDNA— Primer A (4 pM) was used in a 3' RACE protocol (Frohman
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et al., 1988) with an adapter primer (Table 3, Chapter IV this dissertation) to amplify first
strand cDNA pool from mummichog intestine. The first strand synthesis of this cDNA
pool had been primed with an oligo(dT)17-adapter primer (Frohman et al., 1988). The
touchdown cycling protocol used here was identical to that used above for amplification
o f the nucleotide binding fold sequences. To increase the yield of specific product a
second round o f amplification was performed using another sense strand degenerate
primer (primer C, Table 3, Chapter IV this dissertation) which is downstream o f the
primer A sequence. In the second round o f amplification 1 pi of the 3'-RACE reaction
was used with primer C (8 pM) and the adapter primer (0.5 pM). Annealing was at 54° C
for 30 sec followed by extension at 12° C for 30 sec and denaturation at 94° C for 30 sec.
No touchdown was used in this amplification. After 40 cycles, products were extended
for an additional 10 min at 72° C. A 460 bp product (M2) was obtained which was
cloned and sequenced.
Primer C was also used with two gene specific primers in a pair of nested
reactions to amplify mdr cDNA fragments from mummichog liver RNA. In the first
reaction, primer C was used with a downstream spgp-gene specific primer (primer 111,
CT-GAT-GTC-TTG-GCC-TTG-GCG). Primer 111 matches the sequence o f the
mummichog spgp cDNA (reported in Chapter IV) just downstream o f the nucleotides
coding for transmembrane segment 12. We observed that RT-PCR amplification of
mummichog liver RNA with the mummichog spgp specific primer 111 and the
degenerate Walker B primer (primer C) resulted in two products which hybridized to a
fragment o f the MDR1 cDNA in Southern blots (not shown). Because the mummichog

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

165

spgp cDNA is longer than the mdr cDNAs in the region amplified by these two primers,
we assumed that the shorter product detected in Southern blots was an mdr product. We
therefore used the mdr specific primer BLFA (CTG-GTT-ACC-ATG-CAG-ACC-TTC)
that was designed from the sequence of the 460 bp mdr cDNA fragment (M2) from
intestine with primer 111 to reamplify an aliquot o f PCR products derived from liver
cDNA, primer C and primer 111. For primer 111 and primer C annealing was at 45° C
for 1 min followed by extension at 72° C for 2 min and denaturation at 94° C for 30 sec.
After 40 cycles, products were given a final extension for 10 min at 72° C. An aliquot o f
this reaction (1 pi) was then subjected to a second round of amplification with primer 111
and BLFA . This mixture underwent 40 cycles of annealing at 58° C for 1 min, followed
by extension at 72° C for 1.5 min, and denaturation 94° C for 30 sec. Products were
extended for an additional 10 min at 72° C. A 1.2 kb product was obtained which was
cloned and sequenced.
Sequence analysis— Sequences were compiled, edited and analyzed essentially
as described in Chapter IV. Many features of the sequence were identified by inspection
of the multiple sequence alignment and comparison with cDNA and deduced amino acid
sequences o f human (Chen et al., 1986; van der Bliek et al., 1988) hamster (Endicott et
al., 1991) and Xenopus (Castillo et al., 1995) mdr isoforms. Sequences of Pgp homo logs
were obtained from the GENBANK sequence database using the World Wide Web server
at the National Center for Biotechnology Information (National Institutes of Health,
Bethesda, Maryland).
Multiple alignment of the amino acid sequences of Pgp sequences was
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accomplished with the aid o f the computer program CLUSTAL W (Thompson and
Higgins, 1994) using the default parameters of the program. Similarity and identity
scores on aligned sequences were calculated using the computer program Genedoc
(Nicholas and Nicholas, 1996). For amino acid sequences, similarity scores were
calculated using the BLOSUM62 matrix provided with the program.
Relationships among vertebrate P-glycoprotein sequences were assessed by
distance analysis o f the deduced amino acid sequences of vertebrate Pgp homologs. The
sequence o f the MdrA/Pgpl P-glycoprotein from the nematode, Caenorhabditis elegans
(Lincke et al., 1992) was included in the analysis to serve as an out-group sequence. As
discussed in Chapter IV, this nematode sequence cannot be assigned to either the
vertebrate mdr of spgp P-glycoprotein categories. The deduced amino acid sequences
were aligned with the aid o f CUSTAL W over the length o f the mummichog mdr
sequence. This gave an alignment with a consensus length o f 490 positions including
gaps. The distance analysis was done with the aid of the PHYLIP (Version 3.5c)
computer program package (Felsenstein, 1993). A pairwise distance matrix of the
aligned amino acid sequences was calculated with the PHYLIP Protdist program using
the PAM/Dayhoff option. The resulting distance matrix was used in the PHYLIP
implemetation of the Neighbor-Joining (Saitou and Nei, 1987) method to construct a gene
tree.
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RESULTS
Amplification and analysis of the 5' ATP binding region of mummichog mdr
cDNA— Degenerate oligonucleotide primers were used in RT-PCR to amplify a cDNA
fragment (M l) coding for the ATP binding domain of a P-glycoprotein from mummichog
intestinal RNA (Figure 18). The mummichog nucleotide sequence and the deduced
amino acid sequence were most similar to the Xenopus and hamster P-glycoprotein
cDNA sequences corresponding to the 5' or amino (N) terminal ATP binding region.
Optimal alignment with the carboxyl-terminal ATP binding domain amino acid
sequences required inserting a two position gap in the mummichog sequence (Figure 19).
This gap was also required to align the N- and C- terminal ATP binding domains of the
other vertebrate mdr-type P-glycoproteins. At the nucleotide level the identity of the
mummichog sequence to the 5' vertebrate sequences ranged from 71% to 75% identity
while the identity to the 3' sequences was lower, 59-62%. At the amino acid level, the
mummichog sequence was most similar to the N-terminal ATP binding domain o f the
Xenopus and hamster mdr sequences (91-94% similar, 78-81% identical) and less similar
to the C-terminal ATP binding domain o f these proteins (80-83% similar, 58-65%
identical, Table 5). These relationships paralleled the relationships between the two ATP
binding domains of the Xenopus and hamster sequences (Table 5). Furthermore
comparison of the two domains within the individual Xenopus and hamster mdr
sequences gave analogous relationships (78-80% similar, 56-64% identical, Table 5).
Amplification and analysis of cDNA sequences downstream of the 5' ATP
binding domain of mummichog mdr— We used degenerate primers (primers A and C)
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in a nested 3' RACE protocol in an attempt to amplify the 3' end of the mummichog mdr
cDNA from mummichog intestinal RNA. Repeated attempts resulted in no specific
product o f predicted size. However, a 460 bp product was detected in Southern blots of
the 3' RACE reactions probed with a fragment of the human MDR1 cDNA (data not
shown). The sequence o f the 5’ end of this product (M2, Figure 18) was identical with 48
bp o f the 3' end of the amplified mummichog mdr ATP binding domain sequence (M l)
and contains the upstream primer (primer C) and the 3' RACE adapter primer in the
expected orientation. However the sequence continued the reading frame o f the upstream
primer without an in-frame termination codon and therefore did not contain the 3' end of
the cDNA. The deduced amino acid sequence of the 5' end of this cDNA fragment was
similar to that o f the ATP binding domains of vertebrate P-glycoproteins. The amino
acid sequence had the highly conserved amino acid positions surrounding the Walker B
nucleotide binding motif of ABC transporters and the peptide epitope (Val-Glu-Ala-AlaLeu-Asp) for the mAb C219 present in all P-glycoproteins (Figure 18). The deduced
amino acid sequence of the 3' end of the M2 segment was weakly similar to the linker
domain o f vertebrate P-glycoproteins. The deduced amino acid sequence of the M2
fragment was 50-53% identical to the corresponding positions in the carboxyl terminal
ATP-binding domains and linker domains of the hamster, human and Xenopus mdr-type
P-glycoproteins. The overlapping sequence of Ml and M2 occurs in a highly conserved
region. The nucleotide sequences of the highly related hamster pgp I and pgp2 nucleotide
sequences (Endicott et al., 1991) are 100 % identical in this region. For this reason there
is a possibility that Ml and M2 were amplified fragments of different P-glycoprotein
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genes.
The sequence of M2 was used to design a gene specific primers for 3' RACE of
the mummichog mdr cDNA. Repeated 3' RACE attempts yielded no specific product
from mummichog intestinal RNA. The major product amplified was an nonspecific 800
bp fragment which contained the adapter primer at both ends. However we did amplify
an mdr specific product when we used one of the mummichog mdr primers (PBLFA) in a
nested amplification of mummichog liver RNA. The 5' end o f the sequence o f the
resulting 1200 bp product (M3, Figure 18) overlapped with 146 bp of the sequence of
M2. The deduced amino acid sequence of the 3' end of M3 aligned with and was similar
to the transmembrane domain of vertebrate P-glycoproteins. The deduced amino acid
sequence o f the mummichog M3 fragment was 53-55% identical and 72-74% similar to
the corresponding positions o f the linker domain and transmembrane domain of the
hamster, human and Xenopus mdr-type P-glycoproteins. The similarity to the
mummichog spgp sequence was lower (36% identical, 58% similar).
Five membrane spanning helices were identified in the deduced amino acid
sequence of the M3 fragment using the method of Eisenberg (1984). The transmembrane
helices corresponding to TM9 and TM10 of the human and hamster P-glycoproteins were
identified as a single transmembrane helix in our analysis. However because the Kyte
and Doolittle hydropathy plots (Kyte and Doolittle, 1982) of the mummichog M3 amino
acid sequence and the hamster pgpl P-glycoprotein (Figure 20) were nearly identical over
these positions, the locations o f TM9 and TM10 have been assigned by comparison with
the hamster pgpl sequence (Endicott et al., 1991).
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The sequences o f clones o f M2 and M3 were nearly identical (98%) in the 145 bp
overlapping portion that corresponds to the poorly conserved linker domain o f Pglycoproteins. The nucleotide sequence of the hamster pgpl and pgp2 cDNAs are only
67% identical in this region while the pgp3 sequence is 43% and 36% identical to pgpl
and pgp2 in this region. Therefore it is likely that M2 and M3 were derived from
transcripts o f the same gene.
The deduced amino acid sequences o f M2 and M3 contained serine and threonine
residues in consensus protein kinase recognition sequences (Kemp and Pearson, 1990) for
both the calcium and phospholipid dependent protein kinase (protein kinase C) and the
cyclic AMP-dependent protein kinase (protein kinase A). The sequence (Thr/Ser)-X(Arg/Lys) compatible with protein kinase C phosphorylation occured six times in the
combined sequences of M2 and M3 (Figure 18). Only one of these locations is within the
linker domain and coincides with the pair of potential protein kinase A phosphorylation
sites in the sequence Arg-Arg-Lys-Ser-Thr-Arg. This corresponds to the conserved
protein kinase A recognition sequence present in the linker domain of human MDR1 and
rodent mdr la P-glycoproteins (Hsu et al., 1989; Endicott et al., 1991).
The deduced amino acid sequences of M2 and M3 are shown combined in the
multiple sequence alignment of vertebrate P-glycoproteins in Figure 21. The alignment
spans the carboxyl end of the N-terminal ATP binding domain, the complete linker
domain and the complete transmembrane domain with the six putative membrane
spanning segments (TM7-TM12) of the second half of P-glycoproteins. The mummichog
sequence was most similar to the vertebrate mdr-type P-glycoproteins in the alignment

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

171

(56-58% identical, 74-77% similar) and less similar to the mummichog spgp sequence
(42% identical, 61% similar). The Walker B region o f the ATP binding domain and the
intracellular loop between TM8 and TM9 were the best conserved regions among all of
the sequences. The putative extracellular loop between TM7 and TM8 and the linker
domain were regions o f reduced similarity among all sequences. Significant gaps were
required to align the sequences in the linker region particularly to accommodate the
longer and quite divergent linker domain of the mummichog spgp sequence.
Relationships among P-glycoprotein sequences— The pairwise distances
between the amino acid sequences corresponding to the combined mummichog M2 and
M3 segments of vertebrate P-glycoproteins were analyzed using the Neighbor-Joining
method. The resulting phenogram (Figure 22) demonstrated that the mummichog
sequence derived from M2 and M3 was more closely related to the vertebrate mdr-type
sequences than to the mummichog and rat spgp forms. The mummichog sequence was
basal to the remaining vertebrate mdr-type sequences and like the Xenopus sequence was
not assigned to either the mammalian mdrl (human MDR1, hamster pgpl and pgp2) or
the mdr2 (human and hamster mdr2) classes by this method.

DISCUSSION
In this study we cloned and sequenced RT-PCR amplified fragments of a Pglycoprotein cDNA from the mummichog liver and intestinal RNA. The sequence of
these combined fragments indicates that they are amplified fragments of a vertebrate mdrtype P-glycoprotein. This is the first report of an mdr cDNA sequence from a teleost.
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As a part o f our on-going studies of P-glycoprotein expression in mummichog
liver and liver tumors, we have used several RT-PCR strategies to amplify an mdr-type Pglycoprotein sequence from the mummichog. Although our primary interest is
expression in liver we initially amplified the mdr cDNA sequences from mummichog
intestine. In Chapter IV o f this dissertation we report using degenerate oligonucleotide
primers to amplify cDNA sequences corresponding to the ATP binding domain of the
carboxyl terminal half o f mummichog spgp in RT-PCR o f mummichog liver RNA .
Contrary to our expectations, we never obtained sequences for the amino-terminal ATP
binding domain o f spgp or the sequences of any other P-glycoprotein cDNAs from
mummichog liver RNA with this technique. For this reason in the present study we
applied this technique to mummichog intestinal RNA in to amplify mummichog mdr
sequences. This organ was not expected to express spgp and in mammals expresses only
mdrl-type P-glycoproteins (Croop et al., 1989; Teeter et al., 1990; Childs et al., 1995).
Using the degenerate ATP-binding domain primers, we amplified cDNA sequences
corresponding to the carboxyl-terminal ATP binding domain of a P-glycoprotein.
Repeated attempts to amplify the 3' end of this cDNA from intestinal RNA failed
possibly because o f competing amplification of an undesired product. We amplified an
abortive product which matched the N-terminal ATP-binding domain and linker domain
o f vertebrate mdr-type P-glycoproteins. This product may have resulted from mispriming
o f the first strand cDNA by the oligo(dT)17 adapter primer in the A-rich codons of the
linker region.
Using additional RT-PCR strategies we were able to amplify a cDNA fragment
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from mummichog liver cDNA pool that overlapped with the downstream end of the
abortive 3' RACE product from intestinal cDNA and aligned with the linker domain and
transmembrane domain of the carboxyl terminal half o f vertebrate mdr-type Pglycoproteins. Because the sequences of the liver and intestinal cDNA fragments
matched in a poorly conserved region of P-glycoproteins, we conclude that these
fragments are products o f the same mummichog gene which is expressed both in
mummichog intestine and mummichog liver.
The deduced amino acid sequence of the mummichog cDNA is very similar to the
corresponding positions o f vertebrate mdr-type P-glycoproteins and indicates a
homologous structure for these proteins. This includes the highly conserved sequence
near the ATP binding site, a hydrophillic linker domain and a hydropathy profile
indicating the presence of six membrane spanning segments in the transmembrane
domain o f the protein.
Mammalian mdr-type P-glycoproteins may be divided into mdrl and mdr2
categories based on sequence similarities. These two classes also have distinct patterns of
expression and distinct functions in mammalian physiology. The mammalian mdr2-type
P-glycoproteins, which are not involved in multidrug resistance, have been shown to have
a role in transport of phosphatidylcholine into the bile (Smit et al., 1993; Ruetz and Gros,
1994). This is consistent with predominant expression o f the mdr2 forms in the bile
canaliculus o f the liver (Buschman et al., 1992; Smit et al., 1994). The mdrl forms,
which can confer multidrug resistance, may be involved in protection from toxic
xenobiotics either by exclusion o f toxicants from sensitive organs such as the brain and
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testes or by excretion o f xenobiotics through the apical membrane o f excretory epithelia
(Theibaut et al., 1987; Thiebaut et al., 1989; Teeter et al., 1990; Schinkel et al., 1994).
The mdrl forms may also be involved in steroid excretion or uptake in tissues involved in
steroid metabolism (Ueda et al., 1992; van Kalken et al., 1993). The mdr gene products
o f fish have not been previously characterized. Southern blots o f teleost genomic DNA
indicate that fish, similar to humans, have two mdr-type P-glycoprotein genes (Ling et al.,
1992; Chan et al., 1993). The products of these two teleost genes are probably the
functional equivalents o f the human MDR1 and MDR2 proteins.
In a effort to assign the mummichog mdr sequence to either the mdrl or mdr2
categories we have analyzed the relationships among the vertebrate P-glycoprotein genes
using a distance approach. While this analysis confirms that the mummichog mdr
sequence is most closely related to the vertebrate mdr homologs rather than the spgp
homologs, it also indicates that the mammalian mdrl and mdr2 homologs are more
similar to each other than either class is to the mummichog homolog. The high similarity
o f the mammalian mdr sequences has been noted before (van der Bliek et al., 1988;
Endicott et al., 1991; Hsu et al., 1991; Chan et al., 1992). There is evidence that a
homogenization mechanism, concerted evolution (Amheim, 1983), has erased many of
the intraspecies differences between the mdr genes in the hamster (Endicott et al., 1991),
the mouse (Hsu et al., 1991) and man (van der Bliek et al., 1988). This has masked the
more ancient origin o f the mammalian mdrl and mdr2 gene lineages. The concerted
evolution among the mammalian genes within taxa makes the inference o f the functional
class of the mummichog mdr sequence based on sequence homologies difficult. This is
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especially true because the sequential determinants conferring differing functions on the
mdrl and mdr2 P-glycoproteins are unknown.
In spite o f this, comparison of the linker domains of the P-glycoprotein deduced
amino acid sequences indicates that the mummichog mdr sequence may be an mdr I-type
P-glycoprotein. The linker domain is a poorly conserved region that contains sequences
that are not conserved between the mammalian mdrl and mdr2 classes (Hsu et al., 1989).
Evidence from analysis of silent and replacement substitutions along the length o f the
human mdr3 sequence suggested that gene conversion has not affected this domain (Van
der Bliek et al., 1988). The linker region has been identified as a regulatory domain in Pglycoproteins and may be the primary site of phosphorylation. The human MDR1 Pglycoprotein is phosphorylated by both protein kinase A (Mellado and Horwitz, 1987)
and protein kinase C in vitro (Chambers et al., 1992). The linker domain contains
conserved recognition sequences for protein kinase C in both mdrl-type and mdr-2 Pglycoproteins (Hsu et al., 1989; Endicott et al., 1991; Chambers et al., 1993). The linker
region o f mammalian mdrl P-glycoproteins also has protein kinase A recognition
sequences which are lacking in mdr2 P-glycoproteins. An unusual overlapping protein
kinase A recognition sequence with two potential phosphorylation sites (Arg/Lys)(Arg/Lys)-(Arg/Lys)-Ser-(Ser/Thr) is present in the linker regions of the human MDR1
and rodent mdr la homologs (Hsu et al., 1989; Endicott et al., 1991; Chambers et al.,
1993). This sequence is also present in the mummichog mdr linker domain. This is
evidence that the mummichog mdr protein is regulated in a similar manner to mammalian
mdrl proteins and that the mummichog mdr protein may have a function similar to the
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mammalian mdrl proteins.
In mammals expression of both mdrl and mdr2 class genes has been detected in
liver (Theibaut et al., 1987; Teeter et al., 1990; Buschman et al., 1992; Smit et al., 1994).
However only mdrl expression has been found in mammalian intestine (Croop et al.
1989; Teeter et al., 1990). P-glycoprotein in teleosts has been detected by
immunohistochemical staining on the lumenal surfaces of the epithelia of the intestine
and kidney and on the canalicular surface of hepatocytes (Hemmer et al., 1995; Chapters
II and III, this dissertation) just as in mammals. Although the specific homo logs that
were expressed in these sites in fish tissues were not identified in these
immunohistochemical studies, the results indicate that the tissue specific expression
patterns observed in mammals for mdrl and mdr2 P-glycoproteins are probably
conserved in teleosts. Therefore amplification of the mummichog mdr from both liver
and intestinal RNA in the present study is further evidence that the cDNA fragments
reported here those of an mdrl-type P-glycoprotein with similar tissue specific expression
patterns to the mammalian mdrl genes.
We have amplified fragments o f a mummichog mdr cDNA from mummichog
liver. This may be a portion of the cDNA for the mummichog xenobiotic transporter
(mdrl). In Chapter IV we identified another member of the P-glycoprotein gene family
(spgp) expressed in mummichog liver. We have now identified two of the potential gene
products contributing to the signal seen in our immunochemical studies of P-glycoprotein
expression during environmental hepatocarcinogenesis in the Atlantic Wood
mummichog. Gene specific cDNA probes are now in hand for both the mdrl and spgp
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genes. Future studies using cDNA probes should investigate tissue specific expression
patterns o f the mummichog mdrl gene and should study regulation of expression o f both
genes by xenobiotics. It is necessary to test whether increased expression o f either of
these genes is associated with the elevated levels o f P-glycoprotein antigens that we have
observed in liver and liver tumors o f these fish. With a partial sequence o f the
mummichog xenobiotic transporter now in hand, it should be possible to specifically
address the role o f this protein in tolerance or resistance of Atlantic Wood mummichog to
creosote.
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Figure 18. Nucleotide (upper) and deduced amino acid (lower) sequences of the
mummichog mdr cDNA fragment determined from the sequence o f RT-PCR amplified
cDNA products (M1-M3) from mummichog intestine (M l and M2) and liver (M3). The
nucleotide sequence is numbered in 5' to 3' orientation. The upstream degenerate primer
sequence is not included. Amino acids are aligned with the second nucleotide of each
codon. The conserved Walker B sequence of the nucleotide binding fold of ABC
transporters and the C219 epitope are underlined. The six putative transmembrane
segments are indicated with a double underline and are numbered TM7-TM12. Potential
protein kinase A phosphorylation sites are indicated with a ^ and potential protein kinase
C phosphorylation site are indicated with a ★.
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Figure 19. Alignment of the deduced amino acid sequence of the mummichog mdr ATP
binding domain with the amino (N) terminal and carboxyl (C) terminal ATP binding
domains of Xenopus and hamster mdr-type P-glycoproteins. Positions that are identical
to the mummichog sequence are indicated with a dot (.). Gaps are indicated with a
dash (-). References: Xenopus mdr (Castillo et al., 1995); Hamster sequences (Endicott
et al., 1991).
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Table 5. Pairwise comparison matrix of the deduced amino acid sequences of the
mummichog mdr ATP binding domain and the N and C terminal ATP binding domains
o f the Xenopus and hamster mdr-type P-glycoproteins. The three numbers for each pair
below the diagonal give the number of positions that are occupied by identical amino
acids in the two sequences (top number), identical plus conservative substitutions
(BLOSUM62) (middle number) and the number of positions that align with a gap in the
other sequence (bottom number). The region of the matrix above the diagonal gives these
values as percentages. The numbers along the diagonal give the number o f residues in the
region o f comparison. References'. Xenopus mdr (Castillo et al., 1995); Hamster
(Endicott et al., 1991).
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Figure 20. Hydropathy plots (Kyte and Doolittle, 1982) of the mummichog mdr deduced
amino acid sequence for cDNA fragment M3 (A) and the corresponding region of the
hamster pgpl (B) sequence (Endicott et al., 1991). The plots were created using the
SOAP program o f the PCGene computer program package (Intelligenetics, Mountain
View, California) using a window of nine amino acids.
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Figure 21. Multiple alignment of deduced amino acid sequences o f selected Pglycoproteins over the region o f overlap with the mummichog mdr sequence. Multiple
alignments were created with the aid of the computer program CLUSTAL W (Thompson
and Higgins, 1994). Positions with identical amino acids to mummichog spgp are shown
as a dot (.). Gaps inserted into the sequences to optimize the alignment are shown as a
dash (-). The positions o f the conserved Walker B motif of ABC transporters, the linker
region, the putative transmembrane segments (TM7-TM12) and the C219 epitope are
indicated. References: Xenopus mdr (Castillo et al., 1995); human MDR1 (Chen et al.,
1986); human MDR2 (van der Bliek et al., 1988); hamster pgpl, pgp2 and pgp3 (Endicott
et al., 1991); mummichog spgp (Chapter IV, this dissertation).
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Figure 22. Phenogram o f the relationships among P-glycoprotien deduced amino acid
sequences. Relationships derived from Neighbor-Joining analysis of the pairwise
distances between sequences. Branch lengths are scaled to reflect distances along each
branch.The computer program package PHYLIP was used to calculate the distance matrix
and construct the phenogram (Felsenstein, 1993).
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